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Abstract 
 The human skin is a complex ecosystem which supports a diverse population of bacteria. Comparative genomic analyses are increasingly being used to explore the functional potential of this bacterial population . The ubiquity of Staphylococcus  on human skin means this genus represents the most well-studied of the microbial skin residents, however most analysis has focussed on the significant clinical pathogenic species S. epidermidis and S. aureus.  To investigate the biology of S. hominis, the second most frequent 
Staphylococcus species isolated from human skin after S. epidermidis, seven isolates were sequenced using Illumina and PacBio technologies.  An intraspecies comparative genomic analysis was performed with these and several publically available S. hominis genomes to identify core and accessory genes. The complement of encoded cell wall-anchored proteins was studied using bioinformatics to describe the range of surface-attached proteins and revealed a unique species set. Investigation also revealed the presence of S. hominis genes described as virulence factors in S. aureus and S. 
epidermidis. This further highlights non-pathogenic staphylococci as a reservoir of genes, which can be exchanged with pathogenic S. aureus, and the potential for recruitment of these genes into virulence pathways. Interspecies comparative analysis of twenty Staphylococcus species, based on clusters of orthologous genes, confirmed the designation of staphylococcal species groups previously established by DNA-DNA hybridisation and single gene analysis methods. The bioinformatic algorithm randomForest was used to identify drivers forming species groups based on the orthologous gene cluster analysis leading to a subset of orthologous clusters defined as being contributory.  This interspecies analysis also revealed diversity between the staphylococcal species groups with respect to their response mechanisms for antimicrobial peptide (AMP) resistance. Specifically, the presence or absence of the BraRS two-component system (TCS) was identified to be one of the important drivers differentiating a nine species member group that included  
S. aureus, S. hominis and S. epidermidis.. Experimental evolution in the presence of the lantibiotic nisin was used to dissect differences in the global response of the BraRS-positive species S. hominis and S. aureus, from the BraRS-negative species S. 
saprophyticus, . Identified SNPs from the resistance evolution revealed complex relationships between the regulons of staphylococcal TCSs and identified that YurK should be investigated for a potential role in AMP resistance of S. aureus and S. hominis. 
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Chapter 1 
General introduction 
  
  2 
1.1 The human skin microbiome The human skin is a rich and complex ecosystem supporting multiple communities of microorganisms, living in diverse physical and topographic niches. For example, despite the spatial proximity of areas such as the back and the base of the neck, the conditions of the two niches, and therefore the abundances of particular bacterial species which inhabit them, are distinct. The back is dominated by Propionibacteriaceae whereas staphylococcal species are most abundant at the base of the neck (Grice & Segre 2011). The human microbiome consists of a diverse mixture of bacteria which range from obligate aerobes to facultative anaerobes. Characterisation of the full diversity of the human microbiome has been greatly enhanced by the application of molecular-based approaches, since culture based methods reveal only those species which are cultivable in a laboratory environment (Fierer et al. 2008).   Better characterisation of the diversity of skin residents by molecular means has revealed multiple aspects of variation in skin microbial populations. The most obvious driver for variation is the previously mentioned differences in niche environment. Sebaceous niches, such as the forehead, represent the most phylotype poor niches, whereas dry environments support the greatest diversity of phylotypes (Costello et al. 2009).  The population of bacteria present in certain niches varies over time, with occluded sites such as the inner ear and nostril showing the most stability in terms of population and structure. Exposed sites with a greater diversity of inhabitants, such as the forearm and finger web spaces, were found to be the most volatile over time (Grice et al. 2009).  Finally, the microbiome populations between individuals varies greatly. This can depend on multiple host genetic factors and others such as disease and age. The skin microbiome of infants, for example, consists predominantly of staphylococcal species and diversifies throughout the early years of life (Capone 
et al. 2011). Different disease states can favour colonisation by particular bacterial populations. Atopic dermatitis favours colonisation by staphylococcal 
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species, in particular the non-resident species S. aureus. Following phases of intervention in the disease, however, populations of Corynebacterium, 
Propionibacterium and Streptococcus were increased (Kong et al. 2012). As well as variation between individuals of different age groups and disease states, there are also certain differences in the microbiomes of healthy adults. This variation is predominantly observed in exposed niches such as the hands, which share only 13% of phylotypes across individuals. In contrast, sebaceous niches such as the back and forehead exhibit the least variation (Grice & Segre 2011). At the species level, it is the low-abundance community members which represent the greatest variation between individuals. Strain variation is also present between healthy adults for some species such as P. acnes, whereas for strains of other species like S. epidermidis variation occurs predominantly on a site-specific basis, rather than between individuals (Oh et al. 2014).  The functional potential of the human microbiome is beginning to be understood through metagenomic sequencing efforts that elucidate the genetic complement of microbial communities. This has been achieved successfully for the gut microbiome and controversially one study revealed the potential for an obesity-associated microbiome to harvest increased amounts of energy from food (Turnbaugh et al. 2006). However a recent study by Walters et al found only a low correlation between the gut microbiota and clinical presentation of obesity (Walters et al. 2014). One of the issues that has hindered similar studies on the skin metagenome is the lack of reference genomes for the individual residents. Oh et al however exploited reference-free methodologies to investigate the functional potential of the skin microbiome which underlined variation both between individuals and between body sites (Oh et al. 2014).  Colonisation of the skin by resident skin flora inhibits invasion by pathogenic bacteria through competition for nutrients and the production of antimicrobial peptides (AMPs) and is therefore stated to fulfil a barrier function (Cogen et al, 2008; Segre et al, 2006). The importance of the human microbiome to both health and disease is increasingly being recognised. Despite this, there is an interesting dichotomy between efforts to protect and enhance the microbiota of 
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the gut through nutrition and probiotics, and efforts to reduce and remove the microbiota of the skin through hand and foot sanitising products and other personal hygiene cosmetics (Schloss 2014).  
 
1.2 The skin staphylococci The Staphylococcus genus comprises species of bacteria found in diverse niches from fermented meat products to healthy mammalian skin. As human skin residents the staphylococci are associated with a wide spectrum skin disorders such as impetigo, and the more serious staphylococcal scalded skin syndrome (Cho et al, 2010). Furthermore, members of the genus also have implications in an agricultural setting through their association with animal skin and are a frequent cause of bovine mastitis and infections in chickens. Species of staphylococci are used in the food industry as starter cultures for the fermentation of meat products (Dordet-Frisoni et al, 2007).   Due to their ubiquity on human skin, the staphylococci represent the most well-studied microbial skin residents. S. epidermidis is the most abundantly isolated species from human skin, particularly from the axilla and nares (Otto 2009). As previously mentioned skin resident microbes inhibit pathogenic bacteria, preventing them from colonising the skin and causing disease. S. epidermidis prevents S. aureus colonisation and subsequent biofilm formation in the nares. Furthermore, studies have shown that AMP production from keratinocytes is upregulated by S. epidermidis (Lai et al. 2010).  Human skin isolates most commonly segregate into the clonal complex CC2. This is also true of the prolific ST2 isolate which is the most common isolate with a high potential for invasiveness, due to the presence of IS256 and the ica genes that facilitate biofilm formation in this sequence type (M. Li et al. 2009).   In addition to the well-characterised S. epidermidis several other species are abundant on human skin. Kloos et al. found S. hominis to be the most frequently isolated after S. epidermidis, closely followed by S. haemolyticus. Other species of coagulase negative staphylococci are also isolated less frequently from the skin including; S. capitis, S. cohnii, S. saprophyticus, S. simulans, S. warneri and S. 
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xylosus (Kloos 1980). Less is known about the role of these species in the microbiome. Although S. aureus is isolated from human skin it is not considered to be a healthy skin resident but a transient skin coloniser most likely present due to carriage in the anterior nares. This long held view of S. aureus as a non-resident of skin was recently challenged by the identification of particular clones of USA300 that were found to be residents on the skin of non-carriers (Schechter-Perkins et al. 2011). This is contradictory to previous evidence that showed decolonisation of the nares eradicates skin colonisation by S. aureus. For example Reagan et al found that nasal decolonisation with mupirocin resulted in decolonisation of the hand 72 hr after treatment in patients colonised by S. aureus (Reagan et al. 1991). It is to be noted that the study by Schechter-Perkins et al was an isolated incidence of sampling, and so no longitudinal data is available for extranasally-colonised patients (Schechter-Perkins et al. 2011). Further study is needed to determine the basis for this skin residence. Certain disease states such as atopic dermatitis increase the prevalence of S. aureus on the skin and increase the prevalence of anterior nares colonisation of people in the surrounding social community (Chiu et al. 2010).  
1.3 The structure of the human epidermis To better understand the skin as a bacterial niche it is necessary to first describe its structure and function, and the role the skin plays as the largest organ of the human body. The human epidermis primarily acts as a barrier preventing the entry of microbes into the sterile areas such as deep tissues, and prevents the egress of the large amounts of water required for the function of these tissues and organs.   A single hair follicle, sebaceous gland and the accompanying interfollicular epidermis comprises a pilo-sebaceous unit. The epidermis as a whole is made up of multiple repeated units which allow the skin to fulfil thermoregulatory and protective functions. Each unit also harbours a pool of stem cells integral to its protective function and to skin homeostasis (Segre 2006).  
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The epidermis itself is comprised of multiple layers (Figure 1.1). The cells in these layers increase in their differentiation as they move from the stratum basale as basal keratinocytes, through the stratum spinosum where the basal keratinocytes become spinous keratinocytes, to the stratum granulosum as granular cells. Finally in the stratum corneum the terminally differentiated cell become corneocytes (Blanpain & Fuchs 2009). Corneocytes are lost from the stratum corneum following the breakdown of the structures anchoring the cells to one another: corneodesmosomes. This process of proteolysis leads to desquamation. Following this loss of cells from the surface, the cells migrating up through the layers of the epidermis replace the lost corneocytes. This replacement requires multiple changes in cell morphology; firstly the rounded basal keratinocytes become polygonal and flat with a permeable plasma membrane; enucleation occurs; finally a cornified envelope develops and matures around the cell (R. H. Rice & Green 1977). Lipids such as ceramide are present at this stage of differentiation and are covalently attached to the cornified envelope via interactions with proteins (Candi et al. 2005).  Together with the cells of the epidermis, the extracellular matrix (ECM) is also vital to the skin as a niche. The ECM fulfils roles in wound healing, for example, and the molecules present at different skin sites such as the forehead and axilla, help to create the different niches which can be exploited by different species of bacteria.  The composition of the terminal layer of the skin, the stratum corneum, is a stacked bilayer of skin lipids with cholesterol, free fatty acids and ceramides in a ratio of 1:1:1 (Iwai et al. 2012).   
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Figure 1.1 The structure of the human epidermis. The human epidermis has a stratified epithelial structure. As cells move up through the layers, as indicated by the arrow, they move toward terminal differentiation. The corneocytes of the terminal skin layer are surrounded by an extracellular matix of lipids. 
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1.4 The skin as a bacterial niche As a barrier between the outside world and our body systems, the skin represents a harsh environment for bacteria. The very structure of the skin with its stratified composition and turnover of terminally differentiated corneocytes obstructs the initial attachment of bacteria to the skin surface. In addition to this fundamental barrier, the skin produces an arsenal of proteins, lipids and other antimicrobial molecules to prevent bacteria from gaining a foothold and subsequently thriving on its surface. Due to the presence of metabolites, however, the skin represents a source of nutrients for the growth and reproduction of bacterial species able to survive. This section will discuss the obstacles to skin survival for the resident skin microbiome and the mechanisms by which colonising bacteria overcome them (Figure 1.2).  
1.4.1 Adhesins Adhesins mediate attachment of bacterial cells to the host cells  anchoring them in their niche. Staphylococci have a varied repertoire of adhesins which fall into the categories of microbial surface components recognising adhesive matrix molecules (MSCRAMMs), secretable expanded repertoire adhesive molecules (SERAMs) and non-proteinaceous adhesins. The different adhesins exhibit specificity for discrete host molecules and therefore facilitate colonisation of the variant niches of the body. This is discussed in further detail in chapter 3 (section 3.1.4).  In addition to niche specificity, adhesins and host receptor molecules may also differ between the initial attachment stages and long-term colonisation. In the nares, for example, S. aureus initial attachment to the epithelia is facilitated by wall teichoic acids (Weidenmaier et al. 2004) which have been shown to interact with fibronectin in vitro (Hussain et al. 2001). ClfB, on the other hand is implicated in long term nasal colonisation since S. aureus strains lacking the adhesin were cleared from a mouse nasal colonisation model more quickly than the wild type (Schaffer et al. 2006) (Weidenmaier et al. 2008).  
  9 
  
Figure 1.2 The skin survival mechanisms of S. aureus. The conditions on the skin such as dessication, the acid mantle and mechanical shear forces from desquamation, and the antimicrobial lipids and peptides produced, represent obstacles to survival on the skin. S. aureus, in turn, has evolved multiple defence mechanisms to combat these obstacles.  
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1.4.2 The acid mantle and acid tolerance The acidic pH at the surface of the skin constitutes part of the innate immune system preventing colonisation of the skin. The epidermis becomes more acidic from the stratum granulosum which has a pH of 7.4, to the stratum corneum, which has a pH between 4 and 5. This acidic pH at the surface of the skin is due to lactate and fatty acids and is essential to the synthesis of ceramides which in turn are integral to barrier homeostasis (Feingold 2007). The acidic pH is also inhibitory to serine proteases able to compromise the barrier function by breaking down corneodesmosomes (Hachem et al. 2005). As a result of these regulatory functions, alteration of the skin’s acidic gradient is implicated in skin disorders such as atopic dermatitis where the process of desquamation is disrupted and increased pH leads to elevated serine protease activity compromising the integrity of the epidermis (Cork et al. 2009). The acidity of the skin surface also enhances the antimicrobial properties of antimicrobial fatty acids (AFAs) (Cartron et al. 2014) and antimicrobial peptides (AMPs) (Walkenhorst et al. 2013), which will be discussed in later sections (1.4.3, 1.4.5). Finally, the acid pH has direct antimicrobial properties through its ability to denature DNA, disrupt bacterial membranes and damage proteins (Cotter & Hill 2003).   In acidic conditions, proton pumps serve to export protons from the intracellular environment by generating a proton motive force and thereby increasing the pH inside the bacterial cell. In S. aureus NADH dehydrogenase is upregulated in response to acid stress and is able to generate a proton motive force through converting NADH to NAD+ (Bore et al. 2007). As well as working to increase their intracellular pH, skin staphylococci are also able to affect the pH of their local environment through systems such as the arginine deiminase pathway (Cotter & Hill 2003). Bore et al however did not find the genes of the arginine deiminase pathway to be upregulated in response to acid stress (Bore 
et al. 2007). The urease genes were however strongly upregulated and their function is known to result in the production of NH3, which buffers the intracellular pH (Bore et al. 2007). Changes in gene regulation are also observed in response to acid tolerance. Expression of global regulators such as RsbU, 
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PhoB and the Fur-like regulator SACOL1541 is altered (Bore et al. 2007). Equivalent regulators are part of the acid stress response of Salmonella enterica, and gene mutations result in acid sensitivity (J. W. Foster 2004).  In addition to these direct mechanisms of acid tolerance, a range of indirect responses to acid stress also occur in S. aureus. The presence of low pH increases toxicity of metal ions so during acid stress metal ion export is upregulated. Conversely exporters of alkaline compounds such as spermidine and putrescine are downregulated. It is speculated that keeping these compounds inside the cell may act to raise intracellular pH (Bore et al. 2007). Systems important to DNA repair and protein degradation are also upregulated; DNA-damage-inducible protein P (dinP), DNA polymerase A (polA) and the exonucleases rexA and rexB are all upregulated (Bore et al. 2007). RexAB is necessary to repair double stranded breaks (Quiberoni et al. 2001). Finally, mechanisms associated with growth and repair are downregulated, which agrees with altered expression of ribosomes under stress conditions (Bollenbach et al. 2009). The duplication of the gene encoding cardiolipin is implicated in acid tolerance as one cardiolipin gene locus is not expressed under conditions of acid stress, whereas the other locus is (Ohniwa et al. 2013).   
1.4.3 Antimicrobial fatty acids In addition to contributing to the acid mantle of the human epidermis, antimicrobial fatty acids (AFAs) have other bactericidal effects. These AFAs interact with the staphylococcal membrane due to their lipophilic properties. Within the lipid bilayer the structure of the AFAs reduces the so-called packing density of the lipids in the bilayer thus reducing its stability, or in other words increasing membrane fluidity. In turn this results in the loss of proteins from the cell and disruption to metabolic processes such as the electron transport chain (Galbraith & Miller 1973) (Greenway & Dyke 1979) (Desbois & V. J. Smith 2009).  To combat the increased membrane fluidity caused by integration of AFAs into the lipid bilayer S. aureus synthesises the carotenoid pigment staphyloxanthin 
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from the crt operon (N. N. Mishra et al. 2011).  The carotenoid operon is discussed in detail in chapter 3 (section 3.1.4.5). FAME, or fatty-acid modifying enzyme, activity inhibits the antimicrobial effects of AFAs by esterification with primary alcohols and cholesterol. FAME is present in a large proportion, but not all, strains of S. epidermidis found on the skin. This indicates that it is advantageous but not essential to skin survival. In addition to its presence in S. 
epidermidis FAME is also encoded and functional in S. aureus, S. cohnii, S. 
schleiferi, S. saprophyticus, S. warneri, S. caprae, S. simulans, S. hominis and S. 
capitis. FAME is absent from S. lugdunensis and S. haemolyticus (Long et al. 1992). Reduction of hydrophobicity is proposed as an important survival mechanism, for example via the MSCRAMM IsdA, which reduces the capacity of AFAs to interact with the cell surface (Clarke & S. J. Foster 2006).  Upregulation of capsule and peptidoglycan genes may similarly result in reduced hydrophobicity (Kenny et al. 2009). Additional MSCRAMMs involved in defence against AFAs include SasF of S. aureus and the S. saprophyticus homologue SssF. SasF is upregulated in S. aureus in response to AFAs (Kenny et al. 2009), and clinical strains of S. saprophyticus expressing SssF have an increased resistance to AFAs compared to those which do not (King et al. 2012).  
1.4.4 Osmotic stress and osmotic stress tolerance The human epidermis has low relative humidity (water activity) and high salinity; these features lead to osmotic stress for the bacterial inhabitants. Both environmental stresses are counteracted by the skin resident S. epidermidis which has a requirement for relative humidity between 81-84% for growth. The transient species S. aureus requires a higher relative humidity of ~87% which is lower than environmental species such as Pseudomonas fluorescens which require a still higher level of 92-94.5% (de Goffau et al. 2009).   The staphylococci are characteristically capable of growth in high salinity.  Mechanisms to overcome osmotic stress include morphological changes which occur if the relative humidity falls below the level tolerated. Both S. aureus and 
S. epidermidis increase their cell size and cell wall thickness, clustering in cuboidal groups of 8 cells in contrast to their usual “bunch of grapes” formation. 
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These changes probably serve to reduce the surface area to volume ratio to limit water loss and maintain the turgor pressure of the cell. As these morphological changes are also observed in autolysin mutants, these cell wall hydrolytic enzymes might be involved in bringing them about (de Goffau et al. 2011). Ebh is a further cell wall-located protein implicated in osmotic stress tolerance. Mutants of this giant protein result in invaginations along the septum of cells under conditions of high salinity (Kuroda et al. 2008). PIA, or polysaccharide intercellular adhesin, enables producer strains to form a biofilm. PIA producer strains of S. epidermidis have been found to have a high tolerance to low humidity conditions (de Goffau et al. 2009). PIA may act similarly to the exopolysaccharide (EPS) of Pseudomonas aeruginosa which slows the rate of both water loss during osmotic stress, and the rate of subsequent rehydration, to allow time for adaptation of the bacterial cell to the changing conditions (Roberson et al. 1992). Synthesis of cardiolipin in staphylococci has several roles during osmotic stress; it reduces membrane fluidity (Tsai et al. 2011) and reduces the rate of water loss from the cell by regulating solute efflux channels such as the mechanosensitive channel MscL (Romantsov et al. 2009).  
1.4.5 Antimicrobial peptides of the epidermis and staphylococcal defence 
mechanisms In addition to the acid mantle, the host’s innate immune system also consists of antimicrobial peptides (AMPs) which function to prevent colonisation by bacteria. The epithelia produce two major classes of cationic AMPs: defensins and cathelicidins. A calcium gradient exists across the layers of the skin and increases towards the upper layers. The increased calcium concentration in turn leads to increased expression of cathelicidin processing enzymes; the serine proteases called kallikreins in the upper layers of the skin. Cathelicidins and defensins are both most abundant in the upper layers of the skin (Morizane et 
al. 2010). Human β-defensins (HBDs) 1 and 2, as well as cathelicidins, are secreted in the high salinity, low pH environment of the sweat gland. Cathelicin LL-37 is physiologically active at low concentrations here, however the activity of HBDs is uncertain (Murakami et al. 2002) (Rieg et al. 2005). HBDs and cathelicidins bind to the negatively charged surface of the staphylococcal cell 
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membrane through electrostatic interaction. Subsequent accumulated AMPs result in the formation of channels in the cell membrane which eventually effect increased permeability (Ganz 2003).  The staphylococci have evolved multiple signal transduction system to sense AMPs and regulate a downstream response to counteract their bactericidal activity. In S. epidermidis the two component system ApsS and the homologous system in S. aureus, GraRS, sense the presence of cationic AMPs (cAMP). This interaction results in signal transduction from the sensor protein to a regulator to control changes in expression of their cognate regulon of genes involved in resistance to antimicrobial peptides. The GraRS regulon of genes includes the 
dlt operon and mprF. Other TCS involved in resistance to AMPs and other antimicrobials of the skin include the GraRS homologue BraRS; these TCSs are discussed in detail in chapter 4 (section 4.1.4)  Susceptibility to cAMP is counteracted by the dlt operon, the gene products of which add D-alanine to wall teichoic acids. This reduces the negative charge of the staphylococcal cell surface which in turn reduces the electrostatic interaction between the cAMP and the cell (Peschel et al. 1999).  MprF also causes a reduced surface negative charge through the addition of L-alanine and L-lysine to phospholipids of the bilayer as well as translocation of lysyl-phosphatidylglycerol to the outer cell membrane (Ernst & Peschel 2011).  Secreted proteases also play a role in increased persistence in the presence of AMPs. The S. aureus protease aureolysin, for example, degrades LL-37, as well as complement C3, therefore attenuating the immune response and allowing S. 
aureus to evade phagocytosis. LL-37 removal increases S. aureus persistence on the skin surface (Laarman et al. 2011).    Dermcidin is an anionic AMP and, due to its like charge with the staphylococcal membrane, its mode of action is differs from that of the cAMPs. The anionic AMP functions instead by inhibiting protein and RNA synthesis (Rieg et al. 2005) (Senyurek et al. 2009). 
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 Proteases are produced by staphylococci as a defence mechanism against multiple AMPs. Production of SepA, a metalloprotease, is upregulated in the presence of dermcidin and is under the control of sarA, agr and saeRS (Lai et al. 2006). In addition to their role in resistance to cationic and anionic AMPs, secreted proteases also function to promote skin colonisation and destabilise the skin’s barrier function. ET and V8 proteases break down desmoglein-1 in the stratum granulosum and therefore weaken cell-to-cell interactions (Hirasawa et al. 2009).    Lysozyme, an N-acetylmuramoylhydrolase, is produced by the epithelia in addition to many other tissues and secretions. Lysozyme interacts with cell wall peptidoglycans of Gram-positive bacteria and leads to cell lysis (Bera et al. 2004). Lysozyme resistance is mediated by OatA which O-acetylates cell wall peptidoglycans and inhibits interaction by lysozyme. Furthermore, crosslinked wall teichoic acids provide further steric hindrance to lysozyme interaction (Bera et al. 2006).   
1.4.6 The antimicrobial RNase A superfamily RNase 5 and 7 are both expressed by keratinocytes and have multiple roles, including ribonuclease activity. RNase 5 for example is involved in angiogenesis as a secondary function; it is also antimicrobial, and was shown to be active against Candida albicans and Streptococcus pneumoniae in similar physiological conditions to other AMPs (Hooper et al. 2003). Although the results of the study by Hooper et al could not be reproduced (Avdeeva et al. 2006), Abtin et al did confirm the antimicrobial activity of RNase 5 (Abtin et al. 2009).  The cationic RNase 7 exhibits broad spectrum antimicrobial activity and its expression in epithelial tissues is associated with S. aureus inhibition; anti-RNase 7 antibody-treated skin explants exhibited reduced killing of S. aureus (Simanski et al. 2010). Although the mechanism of antimicrobial action of RNase 7 remains unclear, Huang et al suggest that the cationic property of RNase 7 
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influences its ability to interact with S. aureus and bring about permeabilisation of the cell membrane (Y.-C. Huang et al. 2007). 
 
1.4.7 Competition on the skin As previously discussed, the staphylococci which inhabit the skin live as part of complex communities of microbes in the different niches of the body. The individuals in these communities must compete with one another for resources, such as nutrients and space.   There is evidence that there is competitive exclusion within skin niches; S. 
aureus and S. epidermidis, for example, are rarely isolated together from nasal epithelia. Exclusion mechanisms between S. epidermidis and S. aureus include stimulation of the host innate immune system. As a successful skin coloniser, S. 
epidermidis is resistant to the host antimicrobial peptides HBD-2 and HBD-3, whereas S. aureus is not. S. epidermidis produces the serine protease Esp which stimulates the production of these AMPs by keratinocytes and these AMPs in turn inhibit the colonisation of the epithelia by S. aureus (Iwase et al. 2010). 
 In addition to inhibiting S. aureus colonisation by secreting proteases, production of the phenol-soluble modulins (PSM)-γ and –δ by S. epidermidis also inhibits other species found on the skin. These two PSMs work in synergy with one another and the host immune system. PSM-γ –δ both work in concert with LL-37, and PSM-γ also works co-operatively with HBD-2 and HBD-3 (Cogen et 
al. 2010). Although S. aureus also produces PSMs these molecules have a reduced antimicrobial activity in comparison with S. epidermidis PSMs. Instead they are involved in biofilm production and haemolysis (Periasamy et al. 2012).  Several staphylococci are not often co-isolated with certain corynebacteria or 
Propionibacterium acnes (Frank et al. 2010) (Libberton et al. 2014). No antimicrobial production by Corynebacterium species was observed to explain the exclusion of staphylococci, however corynebacteria are proposed to bind more strongly to the nasal epithelia than the species of Staphylococcus which could explain their exclusion (Uehara et al. 2000). S. epidermidis is able to 
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convert glycerol to succinic acid which inhibits P. acnes. This may explain why P. 
acnes and S. epidermidis are not often co-isolated; succinic acid also ameliorated lesions in a P. acnes mouse model (Y. Wang et al. 2014).  The production of AMPs by skin commensals is also known to be a means of out-competing the competition. Many species of staphylococci, for example produce lantibiotics active against the members of their niche community. Staphylococcal lantibiotics will be discussed in detail in chapter 5 (section 5.1).   
1.4.8 Staphylococcal disease 
1.4.8.1 Atopic dermatitis Atopic dermatitis is an inflammatory disease of the skin. Its symptoms include flaky lesions of the skin, infection and subsequent abscess formation. The disease has a high prevalence in a reported 97 countries across the world indicating that it is a significant problem in both developing and developed countries. Atopic dermatitis is associated with an increased production of the IgE antibody in response to food or environmental antigens usually otherwise well-tolerated. This is known as atopy, and can result in allergic disorders where sufferers may develop allergies and asthma, in addition to the atopic dermatitis, early in life (Zheng et al. 2011).   On atopic skin, dysregulation of the innate immune system results in reduced production of antimicrobial peptides, reduced recruitment of neutrophils to the skin and epidermal barrier dysfunction. These factors affect the skin microbiome. Patients with AD have high levels of S. aureus colonisation: up to 80% of the skin microflora may be comprised of S. aureus, with an associated reduction in overall microbiome diversity, in contrast with healthy skin where 
S. epidermidis comprises 90% of the resident microbiota (Baviera et al. 2014). In turn, the severity of atopic dermatitis is linked to S. aureus abundance and the concomitant loss of microbiome diversity (Kong et al. 2012).  
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A study by Nakamura et al. found that the S. aureus isolates present on atopic skin produce high levels of δ-toxin. These isolates promoted the production of the inflammatory cytokines IL-4 and IgE. These two inflammatory cytokines are known to play a role in the release of antimicrobial compounds from mast cells through degranulation. This increased mast cell degranulation by δ-toxin in S. 
aureus was shown through knock out and subsequent complementation of δ-toxin. Furthermore it was suggested that inhibition of δ-toxin in S. aureus may be a worthwhile treatment in atopic dermatitis as results from mouse models indicate that the presence of δ-toxin induces a Th2 immune response(Nakamura et al. 2013). The Th2 immune response is associated with allergic inflammatory responces which would induce inflammation of the skin (Paul & Zhu 2010).   In addition to the high prevalence of S. aureus on atopic skin, production of AMPs, such as hBD-2, was also proposed to be supressed in AD. Several studies by the same group of researchers suggested that a Th2 cytokine response may supress the production of AMPs in AD. This was shown by antibody-mediated neutralisation of Th2 cytokines which led to increased expression of hBD-3 (Howell et al. 2006). The AMPs hBD-2 and hBD-3 were also inhibited by the Th2 cytokines IL-4 and IL-13 (Nomura et al. 2003). It is possible, however, that inhibition of hBD-2 by corticosteroids routinely used in the treatment of AD results in this apparent lower level of hBD-2 on atopic skin. This outcome is supported by a study that showed lower levels of hBD-2 in AD lesions on skin treated with steroids compared with skin where the intervention was not used (Jensen et al. 2011). A separate study also found that an increased time interval since the last steroid treatment resulted in increased levels of hBD-2 in lesional and non-lesional AD skin (Clausen et al. 2013).   The levels of hBD-2 are higher in lesional AD skin than in control groups of healthy skin (Clausen et al. 2013).   Expression of hBD-2 was also found to be elevated in AD by Harder et al, in addition to the increased expression of hBD-3 and RNase7, compared with healthy skin. This study did not, however, correlate AMP expression with levels of S. aureus colonisation (Harder et al. 2010). 
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Gambichler et al also found increased expression of hBD-3 and RNase7 in AD patients and so hypothesise that the increased colonisation by S. aureus associated with the disease does not result from reduced expression of AMPs. The data regarding AMP expression in atopic skin has been extensively reviewed recently (Kopfnagel et al. 2013).  The expression of AMPs also influences the immune response in AD. For example, hBDs are known to recruit cells of the innate and adaptive immune response, such as macrophages and neutrophils, by binding to CCR2 which is expressed on their surface (Röhrl et al. 2010). Furthermore, hBD-2 acts as a chemoattractant for T-helper cells and Th17 cells since it binds to CCR6, which is expressed by these cell types (Yang et al. 1999). Increased levels of hBDs on atopic skin may also result in increased levels of these immune cells.   Skin inflammation may be enhanced by hBD-2 as this AMP can stimulate the production of IFN-gamma by T-cells, thus favouring a Th1 cytokine response, which is associated with inflammation. Under some experimental conditions hBD-2 also enhances IL-22 and oncostatin M production and these cytokines in turn induce the production of hBD-2. Thus a positive feed-back loop may occur on atopic skin resulting in the increased production of hBD-2 that is observed.  LL-37 also upregulates the cytokines IL-22 and oncostatin M (Kanda et al. 2011).   
1.4.8.2 Abscess formation One of the most common presentations of staphylococcal disease is abscess formation and an associated bacterial persistence. These abscess lesions are developed over a period of weeks and the disease forming bacteria are located at the centre of a lesion, separated by a pseudomembrane from the immune cells which infiltrate the abscess. The process of staphylococcal abscess formation after subcutaneous invasion is separated into four stages, each one categorised by a set of surface proteins and virulence factors (Cheng et al. 2011).  
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The first stage of subcutaneous abscess formation is the survival of S. aureus in the bloodstream. Upon inoculation into the bloodstream of a mouse model of infection ~ 99.9% of the staphylococcal inoculum disappears from the blood within around 6 h. Within 3 h, however, the bacteria will have reached the deep tissues where abscess formation will be established; replication of these seed populations is measurable within 24 hr (Cheng et al. 2009). Neutrophilic leukocytes are the hosts main defence against S. aureus circulating in the blood stream (Voyich et al. 2005). S. aureus in turn produces the antioxidant staphyloxanthin which acts to eliminate the toxic reactive oxygen species produced by the neutrophils (Pelz et al. 2005). S. aureus is able to survive within these neutrophils, and these infected immune cells are able to seed infections in naïve mice (Gresham et al. 2000). Production of phenol soluble modulins, secreted peptides which disrupt neutrophil membrane integrity, also increases the persistence of S. aureus in the blood stream (R. Wang et al. 2007). ClfA binds to fibrinogen and fibrin which, in the context of a staphylococcal blood stream infection, allows agglutination of S. aureus cells (McDevitt et al. 1994). This agglutination may act to prolong survival by inhibiting phagocytosis (Palmqvist 
et al. 2004). ClfA may also contribute to prolonged survival by allowing attachment of S. aureus to the epithelia of the blood vessel through interaction with fibrin (Moreillon et al. 1995) (Cheng et al. 2011). Finally, adenosine synthase A supresses the host inflammatory response by producing adenosine from AMP; adenosine is used by the host to signal the end of an inflammatory response (Thiel et al. 2003).  Establishing an infectious lesion is the next stage of staphylococcal abscess formation. Lesions are formed when immune cells such as neutrophils accumulate in a location at high enough frequency to replace normal epithelial tissue at this location. This is discernable ~48 hr post intravenous challenge (Cheng et al. 2009). The recruitment of large numbers of immune cells to lesions and small numbers of staphylococcal cells during the early stages of abscess formation are contradictory. It is possible that S. aureus may release lipoproteins which are recognised by Toll-like receptors, this would cause subsequent pro-inflammatory signals and lead to recruitment of immune cells 
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(Bubeck Wardenburg et al. 2006). The balance between fulfilling the metabolic need for haem, and reducing the haem-toxicity of the lesional environment requires the expression of the isd genes, which are involved in haem uptake, as well as the production of the HrtAB ABC transporter which exports excess haem from the cell (Mazmanian et al. 2003) (Torres et al. 2007).    The abscess formation progresses after several days to stage three which is characterised by a community of S. aureus replicating within a pseudocapsule of fibrin deposits (Cheng et al. 2009). These fibrin deposits are produced from the cleavage of fibrinogen by coagulase-prothrombin complexes (Cheng et al. 2011). This fibrin barrier prevents the immune cells from reaching the replicating S. 
aureus cells at the centre of the abscess (Viana et al. 2010). At this stage of abscess formation staphylococcal protein A (SpA) is also integral and prevents phagocytosis (Forsgren & Sjöquist 1966). Embp is also important during abscess maturation; the protein is expressed on the surface of the cells growing within the fibrin pseudomembrane suggesting it may promote biofilm-like growth (Cheng et al. 2009).  For persistence of the abscess expression of extracellular adhesion proteins (eap) and Ess, via a non-canonical protein secretion pathway, are both important. The Mycobacterium tuberculosis homologue of Ess is involved in aspects of immune evasion such as inhibiting phagocytosis (Davis & Ramakrishnan 2009). S. aureus mutants at this locus are able to establish an abscess but the abscess does not persist (Burts et al. 2008). Eap has both pro-inflammatory activity through induction of cytokines IL-6 and IFN-α from monocytes, as well as anti-inflammatory activity, by inhibiting T-cell activation and adherence of neutrophils to endothelial cells (Scriba et al. 2008) (Haggar et 
al. 2004).  
1.5 Thesis aims At the outset of this study there was an incomplete set of available genomes representing the major staphylococcal species that colonise humans.  The sequencing of those species’ genomes that were not available, or that were yet 
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to be sequenced, would be undertaken to enable the comparative study of the major human-associated staphylococcal species. The genomic study of the staphylococci has focussed mostly on the two clinically important species, S. 
aureus and S. epidermidis. This emphasis has limited the comparative study of the main species that colonise humans.  To enlarge our knowledge of S. hominis, the second most frequent species of the genus colonising humans, a set of skin isolates would be sequenced and compared with the aforementioned species.  A range of bioinformatics tools would then be used to identify components that were differentially present in staphylococcal species, including S. hominis, to gain new insights of colonisation and survival on human skin   
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Chapter 2 
The sequencing, assembly and annotation of 
staphylococcal genomes 
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2.1 Introduction Over the course of the last 40 years whole genome sequencing has exploded, starting from the sequencing of the first bacteriophage genomes in the late 1970s (Koonin & Galperin 2013). The shotgun sequencing of the first bacterial genome, Haemophilus influenzae in 1995, took 13 months to sequence and assemble into 140 contigs at a cost of around $900 000 (Fleischmann et al. 1995). Afterwards the draft human genome sequence was published in 2001 taking a large team around 10 years work (Lander et al. 2001). Today we find ourselves at the point where bench-top sequencing machines, such as the Illumina MiSeq can output a bacterial genome in a matter of days at a cost of around $100. The near future may hold further improvements as nanopore technology matures. Nanopore technology directly sequences long, native DNA fragments without amplification over a short time-frame. This sequencing uses a device the size of an average smart phone and the technique has the potential to yield whole bacterial chromosomes assembled in a single contig (Loman et al. 2015).   Here, the significant sequencing and assembly methods spanning the lifetime of whole genome sequencing are briefly reviewed.  
2.1.2 Sequencing technologies 
2.1.2.1 Sanger sequencing The conception of whole genome sequencing was born from the Sanger sequencing method. This method was developed by Freidrich Sanger in 1977, and has since been automated using capillary electrophoresis and optical reading methods rather than manual sequencing (Sanger et al. 1977) (VARALDO & Kilpper-Bälz 1988). Today, the method is based on a single-stranded DNA template in a sequencing reaction which contains four dideoxynucleotides labelled with different fluorescent tags. Deoxynucleotides are present in excess to allow coverage of the whole DNA template which is amplified in a polymerase chain reaction (PCR) whereby the incorporation of a dideoxynucleotide in the place of a deoxynucleotide terminates the extension 
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step. The resulting fragments after the rounds of extension are then separated by capillary electrophoresis, and the fluorescent tag from each fragment is detected thus allowing the sequence to be read (L. M. Smith et al. 1986) (Prober 
et al. 1987). Although Sanger sequencing is still considered to be the gold standard for DNA sequencing, other sequencing chemistries and platforms have been developed with the aim of making DNA sequencing faster and cheaper without sacrificing accuracy.   
2.1.2.2 454 Pyrosequencing 454 Life Science released the first commercially available genome sequencer to the market in 2005 and were soon after acquired by Roche Diagnostics in 2007.  Sequencing involves fragmentation of the DNA template and ligation of an adapter sequence to each end of these short fragments to act as both PCR and sequencing primers. The fragments are then attached to streptavidin-coated beads via a biotin tag at the 5’ end of one of the adaptors. Only one fragment is intended to anneal to one bead, and these bead bound DNA fragments constitute the DNA sequencing library (Margulies et al. 2005). This method of library preparation was considerably quicker and easier than existing library preparation.  Whole genome sequencing using the Sanger sequencing method instead involved shotgun sequencing of fragments of DNA cloned into BAC or PAC large-fragment cloning vectors (Lander et al. 2001).   Following library preparation the bead bound fragments are used in emulsion PCR, which sees the amplification of bead bound fragments within micro-reactors of the PCR mixture in an emulsion oil. The amplified fragments are immobilised on the beads. Beads without bound DNA are then filtered. The subsequent sequencing reaction proceeded on a so-called sequencing by synthesis basis. In this reaction, single beads are loaded into the wells of a Pico TiterPlate and the previously amplified fragments are exposed to DNA bases sequentially washed over the plates. These sequential washes occur 100 times during sequencing and the incorporation of a complimentary nucleotide results 
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in the emission of a recorded light signal. Signal strength relates to the number of complimentary bases incorporated (Margulies et al. 2005).   One of the advantages to 454 sequencing lies in the long read length produced; the 454 GS FLX+ system could output 1,000,000 reads of around 1000 bp in a run. The platform has a relatively fast throughput time compared to whole genome sequencing using Sanger methodology. However the major drawbacks of the system include the high cost of reagents and the high error rate surrounding runs of the same base longer than 6bp (L. Liu et al. 2012) (El-Metwally 2014).  
2.1.2.3 ABI SOLiD Sequencing by Oligonucleotide Ligation and Detection (SOLiD) became commercially available in 2007 following acquisition in 2006 by Applied Biosystems (now a division of Life Technologies). This sequencing platform is based on sequencing by ligation.   DNA libraries are prepared by annealing SOLiD-specific adapters to the template DNA fragments and adapters complimentary to those found on magnetic beads. Template DNA fragments therefore anneal to the magnetic beads via these complimentary adapter sequences and clonal amplification of the fragments proceeds via the SOLiD-specific adapters. The initial amplification steps are based on the same principle of emulsion PCR found in the 454 sequencing chemistry. The beads are then introduced to a glass slide, treated to allow them to covalently attach to its surface. The SOLiD chemistry differs from other platforms chemistries, since it progresses through incorporation of octamer probe sets, rather than the addition of individual nucleotide bases. These octamer probes are grouped into 4 sets, each set has a different fluorescent dye and represents 4 of 16 possible di-nucleotide sequences. The complementary probe hybridises to the DNA template after the sequencing primer and the dye is cleaved when the fluorescence has been read, exposing a free phosphate group. The next octamer probe is then hybridised and ligated via this free phosphate group. After 7 cycles of probe addition the read length is 
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35bp. More cycles can be added to yield a longer read. After the required number of cycles, the synthesised strand is cleaved and new sequencing primer is annealed in the 2nd base position of the first sequencing primer. Incorporation of the probes proceeds again for the requisite number of cycles. This is repeated several times to ensure multiple coverage of each base (Mardis 2008) www.appliedbiosystems.com.  The benefit of the SOLiD sequencing platform is that it can be scaled to allow 256 indexed samples per run, as well as the presence of 6 isolated lanes per glass slide, allowing multiple chemistries per run, which permits flexibility and reduces machine down time. The drawback of the SOLiD sequencing chemistry has remained the final read length. The SOLiD 5500 xlw released in 2010 had a read length of only 85 bp (Barba et al. 2014).  
2.1.2.4 Illumina Sequencing The first Genome Analyzer sequencer entered the market in 2006 launched by Solexa which was capable of sequencing 1 Gb of data per run. This technology was built by bringing together clustering, or colony DNA sequencing technology from Manteia Predictive medicine, acquired by Solexa in 2004, and technology and skills from Lynx Therapeutics acquired in 2005. This combination enabled the Solexa prototype to be developed into a commercially viable sequencing machine. Solexa was in turn acquired by Illumina in 2007 which optimised the technology to produce the HiSeq platform series which includes the HiSeq 2500 with a read length of 200 bp and the potential to sequence a whole human genome within 24 h (Barba et al. 2014).   The chemistry associated with the Illumina sequencers relies on sequencing by synthesis and clonal amplification of DNA fragments, resulting in cluster generation. Fragment libraries are prepared by mechanical or enzymatic fragmentation of template DNA. The final DNA fragment library is single-stranded and fragments have adapter sequences ligated to their 3’ and 5’ ends. The first of these adapters is complimentary to oligonucleotides present on the surface of the sequencing flow cell, and therefore anneals to this oligo. In this 
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way the DNA fragment library is bound to the flow cell. The oligonucleotide then acts as a sequencing primer and a complement to the single-stranded DNA template fragment is produced. Denaturation then occurs and the original DNA fragment template is removed. Clonal expansion then occurs via bridge amplification during which the second adapter sequence of the DNA fragment template anneals to the complimentary oligonucleotide on the flow cell. The complimentary DNA strand is synthesised and a so-called double stranded bridge structure is produced. When this structure is denatured it reveals the forward and reverse strand of the same DNA fragment. This cycle is then repeated until there are many copies of the DNA fragment and occurs concomitantly with the clonal amplification of the rest of the fragments in the library (Turcatti et al. 2008) (Shendure & Ji 2008).   Sequencing initially requires only the forward strand to produce read 1 therefore after clonal expansion the reverse strands are removed and the 3 prime end of the forward strands are blocked. Extension of the first sequencing primer occurs through competition of the fluorescently labelled nucleotides. Upon incorporation of a nucleotide a fluorescent light excites the expanded clusters of DNA fragments. This causes the emission of a signal characteristic of the nucleotide incorporated therefore the sequence of the DNA fragment is deduced, and the number of cycles of nucleotide additions controls the length of the read. Each read in a cluster and in turn each cluster on a flow cell are read concurrently.  The reverse strand is then generated for each fragment in each cluster and the process is repeated to generate read 2 (Turcatti et al. 2008) (Shendure & Ji 2008).  Due to the high throughput and relatively low cost of the Illumina sequencing platform and its chemistry, as well as the versatility of the technology which allows its utilisation in many different applications, Illumina has become the market leader in the DNA sequencing arena. Long read technologies such as nanopore and PacBio, previously plagued by high error rates, are however being developed and refined, and are able to produce small genomes in a single 
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contig (Loman et al. 2015). The improvements to long read sequencing are increasing the popularity and usefulness of these technologies.  
2.1.2.4 PacBio The benefits of long read sequencing are in the ease of genome assembly. Larger reads allow longer overlapping regions and thus can be matched into contiguous sequences more easily than short reads with shorter overlapping regions. The difficulties in obtaining these long reads have centred on maintaining read accuracy and the comparatively lower cost per base offered by short read sequencing technologies.  Although the per base cost of these short read sequencing efforts is now relatively low, the cost of producing finished genomes from the resulting data, that is genomes with all gaps closed and >99.99% accuracy per base, remains high. As a result it is now de rigour to submit genomes in an unfinished format reducing the average quality of publically available genomes. Long read sequencing is proposed as a way to combat the compromise between quality and cost (Koren & Phillippy 2015).  In 2011 the PacBio RS was released as the first commercially available long read sequencer that produced read lengths in the order of kilobases, as opposed to the few hundred bases previously available. Accuracy, however, was reduced at around 82% as opposed to the 99% offered by Illumina platforms (Koren & Phillippy 2015). These read lengths and overall accuracy meant that PacBio could not be used as a stand-alone method of sequencing and had to be used in conjunction with higher accuracy technologies such as Illumina HiSeq. The combination of the reads types did, however reduce the monetary and time cost of assembling finished bacterial genomes (Ribeiro et al. 2012).  With improvements to the sequencing chemistry, and the release of the second generation PacBio RS II sequencing machine, reads up to 50 kbp are now possible with an accuracy of around 87% per base. The per-read error can be further corrected through statistical methods due to the random, non-biased nature of the sequencing errors. This in turn results in a consensus sequence 
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with >99.99% accuracy, the accuracy required for a finished quality genome (Chin et al. 2013).   The associated sequencing chemistry is known as SMRT sequencing, or Single Molecule, Real-Time DNA sequencing. The reaction is conducted on a SMRT cell which contains ~150,000 Zero-Mode Waveguides where a DNA polymerase associated with a DNA template is immobilised. Phospholinked nucleotides are then added, and their incorporation into the growing complementary DNA strand being synthesised is captured in real time. By linking the fluorescent dye to the nucleotide’s phosphate group the dye is cleaved by the natural process of translation, so translation does not need to be halted in order to cleave the dye. Other sequencing chemistries such as Illumina use a base linked dye moiety which requires dye cleavage before translation can progress. The SMRT cells allow this process to occur in parallel for DNA fragments covering an entire genome (Eid et al. 2009).  In addition to the sequence data generated by PacBio, the methylation status of the DNA template can be inferred through the polymerase kinetics (Flusberg et al. 2010).  
2.1.2.6 Oxford Nanopore New technology being developed by Oxford Nanopore is called strand sequencing. In this method a protein nanopore is inserted into a synthetic polymer membrane with high electronic resistance. When an electronic potential is passed across the membrane it causes a current to flow through the hole in the nanopore. A sequence can be identified as a molecule of DNA is passed through the nanopore; combinations of nucleotide bases cause distinctive disruptions to the current flowing through the nanopore, which can be used to define the sequence of bases. A hairpin structure at the end of the double stranded DNA template enables both the forward and reverse sequence to be read (www.nanoporetech.com)   The sequencer hardware, the grid ION node, has the smallest footprint of any sequencer available thus far. Furthermore, there is a miniaturised version of the instrument, the MinIon, which is the size of a smart phone. The current 
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drawback of this platform is that it is in the early stages of release, and the chemistry and technology are in their infancy. In the future, however, this technology could have many benefits such as fast, automated library preparation and truly portable and low cost hardware (Eisenstein 2015).   
2.1.3 Genome assembly 
2.1.3.1 Short read data The initial method of genome assembly involved taking a read and aligning it to the other sequence reads until a fitting overlap between the ends of the sequence occurred. This was the method employed by early assembly software, such as Celera. Although these assemblers are effective in assembling long, uncomplicated reads, they fail in the face of confounding factors such as repeat sequences which prevent detection of the correct path through the overlapping reads. This results in misassembled contigs which required manual finishing and correction (Myers et al. 2000) (Myers et al. 2000) (Pevzner et al. 2001).   A computational solution to the problem of repeats in a genome is the use and adaptation of a de Bruijn graph. The premise of de Bruijn assembly is to assemble reads into the fewest possible contiguous sequences of reads, or contigs, by overlapping these sequences. This method was made feasible by Pevzner et al with the addition of an error correction step prior to assembly, resulting in a high proportion of error free reads (Pevzner et al. 2001). Velvet is one such assembler which exploits de Bruijn graphs for whole genome assembly. The overlaps are controlled by defining the K-mer size, K-mer refers to the length of the overlapping words which make up a read sequence and adjacent K-mers within a read overlap by K-1. Common K-1 sequences within the genome are known as nodes and these nodes, therefore, represent a set of overlapping K-mers. The complementary DNA sequence is represented by a twin node, and together these make a block. Changes to one node in a block are synonymously applied to the other. These nodes are connected by edges if the nodes overlap by K-2 (Zerbino & Birney 2008). VelvetOptimiser is available as a wrapper script for Velvet and functions to automatically select optimal K-mer 
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size, as well as other variable, user defined parameters with which to perform the subsequent Velvet assembly (www.bioinformatics.net.au/software.shtml).   The SOAPdenovo assembler also uses a de Bruijn based approach. The pipeline first corrects the reads to reduce the overall number of reads and therefore the memory usage of the assembly. Contig assembly then proceeds and nodes of less than 50 bp or of low coverage are removed. Similar bubbles and parallel paths are merged to further simplify the graph. The contigs are then scaffolded by mapping short reads back to them and gap closure is attempted by extracting reads which extend into the gap and performing local assembly of the region (R. Li et al. 2010).   A later assembler based upon the de Bruijn methodology is SPAdes, however it is described as being a universal A-Bruijn assembler. K-mers are established in order to draw an initial de Bruijn graph, and subsequently “forgotten” in later stages of the assembly. Downstream operations are performed based on the spatial arrangement of the graph, read coverage and sequence length. Another difference in SPAdes is the ability to identify the distance between paired reads and thus utilise the pairing in assembly (Bankevich et al. 2012) (Nurk et al. 2013).  The quest for gap closure and resolution of repeats also generated software such as SSPACE, a standalone scaffolder for pre-assembled genomes. SSPACE (SSAKE-based Scaffolding of Pre-Assembled Contigs after Extension) allows the user to select their assembly tool and perform subsequent contig extension and/or scaffolding steps with the independent tool. The performance of SSPACE was found to be superior to that of the similar tool Abyss. The tool allows read correction, mapping of reads to contigs using Bowtie, duplicate reads are filtered, and contig extension can be carried out as an optional step using unmapped reads. After read filtering and contig extension, contigs are paired using paired reads which map to the ends of different contigs at a specified distance set by the user. Following this pairing the contigs are scaffolded if end alignments of a set K length support the link. The program allows the use of 
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both small and large insert libraries and scaffolding occurs in a hierarchical manner with small insert libraries first (Boetzer et al. 2011).  CLC de novo assembler creates de Bruijn graphs from K-mer word tables which allows matching, neighbouring words of length K-1 to be identified forwards and backwards. Bubbles are resolved by storing information about K-mer frequency. Since increased K-mer length can help to resolve repeat regions, CLC de novo assembler automatically selects the optimal K-mer based on the data input. Contig lengths are increased by mapping reads back to the assembled sequences and a scaffolding step is also performed. The major advantage of this assembler over the others discussed is that it eliminates the need to select K-
mer size by trial and error, however the other software discussed is available on an opensource basis, whereas CLC de novo assembler is available to purchase (www.clcbio.com/files/whitepapers/whitepaper-denovo-assembly-4.pdf). 
 As the PacBio platform and long read data becomes more widely used, assembly software is being updated to support long read data as well as short read data; SPAdes and SSPACE both have the capacity to support long read data in their most recent releases. This data can be used to scaffold pre-existing contigs to “upgrade” draft genomes to produce a more complete assembly with reduced contig number (Boetzer & Pirovano 2014) (Nurk et al. 2013).  
 
2.1.3.2 Integrating long and short read data Due to the error prone nature of long read data when PacBio was first released, the data was initially applied to enhance and finish assemblies from short read data. Several assembly platforms were developed to integrate the two types of data. The benefits of integrating the two types of data offer a solution to the problem which has hindered computational assembly of short read data: repeat regions. The goal of short read assembly pipelines has remained the pursuit of genomes assembled in the fewest number of contigs, which have the longest possible sequence. This is described by the N50 statistic which states that half of the length of the sum of all contigs is contained within contigs of this length or longer. 
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 PBJelly was launched in 2012 to improve the quality of draft genome sequences. Although the platform was designed to facilitate using PacBio data, any long reads could be supported. PBJelly improved gaps between contigs by extending neighbouring contigs into the gaps between them, a closed gap refers to two neighbouring contigs joined by sequence constructed from the long read data. The assembly of the draft genome is taken to be accurate and any gap fills can be accepted or rejected through the verbose logging of any changes made. Another useful feature of this improving assembler is that annotations from the draft genome are stored in co-ordinate tables so they can be easily superimposed upon the improved genome, further minimizing the workload required for improving and closing existing draft genomes (English et al. 2012).  One of the first assemblers to generate a finished quality microbial genome through single molecule sequencing was ALLPATHS-LG. At the time the software was published the PacBio read length was around 2-3 kb. The pipeline combined Illumina mate pair and paired end libraries to produce a de Bruijn assembly of the genome and gaps and repeats were subsequently covered and resolved by the long read PacBio data (Ribeiro et al. 2012). The downside to this method is that it required three different sequencing libraries to produce a finished genome, which leads to prohibitive costs.  
2.1.3.3 Long read data High quality assemblies from long read data require an adequate number of redundant long reads from the spectrum of read sizes produced to span and therefore resolve all repeat regions in a genome. With the current PacBio sequencing chemistry the coverage required to achieve the above criteria, and therefore a finished quality assembly is ~50x. Although early releases of the PacBio chemistry, C1 and C2 versions, did not allow for sufficiently long or accurate reads to allow for read self-correction and assembly of data without inclusion of short read data, subsequent releases allowed stand alone assembly of PacBio data.   
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PBcR is a correction and assembly pipeline which deals specifically with the high degree of noise per read associated with long read data. The pipeline improves accuracy per single-molecule sequence and then assembles these error-corrected consensus sequences using the Celera Assembler. The program exploits genome coverage using the short reads produced by PacBio sequencing to produce a consensus sequence. These sequences are then assembled through overlapping regions, and the long reads generated are used to resolve repeat regions. Quiver is then used to polish by mapping the raw reads to the assembly to correct indels and substitutions. PBcR represents an improvement on the ALLPATHS-LG program because complete genomes could be assembled from only one library. The HGAP assembly software distributed by PacBio with its genome sequencers is a variation of the pipeline, although without the added capability of PBcR to support the use of short read data in data correction as well as data generated from the Oxford Nanopore sequencing platform (Koren 
et al. 2013).  Most recently MHAP, for MinHash Alignment Process, has been developed which allows rapid assembly of large genomes, up to 600-fold faster than PBcR and HGAP. The MHAP uses a probabilistic method to create assemblies based on overlap between reads. MHAP is integrated into the PBcR pipeline (Berlin et al. 2015).    
2.1.4 Chapter Aims In this chapter the key aim was to generate sequences of several staphylococcal species for which no genome was available to use for comparative analysis.  A second aim was to sequence a collection of S. hominis isolates to enable a subsequent investigation of genomic features of this species.  Within these aims a selection of the sequencing technologies and assembly softwares described above were tested and compared to examine the quality of the assemblies of staphylococcal genomes. Furthermore, in an effort to improve the quality of the 
S. hominis genome, PacBio sequencing was used to resolve gaps for the strain J31.   
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2.2 Methods 
2.2.1 Bacterial strains and culturing A collection of skin isolates was established through sampling of the inner elbow (provided by Dr Jennifer Kelly (Kelly 2013))and the anterior nares (provided by Dr Benjamin Liberton (Libberton et al. 2014)). All isolates of S. 
hominis and S. haemolyticus sequenced as part of this study were drawn from these strain collections. S. simulans ATCC27848, S. cohnii ATCC29974 and S. 
xylosus ATCC29971 type strains were provided by Ross Fitzgerald (Laboratory for Bacterial Evolution and Pathogenesis, University of Edinburgh).  Overnight cultures of all strains were grown for 18 h at 37 °C in 10 ml Oxoid Brain Heart Infusion broth (3.7 % w/v BHI) (Thermo Scientific) with shaking at 200 rpm. Glycerol stocks of all strains were maintained by adding 700 μl of overnight culture to 300 μl 50% (v/v) glycerol. Stocks were stored at -80 °C.  
2.2.2 Extraction of genomic DNA Cells were harvested from a 1.5 ml sample of a 10 ml overnight culture using centrifugation at 13000 rpm for 5 min; harvested cells were then resuspended in lysis buffer containing 12.5 μg ml-1 lysostaphin (Sigma-Aldrich) and 2 μl of 5 kU mL-1 mutanolysin (Sigma-Aldrich).  A DNeasy Blood and Tissue Kit (Qiagen) was used to purify the DNA according to manufacturer’s instructions for Gram-positive bacteria. Protocol alterations were made: Both lysis and proteinase K incubation steps were extended to 1 h; an on column RNA digest was added as specified by the DNeasy Blood and Tissue Kit manufacturers instructions using 16 μL solution of RNase A (Invitrogen) at 20 mg mL1; an extra wash step was performed with wash buffer 1.   
2.2.3 DNA Quality Checking The purity of DNA was measured using a Nanodrop spectrophotometer (Thermo scientific); samples with 260/280 and 260/230 ratios above 1.8 were assumed to have minimal protein and RNA contamination and were used for sequencing. 
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 DNA molecular weight was assessed after separation using agarose gel electrophoresis with ~2mm thick 0.8% agarose gels run at a current of 80 V for 1 h to ensure a tight band of DNA. Smearing of the DNA indicated the sample was fragmented by the extraction protocol and was not selected for sequencing. In all cases where agarose gel electrophoresis was applied TAE buffer, UV transillumination and GeneSnap gel imaging software (Syngene) were used. 2 μl of Midori green (Nippon Genetics) DNA stain was used in 100 mL of agarose.   DNA quantification of purified samples was carried out using Qubit (Invitrogen) according to manufacturers instructions.  
2.2.4 Bacterial species confirmation Prior to every whole genome sequencing isolate speciation was confirmed using 16S rDNA sequencing (GATC-Biotech). The 16S region was amplified using the primers pA and pH. PCR and thermocycling conditions were used as follows: initial denaturation for 5 min at 95 °C was followed by 30 cycles of denaturation at 95 °C for 60 s, annealing at temperatures specific to individual primers for 60 s and extension at 72 °C for 1 min per 1 kb of product. Lastly a final extension at 72 °C for 7 min.  Agarose gel electrophoresis was used to separate DNA bands to ensure lack of contamination in the reaction and specificity. Each PCR product was then purified before using ExoSAP-IT to dephosphorylate dNTPs and primers and degrade the latter. Specifically, 4 μl of ExoSAP-IT (Affymetrix) was added to every 15 μl of PCR product. The mixture was vortexed for 10 s and incubated at 37 °C for 30 min, followed by a 15 min inactivation of the enzymes at 80 °C. Sanger sequencing of the 16S rDNA PCR products was then carried out by GATC-Biotech. The DNA sequences were analysed using both BLASTn and the RDP seqmatch program (http://rdp.cme.msu.edu/). The closest matching sequences were determined taking into account blast score, blast E-value, blast maximum identity and RDP e-value.  
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2.2.5 Library preparation for whole genome sequencing 
2.2.5.1 Illumina TRUSEQ Illumina TRUSEQ small insert libraries (paired end) were prepared with 300-500 bp insert sizes and were prepared by myself according to manufactuer’s instructions (Illumina). Next, Illumina TRUSEQ large insert libraries (mate pair) were prepared with an insert size of 8 kb by the Centre for Genomic Research, University of Liverpool.  All TRUSEQ libraries were sequenced on the HiSeq 2500 platform.   
2.2.5.2 Illumina Nextera Illumina NEXTERA libraries were prepared by myself according to manufacturer’s instructions (Illumina). Library QC was carried out using the 2100 Bioanalyser (Agilent Technologies) and High Sensitivity DNA chips (Agilent Technologies).  Nextera libraries were sequenced on both the HiSeq 2500 and the MiSeq personal sequencer platforms as specified by the Centre for Genomic Research, University of Liverpool.  
2.2.5.3 PacBio Sequencing libraries  PacBio sequencing libraries were prepared and sequenced on the PacBio RS II platform by the Centre for Genomic Research, University of Liverpool.  
Table 2.1 Comparison of the quality of genome assemblies using the assemblers Velvet, 
CLC workbench and SPAdes. Scaffolding with SSPACE was performed on the contigs produced from all assemblies. Species Assembler Scaffold number N50 (bp) % mapping of MP reads (reads which mapped 1X) 
S. cohnii VelvetOptimiser 84 578,102 69.81 
 CLC workbench 85 902,047 69.95 
 SPAdes 764 487,394 68.56 
S. simulans VelvetOptimiser 47 1,589,405 69.92 
 CLC workbench 41 2,420,180 70.65 
 SPAdes 240 833,978 70.65 
S. xylosus VelvetOptimiser 53 775,104 78.13 
 CLC workbench 30 2,063,813 78.98  SPAdes 1000 939,092 76.21 
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2.2.6 Genome assembly Sequence reads were adapter trimmed and quality filtered by the CGR (University of Liverpool).  Genome assemblers were compared for de novo assemblies of staphylococcal species from Illumina TruSEQ data generated in the initial round of sequencing. See Table 2.1 for strain information. VelvetOptimiser (Velvet version 1.2.06) was used with the K-mer hash of values between 19 and 99. Velvet parameters are automatically optimised and assigned by VelvetOptimiser. Forward and reverse reads in fasta format were used as input for this assembler.  SPAdes (version 2.2.1) was run with the K-mer sizes 21,33 and 55. Forward and reverse reads in fastq format were used as input. CLC genomics workbench (version 5.0) genome assembler was used and K-mer length is automatically optimised. Forward and reverse reads in fastq format were used as input for this assembler.   Scaffolding was carried out using SSPACE-BASIC (version 2.0) for initial de novo sequencing with contig extension parameters of –m = 50 and –o = 15. A contig file in fasta format and a library file in tab delimited text format are required as input for this scaffolder. The library file specifies the library types and signposts the scaffolder to the libraries to use for scaffolding and extending the contigs. Information about insert size is also included.  Scaffolding of resequenced S. hominis genomes was carried out using the perl script actcompare.pl (developed by Roy Chaudhuri for the CGR, University of Liverpool). Actcompare uses NUCmer to align query genomes to a reference and outputs a GenBank file of concatenated contigs which can be launched in the Artemis Comparison Tool (ACT). Contig files in fasta format were used as the input for this scaffolder.   
2.2.7 Genome annotation Annotation of all genomes was carried out using PROKKA version 1.5.2. PROKKA is a command line tool, implemented in Perl, which is capable of 
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annotating a bacterial genome on a desktop computer in ~10 min. Genome features are predicted using the external programs Prodigal, RNAmmer, Aragorn, SignalP and Infernal (Seemann 2014).  A genome in concatenated fasta format was used as input for this program.  
2.2.8 S. hominis genome assembly improvement The S. hominis strain J31 was sequenced using the PacBio platform as described above. The genome was assembled by the CGR (University of Liverpool) using the PacBio distributed assembler HGAP.   Circularity of the contigs was assessed by aligning several kb from the beginning of the contig back to the contig itself using command line blast. Significant hits to the beginning and the end of the contig indicated that the contig was circular. This was used to assess if the genome of S. hominis J31 was present in a single contig. Smaller contigs present in the S. hominis J31 PacBio assembly were also assessed for circularity in the same way and designated as putative plasmid contigs if circularity was observed.  This single contig alignment was then used to improve the contig arrangement of all other S. hominis genomes, both those sequenced as part of this project and those downloaded from public databases. This improvement was achieved by rearranging the contigs of the S. hominis genomes with actcompare using the J31 PacBio assembly as a reference genome.     
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2.3 Results and Discussion 
2.3.1 Assembly of staphylococcal genomes and comparison of assemblers 
The primary aim of this thesis was the comparative genomic analysis of the major staphylococcal species. At the beginning of the project there were no complete reference genome sequences or draft genome sequences for S. cohnii, 
S. simulans or S. xylosus. Sequence data was available for S. hominis and S. 
haemolyticus. A previous comparative genomic analysis of the Staphylococcus genus included only 12 of the 51 staphylococcal species (Suzuki et al. 2012). This study aimed to encompass a larger amount of strains and include more species known to be found on human skin (Kloos 1980), therefore S. simulans, 
S.cohnii and S. xylosus  type strains were sequenced. Type strains were selected for these de novo sequencing efforts since they are readily available to the scientific community. Furthermore, as no reference genomes were available for these species, both mate pair and paired end sequencing libraries were used to scaffold contigs assembled from paired end reads in order to better resolve the macro structure of the genome. As reference assemblies were available for both 
S. hominis and S. haemolyticus, only paired end reads were used to assemble contigs and these contigs were rearranged in relation to these reference sequences. 
During the course of this research study, in 2013, the whole genome sequence of S. simulans was published (Calcutt et al. 2013) and in 2014 the genome sequences of S. cohnii (Hu et al. 2014) and S. xylosus (Labrie et al. 2014) were also published.   As described, there is a plethora of assembly platforms available to assemble and scaffold short read data. Each of them has its advantages and disadvantages, however there is no gold standard for genome assembly. Furthermore, different species have different genome features such as relatively high prevalence of repetitive sequences, or an unusual GC content, which affect the fidelity of sequencing and the ease of assembly.   
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To assess which available assembler produced the optimal assemblies of the staphylococcal genomes sequenced here for use in comparative genomic analysis, three platforms were tested and compared: SPAdes, CLC and Velvet. Both the N50 and scaffold number are accepted bench marks of genome assembly quality and so these are the parameters considered here. It must be cautioned, however, that these measures of assembly success focus on contig length and not necessarily accuracy. A high N50 and low contig or scaffold number is assumed to represent an assembly in which contigs traverse and therefore resolve repeat regions. An alternative possibility is that such an assembly contains large, misassembled contigs (Narzisi & B. Mishra 2011). In this study, mapping of mate pair (MP), or large insert reads, back to the assembly was used as an assessment of the resolution of the macrostructure of the genome. A high degree of contig misassembly would result in low percentage mapping of the MP reads.   The differences in assembly quality bench marks between the three assemblers were compared as part of this thesis. The three assemblers were compared for the three de novo sequencing efforts; the S. cohnii, S. simulans and S. xylosus genomes (Table 2.1). In the absence of a reference genome to scaffold against, contig extension and scaffolding was performed using SSPACE.   In all cases SPAdes with contig extension and scaffolding performed with SSPACE performed the most poorly where contig number is concerned producing 764, 240 and 1000 contigs respectively for S. cohnii, S. simulans and S. 
xylosus, respectively. With S. cohnii and S. simulans, SPAdes also produced the lowest N50 of 487,394 bp and 833,978 bp, respectively. For S. xylosus however, the N50 produced by SPAdes was 939,092 bp. This is higher than the N50 produced by Velvet which was 775,104 bp (Table 2.2).  With all three genomes CLC workbench produced the best assembly in terms of N50 and scaffold number. The N50 was 902,047 bp, 2,420,180 bp and 2, 063,813 bp for S. cohnii, S. simulans and S. xylosus, respectively. The number of scaffolds was 41 and 30 for S. simulans and S. xylosus, while S. cohnii was 
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assembled into 85 scaffolds. The extent of mapping MP reads was >70% for both S. simulans and S. xylosus, but below this value for S. cohnii (Table 2.2). 
 With all three assemblers S. cohnii underperformed in comparison to S. simulans and S. xylosus for all three bench marks (Table 2.2). This differential could indicate a higher proportion of repetitive sequence in the S. cohnii genome which is difficult to resolve and can result in more fragmented assemblies.  From these comparative genome assembly results CLC workbench was considered to be the best platform of the three tested for the assembly of staphylococcal genomes from Illumina sequence data.  This assembler was therefore used to assemble all genomes in this study used for inter- and intraspecies genome comparisons.   
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Table 2.2 Sequencing and assembly statistics for genomes sequencing as part of genome comparison efforts Species Isolate Assembler Scaffolding/ rearrangement method Sequencing platform Library preparation No. of contigs/scaffolds N50 (bp) Coverage (X) 
S. hominis I4 CLC workbench actcompare Illumina HiSeq 2500 TRUSEQ (PE) 83 167,692 277 
S. hominis J6 CLC workbench actcompare Illumina HiSeq 2500 NEXTERA 45 298,133 833 
S. hominis J11 CLC workbench actcompare Illumina HiSeq 2500 NEXTERA 51 298,149 1036 
S. hominis J23 CLC workbench actcompare Illumina HiSeq 2500 NEXTERA 50 193,853 760 
S. hominis J27 CLC workbench actcompare Illumina HiSeq 2500 NEXTERA 40 230,743 499 
S. hominis J31 CLC workbench actcompare Illumina HiSeq 2500 NEXTERA 633 313,790 1101 
S. hominis J31 HGAP   PacBio 5 2,188,325   205                         
S. hominis B10 CLC workbench actcompare Illumina HiSeq 2500 NEXTERA 37 1,174,157 1117 
S. haemolyticus K8 CLC workbench actcompare Illumina HiSeq 2500 TRUSEQ (PE) 125 54,979 195 
S. cohnii ATCC29974 CLC workbench SSPACE Illumina HiSeq 2500 TRUSEQ (PE + MP) 85 902,047 115 
S. simulans ATCC27848 CLC workbench SSPACE Illumina HiSeq 2500 TRUSEQ (PE + MP) 41 2,420,180 115 
S. xylosus ATCC29971 CLC workbench SSPACE Illumina HiSeq 2500 TRUSEQ (PE + MP) 30 2,063,813 133 
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2.3.2 Annotation of sequenced staphylococcal genomes The genomes of all staphylococcal species sequenced were annotated using PROKKA: a command line tool, implemented in Perl, which is capable of annotating a bacterial genome on a desktop computer in ~10 minutes.  The number of protein coding sequences (CDS) ranged from 2187 in S. hominis J23 to 2642 in S. simulans (Table 2.3).  
 The tRNA gene family is the largest known gene family and its repertoire in a species is important as it affects the major codon bias observed in bacterial genomes (Schattner et al. 2005). This major codon bias is implicated in the global optimisation of cell growth efficiency, translation efficiency and control of cellular processes (Quax et al. 2015). The tRNA repertoire ranged from 50 genes in S. hominis J6 and S. xylosus to 59 genes in S. simulans. The tRNA repertoire is expanded in the PacBio assembly of S. hominis J31 and contains 70 genes.  The rRNA gene operon poorly assembles in many whole genome sequences, however there are often multiple copies of this operon in bacterial genomes. At high growth rates multiple copies of the rRNA operon and the resulting ribosomes are thought to offer an advantage by enabling the bacterial cell to respond quickly to favourable environmental conditions by increasing translation. Seven copies of the rRNA operon are observed in E. coli and S. 
Table 2.3 Genome features of sequenced and assembled staphylococcal genomes. Staphylococcal genomes sequenced as part of the genomic comparison were assembled and annotated by Prokka. Species Isolate Protein CDS tRNA rRNA GC % Source 
S. hominis I4 2202 54 4 31.3 Skin 
S. hominis J6 2193 50 3 31.2 Skin 
S. hominis J11 2192 52 3 31.2 Skin 
S. hominis J23 2187 55 4 31.2 Skin 
S. hominis J27 2188 54 5 31.3 Skin 
S. hominis B10 2253 55 3 31.3 Skin 
S. cohnii ATCC 49330 2611 58 8 32.3 Skin 
S. haemolyticus K8 2382 54 3 32.7 Skin 
S. simulans ATCC 27851 2642 59 7 35.9 Skin 
S. xylosus ATCC 29971 2541 50 5 32.7 Skin 
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enterica serovar typhimurium, and 10 copies are found in the B. subtillis genome (Klappenbach et al. 2000).  In the Illumina sequenced staphylococci the number of rRNA genes annotated ranges from three copies in S. hominis strain J6 to eight copies in S. cohnii. The number of copies of rRNA genes was compared between the Illumina assembly of J31 and the PacBio assembly. In the Illumina assembly one 16S rRNA, one 23S rRNA and two 5S rRNA genes were annotated. In contrast the PacBio assembly contained eight 16S, eight 5S and seven 23S rRNA genes annotated (Table 2.3). Furthermore, these annotated rRNA genes are distributed throughout the genome indicating that they have been correctly assembled. Clustering of these genes at the end of the genome sequence among genes associated with plasmids and phage would indicate that these genes had been poorly assembled. This indicates that assemblies from short read data lead to underestimation of rRNA gene copy number in the staphylococci  It is important to take into consideration the GC content of a genome given that the GC content bias may affect read coverage. GC rich locations of a genome can be prone to high coverage whereas low GC areas can exhibit a deficit in read coverage. This sequencing artefact can confound results if gene copy number or expression levels are being investigated (Benjamini & Speed 2012). In genomes with low GC content, such as staphylococcal genomes, this GC bias can result in fragmented assemblies due to the fact that many assemblers assume an even GC coverage across the genome (Chen et al. 2013). Table 2.3 demonstrates that all staphylococcal genomes sequenced here have a consistent GC content between 31 - 36% and that the use of PacBio sequencing, which does not exhibit the GC sequencing bias present in the Illumina sequencing chemistry, does reveal a significantly different GC content for S. hominis strain J31 when compared to Illumina sequence data (Table 2.4).    
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Table 2.4 Comparison of genome features of S. hominis J31. Assemblies from Illumina and PacBio sequence data were annotated by Prokka. Genome feature Illumina PacBio Protein CDS 2635 2233 tRNA 54 70 rRNA 5 23 GC % 31.4 31.5 Source Skin Skin 
Figure 2.1 Genome synteny between S. hominis strain J31 PacBio asembly and Illumina 
assembly. Synteny is shown by a nucleotide mummer plot where blue lines indicate inversions and red lines indicate forward alignments between the two assemblies. Translocations are indicated by deviations from the hypothetical line f(x)=x  
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2.3.3 Improvements to the S. hominis genome using long read sequence 
data PacBio sequencing was used to produce an improved assembly of S. hominis strain J31. Pacbio sequencing of this strain resulted in one large contig, plus a further 4 smaller contigs (Table 2.5). The PacBio assembly was compared to the Illumina assembly by aligning the two using a nucleotide mummer plot (Figure 2.1). Regions of similarity between the two genomes, that is forward alignments with the same topography, are shown in red on the hypothetical line f(x)=x. Reverse alignments are shown in blue and translocated regions are represented by deviations from f(x)=x. The mummer plot shows that many of the Illumina contigs are assembled differently compared to the regions in the PacBio genome.   
Table 2.5 Contig lengths and read coverage per contig resulting from the PacBio assembly of 
S. hominis J31  Contig Length Coverage (X) 0 2,188,298 207 1 60,147 256 2 28,669 92.5 3 40,632 117.5 4 6417 45  Further investigation of the PacBio contigs showed that the longest contig, numbered 0, had coverage of 207X and represents the bacterial chromosome (Table 2.5). Evidence for this contig being the entire, circular bacterial chromosome is found in a 15000 bp region from the start of the contig being repeated at the end. The gene content and synteny of the region is conserved and the presence of an rRNA gene operon is observed. This indicates that some of the tRNAs in the expanded repertoire observed in the J31 assembly of PacBio data, and 4 of the rRNA genes annotated, may be as a result of a sequencing artefact, in addition to the cluster of fol genes present at the end of the chromosome contig (Figure 2.2). When this 15000 bp region is blasted against contig 0 there are an additional 4 significant hits along the contig (Figure 2.3). When the genes in the region of these blast hits were investigated the rRNA operon was found to be the only coding sequences present.  
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The 4 smaller contigs were also examined to investigate if these contigs might represent complete circular plasmid DNA. Bases from the beginning of the contig were blasted against the contig itself and the sequence was assumed to be circular if this produced significant blast hits to both the start and end. Further evidence of the circularity of these contigs can be found in the annotation of the plasmids discussed in chapter 3  (3.3.15.1) as gene annotation from the beginning of the plasmids is repeated at the end. The exception to this is contig 4 which represents the smallest contig. Although there are significant blast hits, of the first 1000 bases to the beginning and the end of the contig, there is also a significant blast hit of the same region equidistant between the two (Figure 2.4 D). One explanation for this may be misassembly of the contig. Another, however, is that this contig represents two copies of a small plasmid. This contig also exhibits lower read coverage (Table 2.5), which may be as a result of the fact that the contig is approaching read length for PacBio sequencing.
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Figure 2.2 Detailed analysis of the alignment of the first 15 000 bp of contig 0 with all contigs of the J31 PacBio assembly. A) the first 15 000 bases of contig 0 aligned with the start of contig 0. The yellow line indicates the end of the speculated overlap region. Genes in the region are annotated (left to right) folP_1, FolP_2, FolB_1, FolK_1 and LysS_1. These genes are followed by rRNA 5S gene, a cluster of rRNAs, rRNA 16S, 23S and 5S genes. B) the first 15 000 bases of contig 0 aligned with the end of contig 0. The yellow line indicates the start of the speculated overlap region, the blue line indicates the end of contig 0. Genes in the region are annotated (left to right) FolP_3, FolB_2, FolK_2 and LysS_2. These genes are followed by rRNA 5S gene, a cluster of rRNAs, rRNA 16S, 23S and 5S genes.   
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Figure 2.3 Alignment of the first 15000 bases of contig 0 with the rest of 
contig 0. Green arrows indicate the locations of distributed rRNA operons which occur as matches to a region of the first 15000 bases containing rRNA genes. The regions indicated by the green arrows are around 5500 bp in length and contain only rRNA genes.  
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Figure 2.4 Visualisation of the circularity of the contigs produced from the PacBio assembly of S. 
hominis strain J31. A) The first 15,000 bp of contig 1 aligned against contig 1 B) The first 10,000 bp of contig 2 aligned against contig 2 C) The first 15,000 bp of contig 3 aligned against contig 3 D) The first 1000 bp of contig 4 aligned against contig 4    
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2.3.4 Gene synteny of the S. hominis genomes sequenced  Since the large contig resulting from PacBio sequencing was taken to be the circular bacterial chromosome, this assembly is considered to be of better quality compared to the Illumina assembly of the J31 genome by the metrics stated earlier, namely, a large N50 and low contig number. Consequently, the contigs resulting from CLC workbench assembly of the S. hominis genomes sequenced on the Illumina platform were reordered relative to the PacBio HGAP assembly of S. hominis J31.   Alignments of the reordered assemblies were performed using Progressive Mauve and visualised using Mauve software (version snapshot 2015-01-25 (1)). Local collinear blocks (LCBs) are used to represent homologous backbone sequence. Rearrangements such as translocations and inversions can be identified by LCBs in different locations on the backbone.  The high degree of synteny among the S. hominis genomes is indicated by the conservation of the arrangements of the LCBs (Figure 2.5). This synteny, together with the differential assembly observed between the J31 Illumina and PacBio assemblies (Figure 2.1), indicates that rearrangements of contigs against a PacBio reference can result in an improved arrangement of assembled contigs.
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Figure 2.5 Progressive Mauve genome alignment of the S. hominis genomes. Contigs resulting from CLC workbench assemblies of Illumina sequence data rearranged using HGAP alignment of PacBio sequence data from strain J31 . The colour bloack indicate homologous regions without any internal rearrangements. Known as Locally Colinear Blocks.  
  55 
2.4 Conclusion  Over the course of this project improving sequencing technologies have been exploited and have demonstrated some of the principles known about the growing field of whole genome sequencing. The Illumina platform has improved to give longer read length and a greater depth of coverage. In the first round of Illumina sequencing ~200X was considered to be deep coverage. In the second round of Illumina sequencing this coverage was greatly exceeded (Table 2.2) however the assembly quality did not improve in proportion to the vastly increased read coverage.  This assembly limitation reveals the fundamental downside of short reads given the vast coverage increases, a finding highlighted by other studies (Koren et al. 2013).  Moreover, the benefits of long read sequencing are clear to see with the resolution of the S. hominis J31 genome into a single chromosome, compared to the assembly from Illumina short read data which resulted in 633 contigs (Table 2.2). Despite this great advantage of long read sequencing over short read sequencing there are also drawbacks. Due to the nature of the large fragment sizes and long read length which enable long read sequencing to produce automated assemblies of whole genomes, small extra-genomic features such as small plasmids and free phage are more difficult to resolve as described with contig 4 of the J31 PacBio genome assembly (Figure 2.4).   As large banks of species-wide whole genome sequence data from short reads have been collected, perhaps long read data can help researchers to fully exploit these resources. This project has reinforced that contig arrangements of assemblies from Illumina data can be improved by alignment to a PacBio genome.       
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Chapter 3 
Intraspecies comparative genomics of 
Staphylococcus hominis  
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3.1 Background 
3.1.1 Staphylococcal speciation Since the late 19th century staphylococcal classification has been inextricably linked with the ability to cause disease and the aetiology of this disease. 
Staphylococcus aureus was first designated S. pyogenes aureus and 
Staphylococcus epidermidis was known as S. pyogenes albus for the colour of the pus associated with infection by each organism(Kloos 1980). Despite some bacteriologists at the time questioning the innocence of commensal staphylococci emphasis continued to be placed on distinguishing the culprit of the yellow pus, believed to be a single species of staphylococci now known as S. 
aureus, from the rest. For almost a hundred years the genus of Staphylococcus was considered to contain only two species, S. aureus and S. epidermidis. This opinion was challenged by Baird-Parker who began to subdivide S. epidermidis and S. aureus into biotypes. He posited that these biotypes may indeed be defined species. Although Baird-Parker refrained from evangelising this opinion he laid the foundation work for the modern taxonomy of the staphylococci. However, even as S. warneri, S. epidermidis, S. haemolyticus and S. hominis were designated as new species, overlapping characteristics were observed among them (Kloos & Schleifer 1975).    Bacterial species designation has progressed from being purely phenotypic, through being driven by pairwise DNA-DNA hybridisation to taking a systematic approach based on 16S rDNA clustering methods (Cohan 2001). A protein sequence clustering approach has now shown a higher resolution for distinguishing between closely related species where the slow rate of evolution of 16S rDNA has failed to differentiate the two species (Palys et al. 2000).   Together with the presence of closely related genes, the question of niche selection is also relevant where species evolution is concerned. Investigating the possibilities that acquisition of new genes or changes to existing ones facilitate the jump to new niches is being aided by increasingly large collections of geographically and ecologically distinct isolates of a given species and the availability of their genome sequences. Large repositories of genome sequences 
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facilitate the identification of genes important to niche adaptation in collections of bacterial species (Gupta et al. 2015) (Y. Zhang & Sievert 2014) (Lowder et al. 2009). It is hoped that the genome sequences of S. hominis sequenced as part of this work will contribute to the understanding of genes important for survival on human skin.  
3.1.2 Pan-genome analysis and speciation While genome sequencing continues to become increasingly accessible the growing number of bacterial whole genome sequences has begun to highlight the sequence variation between isolates of the same species. In the face of this breadth of genomic information, pan-genome analyses contribute to the definition of a species and have quantified the extent to which intra-specific genetic diversity can occur. Standard microbiological techniques to identify isolates, in the clinic for example, mostly use a gene marker-based approach, most commonly 16S rDNA sequencing. Although this approach is able to discriminate to a species level, as previously stated, it is not capable of distinguishing very similar species. Furthermore it does not take into account the degree of genetic variability of the strain and its possible phenotypic implications. This is illustrated by the pan-genome investigation of Bacillus 
anthracis. This species exhibits a closed pan-genome indicating a low degree of variability and appears phylogenetically to be a clone of B. cereus, not a distinct species. The discriminatory phenotypic trait, production of the anthrax toxin, is encoded on one of the two plasmids that differentiate B. anthracis from B. cereus (Rasko et al. 2005). Despite such important phenotypic differences between each species, it could be argued that this is simply minor variability in the accessory genome of B. cereus. This is an example of the discrepancies in current methods of speciation (Medini et al. 2005). By the same token 16S rDNA based species identification uses a single gene snapshot and lacks the resolving power to classify isolates with a highly variable genome such as S. epidermidis (Conlan et al. 2012). Multilocus sequence typing offers a more global understanding of strain differences within a species. By amplification and sequencing of fragments from a set of seven housekeeping genes, an allelic profile can be assigned that is specific to each clonal group (Enright et al. 2000). 
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This scheme can be used to understand the evolutionary patterns and population structure of species of bacteria. As such it can be more informative than 16S rDNA sequencing. MLST, however is still plagued by significant drawbacks. MLST relies on the core genome of the species, which is often stable within a species, and large percentages can be shared by species within a genus; 
S. aureus and S. epidermidis for example share a large proportion of their core genomes. Phenotypes resulting from the sometimes hyper mobile accessory genome, which can be shared through horizontal gene transfer, is not taken into account (Turner & Feil 2007). Pan-genome analyses have highlighted the inadequacies of the previously accepted practice of having a single reference genome sequence to represent a species, since it fails to accommodate the full extent of genetic diversity within a species. MLST typing begins to explore the genetic diversity of a species in more depth than 16S sequencing however, as previously stated, it still only utilises a small fraction of the available genetic variability.   An MLST scheme has been developed for S. hominis by Zhang et al. This MLST scheme categorised 108 isolates collected over the course of 40 years from 10 different countries into 40 sequence types. This indicated a higher degree of genetic diversity among the S. hominis population relative to that of S. aureus and S. epidermidis (Zhang et al. 2013). There are two proposed subspecies of S. 
hominis; S. hominis subsp. hominis and S. hominis subsp. novobiosepticus. The phenotypic traits which distinguish the two subspecies are novibiocin resistance and a lack of acid production from anaerobically metabolised D-trehalose and N-acetyl-D-glucosamine (Kloos et al. 1998). It is difficult, however, to distinguish the two subspecies from one another through phenotypic and sequence based approaches. Furthermore, Zhang et al found that MLST anaylsis of the 108 isolates of S. hominis  did not reveal a distinct sequence type cluster for the presumed S. hominis subsp. novobiosepticus isolates. This indicates that this may be an artificial taxon (Zhang et al. 2013).   Although the concept of the pan-genome began as a way to refer to the full complement of genes in a single species it has now been extended to encompass 
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all genes present in a group of species of bacteria in a given niche, for example (Y. Zhang & Sievert 2014).  As such the pan-genome, representing the total possible genetic diversity, can help in the understanding of the evolution of species and the divergence within them (Donati et al. 2010). The pan-genome can be sub-divided into core genes, present in all (n) isolates of a species, and accessory genes present in ≤n-1 isolates. The core genome describes the essential biological processes of a species whereas, most often, traits such as virulence, antibiotic resistance profiles and niche adaptation can be found in the accessory genome(R. A. Mann et al. 2013). Mathematical modelling of the pan-genome using Heaps law can be used to describe a pan-genome as either open or closed. Heaps law was first developed in the linguistics arena and was used to describe the number of words used in a document as a function of the document length, the use of Heaps law in a genomic context was pioneered by Tettelin et 
al (Tettelin et al. 2008). An open pan-genome refers to a genetic repertoire that is not fully described by the sequences used in the current analysis, whereby successive genome sequences will contribute additional genes. Moreover, an open pan-genome indicates a high degree of variability within a species, which can be accounted for by a large accessory genome.    
3.1.3 Horizontal gene transfer and the accessory genome The movement of genetic material into and out of bacterial genomes, termed horizontal gene transfer (HGT), plays a major role in the composition of the accessory genome.  The process of horizontal gene transfer has the potential to have a negative outcome if genes leaving or entering the chromosome reduce the fitness of a bacterium. In this scenario the bacterium in question will fail to persist in the population and the individual, thus the genetic change will be lost. Neutral effects rely on subsequent events in the population to dictate whether these mutations will be maintained, and HGT that confers increased fitness on a bacterium increases the chance of these individuals persisting in the population and spreading the mutation (C. M. Thomas & Nielsen 2005). The range of 
SCCmec types present in the staphylococci are a prime example of the fitness implications of MGE, with some larger SCCmec types conveying reduced fitness 
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in the community environment compared to a hospital where antibiotic pressures are present (Ma et al. 2002).     There are three key mechanisms by which HGT occurs and these vary in their specificity and efficiency. Natural transformation exhibits a low specificity and accounts for the ability of certain bacteria to acquire genes from outside of their own species (Johnsborg et al. 2007). It is estimated that around 1% of described bacteria can readily incorporate naked, foreign DNA, including plasmid DNA or mobile genetic elements, and the staphylococci are among this number (Morikawa et al. 2012). The HGT process more commonly associated with plasmid DNA uptake is conjugative transfer mediated by cell-to-cell junctions, although other mobile genetic elements such as conjugative transposons are mobilised via this mechanism. Antibiotic resistance genes are frequently transferred by conjugation if the genes involved are found on sections of the chromosome capable of excising themselves and facilitating intercellular relocation (Courvalin 1994). This mechanism has a higher degree of specificity than natural transformation since plasmid transfer systems typically have a defined host range, although the host range of some plasmids will be broader than others (Grohmann et al. 2003). HGT via phage transduction similarly exhibits varying degrees of specificity in line with the host range of the infecting bacteriophage. This virus vector is capable of integrating into the bacterial chromosome, leading to transcription of phage cargo genes. Once integrated into the host genome these foreign DNA elements are termed genomic islands. If these genomic islands contribute to pathogenesis of their host they become known as pathogenicity islands (Novick 2003). The enrichment of genes of unknown function in the accessory genome is often a result of the presence of genomic islands of phage origin bearing such genes.  Generalised transduction, whereby bacterial DNA is packaged instead of phage DNA in error, contributes further to the spread of genes in the absence of phage genomes (Canchaya et al. 2003).  The possibility for horizontal gene transfer between species is reported to be a key factor defining human skin as a niche which promotes adaptive evolution 
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(Dethlefsen et al. 2007). An almost ubiquitous presence of antibiotics in host populations has helped to drive this adaptive evolution in populations of skin resident bacteria through the spread of antibiotic resistance determinants by HGT. This is an important consideration in the Staphylococcus genus as the gain of certain genes has been linked to clinically important phenotypes. There are several notable examples of clinically important HGT events in staphylococci. The acquisition of Panton-Valentine leukocidin (PVL) by the USA300 epidemic clone of community acquired S. aureus has been associated with the rapid spread of clones able to cause antibiotic resistant skin and soft tissue infection (Tenover & Goering 2009), though more recent debate has questioned the importance of PVL. The differential effects of PVL in mouse and rabbit infection models triggered this debate. In a mose acute pneumonia model PVL was indicated to result in transcriptional changes of cell wall and secreted proteins of S. aureus and recruitment of neutrophils to the lungs, inflammation of the parenchyma and other tissue damage. These pathologies were absent in mice infected with the PVL-negative strain (Labandeira-Rey et al. 2007). These findings were however contradicted by a further two studies which found no decreased virulence in PVL knockout strains of S. aureus (Bubeck Wardenburg 
et al. 2007); (Voyich et al. 2006). A further study showed that mouse neutrophils are infact resistant to PVL, and that the actions of the toxin are species specific with both human and rabbit neutrophils showing susceptibility (Löffler et al. 2010). A rabbit infection model indicated that PVL may have a ‘modest and transient’ effect during acute stages of infection (Diep et al. 2008). As a result of this controversy  greater significance was afforded to the arginine catabolic mobile element (ACME) in the evolution of CA-MRSA (Thurlow et al. 2012).  It has been suggested that the significance of ACME in the virulence of CA-MRSA is as a result of the polyamine resistance determinants it carries. Host polyamines have been indicated to play a role in wound healing in a mouse skin and soft tissue infection model. These compounds are also known to be peculiarly toxic to S. aureus and are thought to inhibit its proliferation (Joshi et 
al. 2011). Excess host polyamines are produced as a result of the arginine to 
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ornithine metabolism mediated by the arc arginine deiminase genes present on ACME. The presence of speG which encodes a polyamine-resistance enzyme counteracts this excess of host polyamines and in turn results in S. aureus resistance to the compound (Thurlow et al. 2013).  
3.1.4 Genome features associated with niche adaptation 
3.1.4.1 Cell wall anchored proteins Cell wall anchored (CWA) proteins in staphylococci and other Gram-positive bacteria are exposed proteins on the cell surface. Due to their exposed nature they are often found to interact with target ligands on host cells and the extracellular matrix. These interactions can promote adherence and so persistence in a given niche, or evasion of the host immune system. Key features of CWA proteins include an N-terminal secretion signal peptide, a region containing multiple domains which often fold into IgG-like structures and a tandem repeat region. Also required is a wall spanning region that tethers the protein to the cell and an LPXTG-motif required for processing by the sortase transpeptidase enzyme producing covalent linkage to the peptidoglycan wall (Bowden et al. 2005).  
 
3.1.4.2 MSCRAMMs MSCRAMMS are the best-characterised group of staphylococcal adhesin proteins and mediate attachment to the host extracellular matrix. The diversity of tissue specificity across the repertoire of MSCRAMMs and other adhesins within a given genome is proposed to dictate the range of niches the organism can inhabit. It is known that the S. aureus genome, for example, encodes 20 MSCRAMMs and is capable of colonising multiple niches, from asymptomatic colonisation of the anterior nares through ClfB-mediated loricrin binding (Mulcahy et al. 2012), to post-surgical infections resulting from the colonisation of implanted medical devices and prostheses mediated by the fibronectin binding protein genes fnbA and fnbB (Lower et al. 2011).   
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The ability to colonise various niches has been implicated in the lifestyle of the staphylococci as opportunistic pathogens, particularly S. aureus. Although colonisation of the anterior nares is in itself asymptomatic it is known to be a risk factor for nosocomial infection within particular patient groups.  The decolonisation of surgical patients carrying meticillin-resistant strains of S. 
aureus often occurring as a pre-operative measure to control post-surgical infection (Simor 2011).  Coagulase-negative staphylococci are thought to have a reduced repertoire of adhesins in their genome with 12 MSCRAMMS having been characterised in the 
S. epidermidis genome, fewer than the 20 encoded in the S. aureus genome. The complement of MSCRAMMs in other coagulase-negative staphylococci is however poorly understood. S. saprophyticus is the next best characterised staphylococcal genome in terms of its adhesins and has so far been found to express three genes associated with attachment to host molecules; SdrI (Sakinç 
et al. 2009), UafB (King et al. 2011) and Aas (Hell et al. 1998). Other staphylococcal genomes found to contain adhesins include S. lugdunensis and S. 
caprae (Coates et al. 2014). To my knowledge the S. hominis genome has not been interrogated for the presence of adhesins.   The presence of a sortase enzyme in the genome can be used as a method for predicting the presence of MSCRAMMS. Sortases catalyse attachment of MSCRAMMS to the cell surface by cleavage between the threonine and glycine residues of the conserved LPXTG motif and amide-linking the protein to the bacterial cell surface during the synthesis of the peptidoglycan cell wall (Mazmanian et al. 1999). 
 
3.1.4.3 Other adhesins associated with niche selection Biofilm production requires the production of an intercellular adhesin to facilitate cell-to-cell contact of bacteria within the biofilm structure. One such adhesin is synthesised upon expression of the ica operon, the intercellular adhesion locus, and is a polysaccharide comprised of linear β-1,6-linked glucosaminylglycans known as PNAG or PIA. Expression of icaA alone is capable 
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of producing low activity of the enzyme N-acetylglucosaminyltransferase required to synthesize the polysaccharide. Concomitant expression of the icaD gene however results in increased activity of  N-acetylglucosaminyltransferase and is thus associated with a biofilm forming phenotype (Arciola & Baldassarri 2001). Due to its association with phenotypic biofilm production and the implications of biofilm production in antibiotic resistant nosocomial infections the ica operon has become a commonly used marker for invasiveness in the clinic. EbpS, a giant, membrane-spanning protein of S. epidermidis has also been associated with the accumulation of S. epidermidis biofilms (Christner et al. 2010). EbpS and its homologue Ebh in the S. aureus genome are non-covalently attached surface proteins which bind fibronectin. The cognate genes are the largest found in the S. epidermidis and S. aureus genomes andthe encoded megadalton proteins have an extracellular domain, a membrane spanning domain located at the C-terminus and an intracellular, positively charged repeat region (Linke & Goldman 2011) (Heilmann 2011) The SERAMS or secretable expanded repertoire adhesive molecules comprise a further subgroup of adhesive molecules which includes the protein coagulase (Friedrich et al. 2003). The SERAMS are secreted, surface-associated proteins which bind to the bacterial cell in an as yet undefined manner as opposed to the cell wall anchored proteins which interact with the cell wall in a defined and characterised way (Guggenberger et al. 2012). These SERAMS, Eap and Emp in particular, are proposed to have a lower binding specificity for the bacterial cell surface than the MSCRAMMs that might relate to their described roles in infection of the blood vessels through interaction with both the extracellular matrix and directly with the surface of endothelial cells. Emp and Eap also facilitate uptake of staphylococci by eukaryotic cells and inhibit phagocytic activity and neutrophil binding to the endothelium (Linke & Goldman 2011) (Heilmann 2011)  
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3.1.4.4 Biofilm forming capabilities The formation of a biofilm involves four defined stages, however the precise mechanisms of these four stages are as yet unknown.  The first stage is adherence to a surface, which could be either host cells or a synthetic surface such as catheters, artificial joints and other indwelling medical devices. This first step is proposed to occur through non-specific hydrophobic interactions (Vacheethasanee et al. 1998). Certain cell surface adhesins are also thought to facilitate these interactions. AtlE, for example, may play a dual role as an adhesin by binding to vitronectin in addition to its described autolytic activity which releases extracellular DNA (eDNA) (Heilmann et al. 1997); the presence of eDNA was shown to contribute to biofilm adherence (E. E. Mann et al. 2009). The extracellular matrix serum proteins and platelets that coat indwelling medical devices can be bound by other staphylococcal surface proteins and MSCRAMMS, such as SdrG that is known to bind fibrinogen (Sellman et al. 2008), and Embp known to bind fibronectin. Studies have shown that Embp is sufficient to establish a functional and significant biofilm (Christner et al. 2010). Other uncharacterised LPXTG-motif containing proteins were proposed to play a role in staphylococcal biofilms and may influence adherence (Bowden et al. 2005).   Accumulation is the second stage of biofilm formation and can be facilitated through polysaccharides by polysaccharide intercellular adhesin (PIA) encoded by the icaADBC locus, or proteinaceous factors, e.g. Bhp, Aap, Embp and their homologues. The ica locus is important in initial adherence of cells, cell-to-cell adhesion as well as subsequent accumulation of cells within the biofilm (Fey & Olson 2010). Proteinaceous biofilm accumulation through Aap is mediated by the proteins B domain which dimerises in a zinc-dependent manner with the B domain of a second Aap on a proximal cell (Conrady et al. 2008). The corneocyte binding capabilities of the N-terminal A domain of Aap have been said to implicate Aap in skin colonisation (Macintosh et al. 2009). The S. epidermidis protein Bhp is capable of supporting biofilm accumulation in the absence of PIA (Tormo et al. 2005). However bhp is only found in less than 45% of S. 
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epidermidis isolates and more rarely on a pathogenicity island of S. aureus (Tormo et al. 2005).   Maturation of a biofilm is the process by which growing and dividing cells are linked to one another and by which channels form in the layers of cells to allow nutrients to permeate the biofilm. Formation of these channels also leads to the detachment of clusters of cells which can cause biofilm expansion (Otto 2013). A host of transcriptional changes also occur during this stage of the biofilm and cells within the same biofilm can exist in different metabolic states (Rani et al. 2007). The arginine deiminase operon was found to be consistently upregulated in both S. aureus and S. epidermidis biofilms. It is hypothesised that the arginine deiminase operon may aid biofilm maturation by enabling pH homeostasis and yielding ATP (Fey & Olson 2010).  Finally, biofilm detachment occurs. This event can occur piecemeal as a result of the formation of channels in the biofilm, discussed previously, or it can occur as a dramatic event mediated by auto-inducing peptide (AIP). Proteins such as delta-toxin and some phenol soluble modulins (PSMs) may act a surfactants and thus hinder bacterial surface interactions. In the detachment of proteinaceous biofilms the action of metalloproteases and serine proteases are capable of destroying these structures (Boles & Horswill 2008).  The ability of a staphylococcal species to form a biofilm is important due to their clinical significance. Biofilms are known to reduce the antibiotic susceptibility of the infection and can result in persistent infections (Høiby et al. 2010). The ability of  S. epidermidis to form a biofilm is the key factor associated with virulence and isolate invasiveness, with PIA being the major clinical marker for this phenotype. Since other CoNS are more frequently being isolated from infections it is important to understand the process of biofilm formation in these species and determine how it may differ from the better studied S. aureus and S. epidermidis.  
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3.1.4.5 Staphylococcal pigmentation The staphylococcal pigment is a carotenoid, staphyloxanthin, associated with the golden colour that gives S. aureus its species name. Bacterial pigments can serve various protective functions across a wide range of species and can act as virulence factors (G. Y. Liu & Nizet 2009). The physiological role of staphyloxanthin is proposed as being required for maximal resistance to reactive oxygen species such as hydrogen peroxide which are associated with survival in the host macrophage (Olivier et al. 2009) (Clauditz et al. 2006) and increased survival of neutrophil killing (C.-I. Liu et al. 2008). It is also known that S. aureus strains which lack the crtOPQMN operon have reduced ability to form abcesses in a mouse infection model thus implicating staphyloxanthin in the virulence of the species(G. Y. Liu et al. 2005). The pigment also has a role in regulating membrane fluidity, which conveys resistance to cationic antimicrobial peptides. The mechanism by which this is achieved is not known as phospholipid composition, surface charge, fatty acid complement or thickness of the cell wall did not appear to change in a S. aureus mutant overexpressing crtMN of the crtOPQMN operon (N. N. Mishra et al. 2011). A study by Grinsted & Lacey found that pigmented strains of S. aureus had increased survival in the presence of linoleic acid and under conditions of desiccation (Grinsted & Lacey 1973). A S. aureus crtM mutant was also demonstrated to have reduced linoleic acid survival (Kenny et al., 2009). Another study found that variation in pigmentation could not be correlated with survival differences (Noble 1977). The same study posited that the carotenoid pigment could afford pigmented bacteria protection from DNA damage by UV sunlight. There is evidence for bacterial protection against UV DNA damage in 
Sporothrix schenckii (Romero-Martinez et al. 2000).  
 
3.1.5 Staphylococcus hominis 
S. hominis was first isolated from healthy human skin (Kloos & Schleifer 1975) and is now known to be a consistent member of the human microflora. Investigation of the anterior nares showed 10% of people to be persistently colonised (Faria et al. 2014) and that S. hominis is the second most abundant staphylococcal species on human skin, making its genome an important part of 
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the bacterial pan-genome potentially available for horizontal gene transfer in this niche. There is evidence to suggest that S. hominis acts as a reservoir for mobile genetic elements, such as the SCCmec element which carries the genes involved in meticillin resistance (Faria et al. 2014).   Despite its commensal status, S. hominis, along with other coagulase negative staphylococci, is an emerging clinical pathogen capable of causing infection in a variety of niches, such as the blood (Bouchami et al. 2011), particularly in the presence of long term indwelling medical devices (Weinstein et al. 1998), and the urogenital tract (Orrett & Shurland 1998) (John et al. 1978) . Furthermore, the presence of multidrug resistance phenotypes in the S. hominis population were identified (Mendoza-Olazarán et al. 2013) (Jiang et al. 2012), which is significant given the increasing rates of nosocomial S. hominis infections (Macía-Heras & Donate-Correa 2013) (Chaves et al. 2005; Mendoza-Olazarán et al. 2013).   Although it is undeniable that S. hominis constitutes a significant resident of the human microbiome efforts to understand its role in human health and disease are significantly earlier in their infancy than those of S. aureus, S. epidermidis and even S. haemolyticus. At the time of writing there were around 138 publically available S. epidermidis genomes, 13 S. haemolyticus genomes but only 5 S. hominis genomes with none of these being a complete reference genome (GOLD genomes online database, accessed 28.4.15).  As part of this study this deficit of S. hominis genome availability has begun to be addressed by sequencing and annotation of 7 recent skin isolates. The addition of these genomes to those already publically available will enhance the knowledge of S. 
hominis as an important species of the human skin niche.  
3.1.6 Aims The specific aims of the research presented in this chapter were to genetically characterise S. hominis as a species through interrogation of the entire genome sequences of both clinical and commensal isolates. The data from intra-species comparisons and pan-genome investigations will increase understanding of S. 
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hominis and its little studied genetic repertoire, which is available as a reservoir of genes for other species of bacteria which share the skin niche, such as the transient and pathogenic species S. aureus. 
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3.2 Methods 
3.2.1 Assembly of the S. hominis pan-genome In order to understand the genetic relatedness of the group of S. hominis  isolates used in the pan-genome analysis a tree based on the housekeeping sense aroE, gmk, pta and tpi was produced. The housekeeping genes were pulled out of all 11 S. hominis genomes using Artemis (version 14.0.0) and concatenated together. A multiple sequence alignment was produced using a Geneious alignment and the Blosum62 cost matrix. The Geneious tree builder was then used to produce a consensus tree based on 1000 bootstrap replicates. Geneious version 8.1.7 was used.  Intraspecies analysis of S. hominis required the use of all available genomes. Therefore all S. hominis isolate sequences from this study and those genomes publically available on the NCBI-FTP website were downloaded for incorporation into the study. Strain IDs and EBI project accession numbers are listed in Table 3.1. All read, contig and annotation information is available within the EBI project. 
  
Table 3.1 List of strains. The ID and EBI project accession number of the strains used in this study, where the genome sequence is available the public  
Species Strain ID Accession number 
S. hominis B10 PRJEB10524 
S. hominis C80 UID61127 
S. hominis J6 PRJEB10524 
S. hominis J11 PRJEB10524 
S. hominis J23 PRJEB10524 
S. hominis J27 PRJEB10524 
S. hominis J31 PRJEB10524 
S. hominis I4 PRJEB10524 
S. hominis SK119 UID55861 
S. hominis VCU122 UID180067 
S. hominis ZBW5 UID200270 
S. epidermidis RP62A UID57663 
S. aureus Newman UID58839 
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The contigs from publically available draft genomes were scaffolded against the PacBio assembly of the S. hominis J31 genome using the script ACT compare (Table S2).  Gene calling and annotation was then carried out using PROKKA version 1.5.2. OrthoMCL version 1.4 was used to cluster the predicted genes from all isolates into orthologous groups; the following parameters were used, e-value cut-off: 1e-5, percentage identity cut-off: 30, percentage match cut off: 20 (L. Li et al. 2003).  The number of singleton genes, defined as being present in only 1 genome,  shared genes, defined as being present in 2 or more genomes, and the total number of all genes was calculated for each combination of 2 to 11 genomes. This was achieved using the R scripts pan_and_core_genome and new_genes (Table S2).  The size of the pan-genome was estimated using Heaps’ law, which is described by the equation n = κ x N^γ.κ and γ are the intercept and slope of the line, respectively, n is the total number of genes and N is the number of genomes. γ is  
used to solve α=1- γ to determine if the pan-genome is open or closed. α ≥ 1 indicates a closed pan-genome and α < 1 indicates an open pan-genome. The number of new genes added and the size of the core genome was estimated using an exponential decay model described by n = κ * exp(-N/ γ) + tg(Θ), where 
n is the number of genes, N the number of genomes and tg(Θ) is the predicted number of new genes added and the size of the core genome, respectively.   
3.2.2 Functional annotation of the pan-genome The web server WebMGA (Wu et al. 2011) was used to assign all of the predicted coding genes in all of the isolates to COG (clusters of orthologous genes) categories. WebMGA aligns all genes against the COG database using RPSblast with an e-value cut-off of 0.001. OrthoMCL clusters of core and accessory genes were then annotated with the corresponding COG category if all genes within a cluster were consistently annotated. This was achieved using the perl script extract_COGID.pl (Table S2). 
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3.2.3 Investigation of biofilm forming capabilities 10 ml of BHI broth was inoculated with the S. hominis isolates and the cultures were incubated overnight at 37°C with shaking. OD600 of these cultures was adjusted to 0.1 in BHI broth supplemented with 0.25% glucose. These cultures were then incubated at 37°C until OD600 was 1.0 then 100 µ of these cultures were used to inoculate the wells of a polystyrene microtiter plate (Nunclon tissue culture-treated) in triplicate. The plates were incubated for 24 h at 37°C without shaking and then washed three times with distilled water. After drying for 1 h at 65°C the wells were stained for 10 min with 0.4% (w/v) crystal violet solution. The plates were again washed three times with distilled water, 100 µl of 33% (w/v) sodium acetate was added to the wells and the absorbance measured at 490 nm.   
3.2.4 Investigation of putative cell wall-associated proteins A modification of the method by Bowden et al was used to determine the set of putative cell wall-associated proteins of S. hominis (Bowden et al. 2005). Firstly, the perl script LPXTG_capture.pl (Table S2) was used to search for the extended LPXTG motif in all S. hominis genomes. Next, a locally installed stand alone version of PSI-blast, provided by the NCBI, was used to investigate this set of proteins for homology to a set of staphylococcal adhesins defined by Coates et al, 2014. Homology between two sequences is indicated by a low e-value obtained for a PSI-blast alignment. This was achieved using the script psi-
blast.sh where the adhesin protein sequence was the query, and the S. hominis genomes were formatted as the database. Results were then concatenated into a single file for each isolate.  The expanded set of proteins was filtered on the criteria that the proteins contained a signal peptide (http://www.predisi.de/) and more than 1 transmembrane domain (http://www.cbs.dtu.dk/services/TMHMM/). LPXTG-motif proteins which fulfilled all three criteria of homology to known staphylococcal adhesins, presence of a signal peptide and presence of transmembrane domains were defined as putative cell wall-associated proteins. LPXTG-motif proteins which did not fulfil the criteria of homology by PSI-blast to known staphylococcal 
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adhesins were defined as discrete S. hominis cell wall-associated proteins. The rationale for this strategy was that S. hominis may have CWA proteins without significant homology to CWA proteins in other species, therefore these may not be identified by PSI-blast. Proteins may not fulfil the criteria of having an LPXTG motif  or transmembrane domains if they are attached to the cell wall by alternative mechanisms such as interacting with specific domains of cell wall components (Desvaux et al. 2006).  
3.2.5 Carotenoid Assay 
S. hominis isolates, together with S. aureus control strains SH1000 and Newman, were grown for 48 h in 5 ml of BHI broth at 37 °C with shaking at 200 rpm. Lids were loosened to allow maximum aeration of the culture. Ten-fold diluted cells were then plated on BHI agar and incubated for 48h at 37C. Plates were then incubated for a further 48h at room temperature to allow maximal pigment expression  Methanol extraction was carried out by first harvesting the bacterial cells from 2 mL of culture followed by resuspension in 200 μL of 100% (v/v) methanol. The methanol suspended cells were then incubated overnight at 37°C without shaking.   
3.2.6 Antibiotic resistance gene profiles The antibiotic resistance gene profiles were investigated using ARDB, the antibiotic resistance database (http://ardb.cbcb.umd.edu/). The antibiotic resistance database is a curated database which collates publically available information regarding antibiotic resistance including mechanisms of action, COG annotation and sequence data (B. Liu & Pop 2009).   
3.2.7 Investigation of S. hominis plasmids Putative plasmid encoding contigs that were identified in the PacBio sequencing of S. hominis J31 (section 2.3.3) were extracted from the genome assembly and reannotated using PROKKA (Seemann 2014). The circularised sequence of 
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plasmids was confirmed through the observation of duplicated genes at the beginning and ends of the plasmid contigs.   The conservation of plasmid genes across the isolates was investigated by clustering the coding sequences found on the plasmid contigs with the coding sequences of the S. hominis genomes. Orthologous groups containing plasmid genes were extracted from the OrthoMCL output and a presence/absence matrix of these genes across the S. hominis isolates was created using the python script table_alt_cluster-1.py (Table SI). The percentage of clusters from each plasmid present in each of the genomes was then calculated.   
3.2.8 Insertion sequences Transposable elements in each genome were identified and annotated using ISFinder; this is an annotated database of insertion sequences which provides an online tool to allow the user to BLAST search sequences of interest against this database to identify possible insertion sequences (Siguier et al. 2006).  
3.2.9 Bacteriophage annotation Bacteriophages were annotated using PHAST, which searches a genome for phage-like genes with homology to a phage/prophage protein database and uses the DBSCAN algorithm to determine the clustering of these genes in the database. The density of phage-related proteins across these clusters is then identified together with the presence of essential phage protein families. Performance of a cluster using these criteria generates a phage completeness score out of 150. Less than 60 results in a cluster being designated as an incomplete prophage, 60-90 is a questionable prophage, while above a score of 90 represents a likely complete prophage (Y. Zhou et al. 2011).  
3.2.10 Genome manipulation and interrogation Genome manipulation and interrogation was carried out using a locally installed version of Artemis (version 14.0.0). The Artemis tool was developed by The 
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Sanger Institute to enable visualisation of sequencing data (Rutherford et al. 2000) (Carver et al. 2012).  
3.2.11 Protein sequence aligments Multiple sequence alignments were carried out using ClustalW2, which is an open source program hosted by the European Bioinformatics Institute. Average percentage sequence identity was calculated for the alignments. Sequence identity refers to the amount of exact character matches between two sequences. Gaps are not considered and the score is relative to the shortest sequence.  BLAST (basic local alignment search tool) is a tool used to find pairwise local sequence similarity. Similarity is the degree to which two sequences resemble one another. This measure takes into account identity, chemical properties of the amino acids and the number of insertions, deletions and substitutions (mutations) that occur between sequences (Altschul et al. 1990). Multiple algorithms (BLASTN, BLASTP, psi-BLAST) were used in this analysis in both web based and locally installed forms.     
3.3 Results and discussion 
 
3.3.1 The S. hominis pan-genome A pan-genome analysis is influenced by the genomes included. For this reason the diversity of the isolates used in the S. hominis analysis presented here was investigated using multiple alignment of the housekeeping genes aroE, gmk, pta and tpi. Isolates B10, I4 and the “J” isolates were found to be closely related at these housekeeping gene loci branching together in a neighbour joining tree. (Figure 3.0) This close relationship of 7 of the 11 isolates used in the pan-genome analysis could result in a lower estimated repertoire of genes for S. 
hominis.  
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To identify the S. hominis pan-genome and its genetic repertoire, the number of genes present in all available strains was quantified and plotted as a function of the number of genomes added for all possible combinations of 2-11 genomes. As genomes were sequentially added to the analysis, the size of the S. hominis pan-genome increased until it reached ~3115 genes at 11 genomes (Figure 3.1, panel A). This is an estimated number of genes due to the presence of paralogues in 1% of the clusters from the orthoMCL analysis. Heaps’ law, a sub-linear power law of frequency distribution, was used to perform a regression analysis. This statistical process is described by the equation n = κ x N^γ, where κ and γ describe the intercept and slope, respectively, n is the total number of genes and N the number of genomes. α=1- γ was then used to determine if the 
pan-genome is open or closed, where α ≥ 1 indicates a closed pan-genome and α < 1 indicates an open pan-genome. An open pan-genome will increase in size with the addition of new genomes. For S. hominis Heaps’ law predicts κ = 7.661506, γ = 0.125405 therefore α = 0.874595 indicating an open pan-genome with respect to the number of input genomes studied (Figure 3.1, panel A).  
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Figure 3.0 Neighbour joining tree of housekeeping genes. The basis of the tree is the concatenated protein sequences of the housekeeping genes aroE, gmk, pta and tpi. Bootstrapping using 1000 repetitions was carried out. 
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n=exp(6.005717)*exp(-0.24690*N)+1779  
n=exp(7.661506)*N^(0.125405)  
A 
B 
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Figure 3.1 Core genome, pan genome and new genes added plots for S. hominis. A) Core genome plot represents the n number of shared genes among N number of genomes. The equation of the line, fitted to the median of data, is the exponential decay model n = ! * exp(-N/") + tg(#) B)Pan genome plot represents the total number all genes (n) in the (N) number of genomes. The equation of the line, fitted to the median of the data, is a modified non-linear least squares known as Heaps’ law with the formula n = ! x N^". C) New genes added represents the number of new genes added (n) per new genome (N). The equation of the line, fitted to the median of data, is the exponential decay model n = ! * exp(-N/") + tg(#). 
C 
n=exp(4.65740)*exp(-0.25879*N)+41 
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3.3.2 Growth of the S. hominis pan-genome The number of new genes added to the pan-genome with the addition of every new genome was investigated for all possible combinations of 2-11 genomes.  A non-linear least squares model was fitted to the data using an exponential decay model, which is defined by n = κ * exp(-N/ γ) + tg(Θ), where n is the number of 
genes, N the number of genomes and tg(Θ) is the predicted number of new genes accrued with the addition of each new genome. For this analysis tg(Θ) = 41, predicting that 41 new genes were added to the pan-genome with each additional S. hominis genome. This agrees with the prediction that the pan-genome is open and supports that for the collection of isolates in this analysis the pan-genome is approaching closure, with a value of α = 0.874595. This α value agrees with previous studies containing similar numbers of strains of other species of bacteria (Tomida et al. 2013; Conlan et al. 2012). Soares et al in particular found an α value of 0.89 for a pan-genome analysis completed with 15 strains of Corynebacterium pseudotuberculosis (Soares et al. 2013). Despite this having 7 isolates that appear closely related at housekeeping gene loci may reduce the diversity of the strain set investigated here and so indicate a higher α value which is not representative of the species. 
 
 3.3.3 The S. hominis core genome The pan-genome of a species comprises both the core genome, containing genes required for essential biological and metabolic processes, and the accessory genome representing genes for specific adaptations. The size of the S. hominis core genome was determined by calculating the number of genes shared by all strains. This value was then plotted as a function of the number of genomes (Figure 3.1, panel B). A non-linear least squares model was fitted to these data using an exponential decay model, which is defined by n = κ * exp(-N/ γ) + tg(Θ) 
where n is the number of genes, N the number of genomes and tg(Θ) is the predicted 
size of the core genome. Analysis identified that the predicted size of the S. 
hominis core genome is 1770 genes, which is equivalent to the asymptote of the regression line (Figure 3.1, panel B). At 11 genomes the size of the core genome is 1879 genes, or 60% of the total pan-genome, which is approaching the predicted total size.  
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 The discrepancy between the predicted core genome size and the core genome size for 11 strains indicates that sequencing of additional isolates of S. hominis from diverse sequence types or ecological and geographical locations will be required to fully define the core S. hominis genome. For individual strains the core genome comprises an average of 83% of the total genome, 17% is therefore comprised of accessory genes. These genome proportions of individual strains, attributable to the core and accessory genomes, agrees with a previous study of staphylococci (Conlan et al. 2012). These values indicate that the pan-genome overestimates the proportion of genes in the S. hominis genome contributed from the accessory genome. Within individual strains it is clear that the majority of the genome is comprised of essential core genes, with only a small percentage being drawn from that variable accessory genome. This relatively larger pool of non-essential accessory genes in the pan-genome speaks to the variability present between different strains.    
3.3.4 The S. hominis accessory genome 
 The accessory portion of the genome can be further subdivided into shared accessory genes present in 2 or more, but not all strains, and strain-specific singleton genes present in only one strain. The S. hominis singleton accessory genome was found to contain 541 genes across the 11 genomes, whereas the shared accessory genome contained 659 genes. The number of strain specific genes present can be used as a measure of the divergence between the strains present in the analysis. As the number of singletons is not normally distributed across the dataset it can be stated that particular strains are more divergent than others (Figure 3.2). For example, the drug resistant isolate ZBW5 contains 208 singletons, whereas all “J” isolates plus strain B10 contain no singletons. It was postulated that the accessory genome could contain genes designated as sub-core genes for strains isolated from different niches, and that these sub-core genes might contribute to niche adaptation and survival (Gupta et al. 2015). It is evident that additional S. hominis isolates from different environments must be added to the pan-genome analysis to enable conclusions 
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to be drawn regarding niche specific adaptations.  
 
 
 
3.3.5 Functional diversity of the core and accessory genomes. 
 The functions of genes within the core and accessory genomes of S. hominis were investigated by assigning all gene clusters discerned by OrthoMCL analysis to clusters of orthologous groups (COGs).    The majority of genes in the accessory genome (~64%) could be assigned to the COG categories general function prediction only, function unknown or unassigned function. This group of genes was enriched in comparison to the core genome where only 33% of genes were similarly assigned (Figure 3.3). This indicated the presence of novel gene clusters in the S. hominis genome.  
Figure 3.2 Distribution of strain specific genes assigned by orthoMCL analysis of the S. 
hominis genomes. Whiskers represent the highest and lowest values, the perimeters of the box show the 1st and 3rd quartile range while the thick black line shows the median. 
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Figure 3.3 Functional annotation of the core and accessory genome. Percentages of the S. hominis accessory and core genomes annotated as either function unknown, general function prediction only or unassigned function, as well as the percentage of genes annotated with an assigned COG function. 
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Genes associated with both of the categories, defense mechanisms and replication, recombination and repair were found to be enriched in the accessory genome (Figure 3.4), which agrees with analyses of other species of staphylococci (Conlan et al. 2012). Despite the enrichment in the replication, recombination and repair COG category there is limited diversity in this group of genes. Approximately 30% of these gene clusters are involved in the integration and excision of mobile genetic elements from the genome. A further 29% of the gene clusters in the recombination, replication and repair group encode recombinases. It has been suggested that movement of genes on mobile genetic elements and through genetic recombination are important in the diversity of staphylococcal phenotypes.   Around 58% of the genes in the enriched defence mechanism COG category of the accessory genome were associated with drug resistance. This identifies that 2% of the accessory genome accounts for COG groups associated with virulence in species that are designated as pathogenic species. This relatively low percentage of virulence-associated genes is in accordance with the  lifestyle of S. 
hominis being predominantly commensal, however their presence also corroborates the potential of S. hominis as an opportunistic pathogen.  All other COG clusters were enriched in the core genome potentially indicating greater functional diversity in the core genome compared with the accessory portion. However, 64% of the genes in the accessory genome were unassigned or poorly assigned to COG categories, and it is likely that these unassigned clusters account for the apparent drop in functional diversity between the core and accessory genome.   
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Figure 3.4 COG assignment of the core and accessory genome. Percentage of genes in each of the COG categories in the S. hominis accessory genome and core genome. 
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COG annotation of the S. hominis core genome reveals that the majority of the genes are associated with housekeeping functions including essential processes of metabolism and cell replication. The most abundant COG category in the core genome is translation, ribosomal structure and biogenesis in contrast to the accessory genome where replication, recombination and repair corresponds to the most abundant COG category.   
3.3.6 Crt operon In S. aureus the crtOPQMN operon encodes the five enzymes known to be necessary and sufficient in the biosynthesis of the triterpenoid carotenoid staphyloxanthin (Pelz et al. 2005). The crtOPQMN operon is regulated by a σB dependent promoter (Morikawa et al. 2001). Production of staphyloxanthin is considered to be a virulence factor in S. aureus due to the association between the pigment, antioxidant defence and establishment of infecton (C.-I. Liu et al. 2008).  8 out of the 11 isolates of S. hominis examined in this study contain the crtPQMN genes of the staphyloxanthin carotenoid operon. In isolates where the crtPQMN genes are present the protein sequences were conserved across all isolates with greater than 99% sequence identity. This agrees with the level of sequence identity observed in the crtPQMN operon across different S. aureus genomes. This suggests, within the subset of S. hominis isolates investigated here, previous findings that the gene sequences of the crt operon are conserved across a species with respect to gene synteny and genomic location (Pelz et al. 2005). Two isolates, B10 and VCU122, contained only a fragment of crtN; this fragment also has >99% sequence identity with crtN of other S. hominis isolates. Uniquely, the multidrug resistant isolate ZBW5, did not contain an identifiable 
crt operon or any gene fragments.  The sequence identity between the CrtPQMN proteins present in S. hominis and 
S. aureus was investigated. CrtN and CrtP were the most highly conserved between the two species sharing 69.5% and 70.3% amino acid sequence 
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identity, respectively. CrtM and CrtQ shared 51.4 and 49.9% identity, respectively.  Culture of S. hominis strains revealed that the isolates of S. hominis containing 
crtPQMN could produce pigment suggesting the operon may be expressed in these isolates (Figure 3.6). This pigment cannot, however, be extracted using a standard protocol for staphyloxanthin extraction (Morikawa et al. 2001). This is consistent with the fact that the crtO gene is not present in any of the S. hominis genomes. CrtO is an acyltransferase which esterifies glucose to form glycosyl-
4,4′-diaponeurosporenoate, the last step in the staphyloxanthin biosynthesis pathway (Pelz et al. 2005). Lack of crtO results in the accumulation of the yellow pigment glycosyl-4,4′-diaponeurosporenoate without the development of the orange colour associated with staphyloxanthin. CrtO was found to have no sequence similarity to any as yet characterised carotenoid biosynthesis genes (Pelz et al. 2005). Perhaps the yellow pigment glycosyl-4,4′-   
Figure 3.6 expression of the crtOPQMN operon in S. hominis 1) S. aureus SH1000 positive control, known to produce staphyloxanthin 2) S. hominis B10 3) S. hominis J6 4) S. 
hominis J11 5) S. hominis J11 6) S. hominis J23 7) S. hominis J27 8) S. hominis J31 9) S. 
hominis I4 
1 2 
3 
4 
5 6 
7 
8 
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diaponeurosporenoate of S. hominis fulfils the role of membrane stabilisation in the face of antimicrobial peptides and fatty acids which will be encountered by commensal bacteria such as S. hominis on the skin. The terminal step in the biosynthetic pathway for staphyloxanthin may have evolved as a result of the S. 
aureus lifecycle as a more virulent opportunist pathogen, compared with the less virulent commensal staphylococci with respect to oxidative stress resistance or stabilising the cell membrane.  Further investigation is required to understand 1) the membrane function of glycosyl-4,4′-diaponeurosporenoate and how it is localised and 2) the degree of protection offered by this molecule for bacterial fatty acid and antimicrobial peptide survival. Heterologous expression of crtO in S. hominis would also provide insights via potential gain of function.  
3.3.7 Sortases The LPXTG motif is conserved in MSCRAMMs across the staphylococci and it acts to both direct cell wall sorting and promote attachment of MSCRAMMs to cell wall peptidoglycan catalysed by the enzyme sortase (SrtA) (Navarre & Schneewind 1999). The presence of a sortase enzyme indicates the presence of cognate proteins containing the LPXTG motif. A srtA gene is present in all 11 S. 
hominis isolate genomes which indicates that this mechanism of covalently attaching protein to the cell surface is also conserved in this species.  A multiple sequence alignment of the S. hominis SrtA protein sequence showed SrtA to be conserved among the S. hominis isolates with an overall average identity of >99% across the 11 S. hominis genomes. There were 9 amino acid changes between the isolate ZBW5 and the rest of the isolates, and 1 amino acid change between B10 and the other 10 S. hominis isolates. Average identity to S. 
epidermidis UniProt SrtA protein Q5HL98_STAEQ is 82%, and identity beween the S. hominis SrtA and the S. aureus  UniProt SrtA protein Q9S446_STAAU is 85%. S. aureus and S. epidermidis have a distance of 1.507 showing that both the 
S. epidermidis SrtA protein sequence and the S. aureus SrtA protein sequence have a higher identity to that of S. hominis SrtA than to each other. This is 
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supported with Blast comparisons which show S. epidermidis SrtA has 72% identity with S. aureus whereas S. hominis shares 76% identity. 
Table 3.2 Putative S. hominis cell wall associated proteins. Homologous genes are grouped together and the S. hominis surface protein nomenclature is shown in bold. The closest match by blast is the sequence with the highest blast score after searching the cell wall associated protein against the BLAST database. Average identity is the average protein sequence identity between the protein sequences from the isolates which contain the cell wall associated protein. 
Protein ID Prokka annotation Closest match by 
BLAST 
Average identity 
ShsA B10-PB_00037 Trifunctional nucleotide phosphoesterase protein YfkN precursor 
5’-nucleosidase, S. 
hominis 99.7 C80-PB_00043 J6-PB_00037 J11-PB_00037 J23-PB_00036 J27-PB_00038 J31-PB_00038 I4-PB_00037 SK119-PB_00038 VCU122-PB_00035 
ShsB B10-PB_00206 Lowaffinity inorganic phosphate transporter 1, PitA Inorganic phosphate transporter, S. hominis 99.9 C80-PB_00156 J6-PB_00133 J11-PB_00133 J23-PB_00131 J27-PB_00133 J31-PB_00133 I4-PB_00132 SK119-PB_00139 VCU122-PB_00138 ZBW5-PB_01046 
ShsC B10-PB_01086 Hypothetical protein Hypothetical protein, predicted metal-dependent hydrolase domain 
100% J6-PB_01008 J11-PB_01009 J23-PB_01005 J27-PB_01007 J31-PB_01009 I4-PB_01006 SK110-PB_00993 VCU122-PB_01012 
ShsD B10-PB_01322 Rod shape-determining protein RodA Cell division protein FtsW 99.7 C80-PB_01272 J6-PB_01237 J11-PB_01266 J23-PB_01178 J27-PB_01265 J31-PB_01270 I4_PB_01244 SK119-PB_01224 VCU122-PB_01252 ZBW5-PB_01274 
ShsE 
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B10-PB_01471 Swarming motility protein SwrC Multidrug transporter 99.2 C80-PB_01425 J6-PB_01407 J11-PB_01410 J23-PB_01406 J27-PB_01409 J31-PB_01415 I4-PB_01413 SK119-PB_01393 VCU122-PB_01422 ZBW5-PB_01453 
ShsF B10-PB_01722 EIICBA Glc PTS glucose transporter subunit IIABC 99.8 C80-PB_01681 J6-PB_01643 J11-PB_01644 J23-PB_01639 J27-PB_01644 J31-PB_01651 I4-PB_01647 SK119-PB_01646 VCU122-PB_01676 ZBW5-PB_01708 
ShsG J6-PB_01850 Lipase precursor Hypothetical protein, S. 
haemolyticus 100 J11-PB_01850 J23-PB_01846 J27-PB_01851 J31-PB_01857 I4-PB_01854 
ShsH B10-PB_02302 Hypothetical protein Staphylococcal peptidase 100 J6-PB_02165 J11-PB_02163 J23-PB_02165 J27-PB_02169 J31-PB_02177 I4-PB_02159 ZBW5-PB_02260 
ShsI B10-PB_00702 Glyceroaquaporin Glycerol transporter, S. 
hominis 99.6 C80-PB_00658 J6-PB_00629* J11-PB_00630 J23-PB_00627 J27-PB_00629 J31-PB_00629 I4-PB_00629*  SK119-PB_00616 VCU122-PB_00625 ZBW5-PB_00669* 
ShsJ B10-PB_02072 Citrate/succinate antiporter Staphylococcal membrane protein 99.2 C80-PB_01983* J6-PB_01934* J11-PB_01934* J23-PB_01929* 
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3.3.8 Putative cell wall associated proteins To investigate putative S. hominis MSCRAMMS and adhesins all possible cell wall-associated (CWA) proteins encoded in the S. hominis genomes were first located. In silico analysis predicted 14 proteins containing the LPXTG motif, an N terminal signal peptide, a hydrophobic transmembrane domain and a relationship with known staphylococcal MSCRAMMS determined through PSI-blast (Table 3.2). These criteria represent the key features of CWA proteins. The number of LPXTG motif-containing proteins found in S. hominis is close to the 11 predicted in the S. epidermidis genome (Bowden et al. 2005). Although more LPXTG proteins were predicted in S. hominis than in S. epidermidis this may be explained by the fact that 11 isolates were used in this analysis whereas only isolate RP62A was used in the analysis of S. epidermidis CWA proteins.   
J27-PB_01936* J31-PB_01942* I4-PB_01933* SK119-PB_01911* VCU122-PB_01960* ZBW5-PB_01969 
ShsK    B10-PB_01223* Sensor protein VraS Staphylococcal sensor histidine kinase 99.9 C80-PB_01173* J6-PB_01140* J11-PB_01169* J23-PB_01081* J27-PB_01168* J31-PB_01173* I4-PB_-01147* SK119-PB_01126* VCU122-PB_01151* ZBW5-PB_01176 
*absent from analysis but present on interrogation of the genome 
Singleton LPXTG-containing proteins 
Protein 
ID 
Putative 
surface 
protein 
Prokka annotation Closest match by BLAST 
B10-PB_01770 ShsL Hypothetical protein Cell wall surface anchor protein ZBW5-PB_01352 ShsM Hypothetical protein Staphylococcal hemolysin III ZBW5-PB_01982 ShsN Inner membrane transport permease YbhR Antibiotic ABC transporter permease 
  93 
Of the 14 LPXTG motif-containing proteins identified, 7 were conserved across the 11 S. hominis isolates with greater than 99 % identity (Table 3.2). The rest of the predicted proteins were conserved among subsets of the 11 isolates. Conservation of a core group of MSCRAMMS among all isolates and distribution of an accessory set of MSCRAMMs was also seen by McCarthy and Lindsay when the distribution of surface proteins among a group of S. aureus isolates was investigated (McCarthy & Lindsay 2010). 3 of the proteins were identified in only one isolate and designated as singleton LPXTG-containing proteins; The multidrug resistant isolate ZBW5 showed the most divergence in its repertoire of LPXTG-motif containing proteins sharing 8 of its 10 LPXTG-motif containing proteins with two or more other isolates. It does not however display an expanded repertoire of putative CWA proteins as it contains 10 in line with the rest of the isolates which also contain between 8 and 11 proteins each. Since no 
S. hominis surface proteins have been identified in the literature the putative surface proteins proposed  here have been designated ShsA-N according to the nomenclature proposed by (Mazmanian et al. 2001) and will be referred to as such from here onwards.  
 
3.3.9.1 ShsA 5’- nucleosidases have been identified as substrates for the sortase enzyme through investigation of LPXTG-motif containing proteins in the Gram-positive species S. aureus, Streptococcus pyogenes, Bacillus anthracis, B. subtilis, 
Clostridium difficile and C. acetobutylicum (Pallen et al. 2001). The S. aureus surface protein SasH has 32% homology with a 5’ nucleotidase from Bacillus 
halodurans (Roche, Massey, et al. 2003) and so has been designated as a putative 5’ nucleotidase. It has also been found to be associated with invasive disease (Roche, Massey, et al. 2003). Across all isolates found to contain ShsA the putative S. hominis CWA protein shares an average of 47 % identity with S. 
aureus SasH, which has been renamed AdsA due to  the protein function to synthesise adenosine from 5’-AMP. This synthesis is mediated by the 5’-nucleosidase activity of the protein and is necessary for S. aureus survival in blood, reducing neutrophil killing of S. aureus in the bloodstream. As a result of these functions, AdsA was designated as a virulence factor (Thammavongsa et 
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al. 2009) (Thammavongsa et al. 2011).  Thammavongsa et al found an AdsA homologue in the pathogen Bacillus anthracis; sequence identity between B. 
anthracis adenosine synthase (accession no. BAS4031) and the USA300 AdsA/SasH protein was 15 %. Identity of the ShsA protein across the studied S. 
hominis species was 16%. There are differences in the length of the S. hominis protein (958 amino acids), and the S. aureus and B. anthracis proteins (786 and 790 amino acids, respectively). Thammavongsa et al also identified the presence of 5’-nucleosidases with LPXTG motifs in other Gram-positive species (Thammavongsa et al. 2009), and still others secrete 5’-nucleosidases (Punj et 
al. 2000).     During genome annotation ShsA was annotated by Prokka as a trifunctional nucleotide phosphoesterase protein (YfkN) precursor. YfkN is secreted by B. 
subtilis and has 5’ nucleotidase activity together with 2’, 3’ cyclic nucleotide phosphodiesterase and 2’ nucleotidase activities (Chambert et al. 2003).  YfkN has a large reading frame (4386 nucleotides) that is proposed to have arisen from a gene fusion event between genes encoding the 2’, 3’ cyclic nucleotide phosphodiesterase activity of the enzyme, with another possessing 5’ nucleotidase activity (Yamamoto et al. 1996). The putative S. hominis CWA protein ShsA is comprised of 962 amino acids and so falls far short of the expected length of YfkN.  A region of 522 residues at the C-terminus of YfkN shares 26.8% identity with a 5’ nucleotidase precursor of Homo sapiens (Yamamoto et al. 1996). This agrees with an average 22.6% sequence identity between S. hominis ShsA and a 574 residue fragment of the Homo sapiens 5’ nucleotidase.   Taken together, the identity between S. aureus AdsA and the B. subtilis YfkN 5’ nucleotidase precursor proteins indicate that ShsA may be a surface anchored 5’ nucleotidase. The presence of this protein in S. hominis, a non-pathogenic commensal bacteria, calls into question the designation of AdsA as a virulence factor (Thammavongsa et al. 2009).  
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3.3.9.2 ShsC From sequence comparisons using BLAST, ShsC contains a predicted metal-dependent hydrolase domain. Staphylococcal cell wall hydrolases are typically peptidoglycan, (murein) hydrolases. Peptidoglycan hydrolases have many housekeeping roles in cell division and homeostasis of the peptidoglycan layer (Frirdich & Gaynor 2013). Cell wall peptidoglycan hydrolases are implicated in pathogenicity of staphylococci with the murein hydrolase regulator CidA contributing to DNA release and biofilm development and  LrgAB regulating penicillin sensitivity (K. C. Rice et al. 2007). The S. aureus surface protein AtlA is the most studied murein hydrolase of the staphylococci together with its S. 
epidermidis and S. caprae homologues AtlE and AtlC, respectively. The repeat regions of Atl proteins are know to bind fibronectin. ShsC shares little sequence identity with AtlA or AtlC therefore ShsC may represent a novel S. hominis CWA hydrolase.  Further study is required to predict its substrate specificity.     
3.3.9.3 ShsD ShsD was revealed using BLAST to share similarity with the essential cell division protein FtsW. The membrane protein FtsW was shown in E. coli to connect cell wall synthesis and the cell division machinery and it is localised at the septum during cell division where it interacts with PBP3. More recently FtsW was revealed to transport the lipid-linked peptidoglycan precursor, lipid II, across the cytoplasmic membrane (Mohammadi et al. 2011).  
3.3.9.4 ShsE ShsE was determined to share similarity with SwrC. In B. subtillis SwrC is known to convey resistance to surfactin production and is thought to belong to the resistance-nodulation cell division (RND) family of transmembrane efflux transporters (X. Li et al. 2015). In S. aureus an RND transporter with some similarity to SwrC has been shown to interact with other proteins of the cell wall synthesis pathway (Quiblier et al. 2013).  
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3.3.9.5 ShsK ShsK was annotated by Prokka as VraS and confirmed by BLAST similarity as a staphylococcal histidine kinase. VraS forms part of a two component sensor-regulator system VraRS and a member of the cell wall stress stimulon (Utaida et 
al. 2003). It is also known to have a role in the cell wall biosynthesis pathway (Kuroda et al. 2003). Expression of VraRS is upregulated in S. aureus in response to antibiotics whose action targets the cell wall (McAleese et al. 2006). Kuroda et al proposed that VraRS controlled the transcription of a set of 46 genes in the meticillin-resistant N315 strain of S. aureus, and that the cell wall stimulon including VraRS was induced as a result of peptidoglycan synthesis inhibition as opposed to the presence of cell wall active antibiotics (Kuroda et al. 2003). In S. 
hominis VraS was conserved across all 11 isolates, although sequence diversity was observed as only VraS in the multidrug resistant isolate ZBW5 was present in the PSI-blast analysis of the LPXTG-motif containing proteins (Table 3.2).   
3.3.9.6 ShsN ShsN was found to have evolutionary relationship to the DrrB family of ATP transporters. This family of ABC transporters was identified to have specificity for drugs, however some are also known to transport other substrates such as lipids and steroids (Borges-Walmsley & Walmsley 2001). ShsN lies immediately upstream of a homologous gene with an overlapping reading frame. This is in line with the expected structure of an ABC drug transporter which typically comprises two similar subunits.  
3.3.9.7 Cell Wall-Associated Lipases Lipases are commonly isolated from the staphylococci and are proposed to have roles in virulence and skin colonisation with evidence that surface bound lipases may interact with the extracelluar matrix(Sakinç et al. 2005). GehD of S. 
epidermidis is an example of one such surface-associated lipase shown to bind collagen (Bowden et al. 2002). One study found lipase production in 9 out of a panel of 11 species of CoNS tested; S. hominis exhibited lipase production in 50% of strains (Long et al. 1992). In the strains investigated here 6 of the 11 
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isolates were predicted to contain a possible lipase precursor (ShsG, Table 3.2), which agrees with the results of the previous study. Of note, the two species described to be negative for lipase production in 100% of strains tested were S. 
haemolyticus and S. lugdunensis, both of which are recognised as increasingly important opportunistic pathogens (Ravaioli et al. 2012)  (Barros et al. 2012) .   
3.3.9.8 CWA Peptidase and Haemolysin in S. hominis The presence of a possible haemolysin in one of the 11 isolates from this study is not without precedence. Kloos & Schleifer found that 5 out of 20 isolates of S. 
hominis from two geographically distinct locations showed weak haemolytic activity (Kloos & Schleifer 1975).   Membrane-associated peptidases are known to occur in staphylococci, most notably the acquired transpeptidase PBP2a, which is encoded by the mecA gene, that confers resistance to meticillin in several species of staphylococci (Łeski & Tomasz 2005). The lateral transfer of PBP2a sets a precedent for peptidases as part of the accessory genome which is interesting since ShsH, a putative staphylococcal peptidase, is not universal but is present in a majority subset of 8 of the 11 isolates.  
3.3.9.9 Putative CWA transporter proteins The putative CWA proteins ShsB, ShsD, ShsI, ShsJ and ShsN were all identified as likely surface-associated transporter proteins. ShsB was annotated by Prokka as PitA, a low affinity inorganic phosphate transporter and this annotation was supported by BLAST. PitA is conserved across several species of bacteria including E. coli, Listeria monocytogenes and S. aureus. In E. coli PitA, as part of the PitAB transporter is concerned with the transport of inorganic phosphates as well as efflux of zinc(II) (Beard et al. 2000). In S. aureus PitA is a member of the GraRS regulon and shown to be upregulated by GraRS through expression profiling (Falord et al. 2011). In this study ShsB was conserved across all 11 isolates.  
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ShsF was found to encode a phosphotransferase system (PTS) glucose transporter, E11CBA. PTS systems are important in the regulation of many catabolic pathways and consist of the two general proteins cytoplasmic soluble enzyme I (EI) and a histidine-containing phosphocarrier protein. These general proteins are involved in the transport of all PTS sugars (Reizer et al. 1999). The specificity of the system comes from enzyme II (EII) which is a permease specific for its substrate comprising three domains. EIIA and EIIB are both hydrophilic domains located in the cytoplasm. EIIC is a hydrophobic transmembrane domain which interacts with and translocates the sugar substrate into the cell (Christiansen & Hengstenberg 1999). ShsF is conserved across all 11 isolates of S. hominis.  ShsJ was annotated by Prokka as a citrate/succinate antiporter. Citrate/succinate antiporters participate in the tricarboxylic acid (TCA) cycle which is accepted as a metabolic hub in aerobes and a system which undergoes regulation in pathogenic bacteria to modulate stress tolerance (Somerville & Proctor 2009). In S. epidermidis iron limitation and the presence of ethanol depress the TCA cycle and activate biofilm formation (Sadykov et al. 2010).  It has also been suggested that mutations in the TCA cycle found in clinical isolates of S. epidermidis could contribute to increased survival in the presence of some 
β-lactam antibiotics (V. C. Thomas et al. 2013). Although ShsJ only fulfilled all 4 criteria for designation as a putative surface protein, in 2 of the 11 isolates tested it was conserved across all 11 isolates (Table 3.2). In the remaining 9 isolates ShsJ contained a signal peptide, a transmembrane domain and an LPXTG motif however it was not found to have homology with any of the staphylococcal surface proteins tested through PSI-blast. Average identity between the remaining 9 isolates was 99.8%.  
3.3.10 Discrete S. homnis CWA proteins Alongside the previously described putative CWA proteins there was another set of LPXTG-motif containing proteins which did not fulfil the criteria of homology to the panel of adhesins used as templates for PSI-blast (Table 3.3). These additional proteins did, however fulfil all other criteria for the analysis 
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and so were investigated as a secondary, discrete group of putative CWA proteins.    
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Table 3.3 Discrete S. hominis cell wall associated proteins. Homologous genes are grouped together. The closest match by blast is the sequence with the highest blast score after searching the cell wall associated protein against the BLAST database. Average identity is the average protein sequence identity between the protein sequences from the isolates which contain the cell wall associated protein. 
Protein ID Prokka annotation Closest match by 
BLAST  
Average identity 
1 B10-PB_01650 Antiholin-like protein LrgB LrgB 99.9 C80-PB_01608 J6-PB_01569 J11-PB_01570 J23-PB_01565 J27-PB_01570 J31-PB_01577 I4-PB_01573 SK119-PB_01572 VCU122-PB_01601 ZBW5-PB_01629 
2 B10-PB_00664 Phosphatidate cytidylyltransferase Phosphatidate cytidylyltransferase 99.7 C80-PB_00620 J6-PB_00591 J11-PB_00592 J23-PB_00589 J27-PB_00591 J31-PB_00591 I4-PB_00640 SK119-PB_00576 VCU122-PB_00587 ZBW5-PB_00631 
3 C80-PB_01812 Inner membrane transport protein YnfM Major facilitatior protein  97.7 B10-PB_01860 J6-PB_01778 J11-PB_01779 J23-PB_01774 J27-PB_01779 J31-PB_01786 I4-PB_01782 SK119-PB_01763 VCU122-PB_01801 ZBW5-PB_01824 
4 J6-PB_01899 Hypothetical protein Hypothetical protein  J11-PB_01899 J23-PB_01894 J27-PB_01901 J31-PB_01907 I4-PB_01898   
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3.3.10.1 LrgB One of the discrete CWA proteins was annotated as the antiholin-like protein LrgB, which was confirmed by BLAST. LrgB is part of a family of bacterial cell death effectors characterised in S. aureus. The antagonistic effects of the lrg operon and the cid operon were shown to modulate the activity of murein hydrolase activity and susceptibility to antibiotics in liquid culture (Groicher et 
al. 2000). Coordination of cell lysis and death under the conditions of biofilm formation was observed to be a function of Lrg. An lrgAB mutant with decreased 
lrgAB expression exhibited increased lysis during biofilm formation consistent with its role as an inhibitor of cell lysis. Increased cell lysis leads to an increase of extracellular DNA and in turn leads to increased adherence of the biofilm (E. E. Mann et al. 2009). LrgB was conserved across all S. hominis isolates with a identity of 99.9%. The S. hominis protein shared 65.7% identity with S. aureus LrgB. In the S. hominis genome, lrgB was located next to a gene annotated by Prokka as lrgA and confirmed by BLAST. The protein shared 56.5% identity with S. aureus LrgA.  
3.3.10.2 Cds Cds is a phosphatidate cytidylyltransferase which catalyses the synthesis of CDP-diacylglycerol from phospatidic acid (PtdOH) and cytidine triphosphate (CTP). The reaction product is then subsequently used to produce peptidoglycan. Cds was shown to be an essential protein since deletion of the cognate gene was lethal (Kuhn et al. 2015). Cds is conserved with an average 99.7% identity across all 11 isolates of S. hominis sharing an average 84.7% identity with S.aureus CdsA.  
3.3.10.3 Inner membrane transport protein YnfK Annotation by Prokka revealed the presence of YnfK, a hypothetical transport protein of E. coli. BLAST showed that the protein was part of the major facilitator family of transport proteins. S. aureus is reported to contain aproximately 20 multi drug resistance efflux pumps, and the most abundant protein family among them is the major facilitator family of proteins (DeMarco 
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et al. 2007). The YnfK inner membrane transport protein was conserved across all isolates of S. hominis with an average identity of 97.7%. The S. hominis protein shared an average of 22.9% identity with the E. coli transporter YnfK and between 11.2 and 20.2% identity to characterised S. aureus MFS proteins (Table 3.4).  The S. aureus MFS transporters which shared the highest identity with the S. hominis protein were NorA with 18.1% identity and Tet38 with 20.2% identity. NorA is proposed to have a broad substrate specificity and as such is able to transport hydrophilic quinolones and barbicides (H. Yoshida et 
al. 1990). Tet38 is known to be chromosomally encoded in S. aureus and has been shown to be important in skin colonisation in a BALB/c mouse model. Furthermore Tet38 expression was upregulated in the presence of subinhibitory concentrations of fatty acids (Truong-Bolduc et al. 2013).    
Table 3.4 Analysis of the S. hominis multi facilitator superfamily proteins. sequence identity between the gene products of the well-characterised S. aureus MFS proteins and the S. 
hominis secondary CWA protein with sequence identity determined by BLAST to the multi facilitator superfamily of proteins. 
S. aureus MFS protein Reference Average sequence identity with 
S. hominis MFS protein NorA (Ubukata et al. 1989) 18.1 QacA/B (Tennent et al. 1989) 16/17 MepA (Kaatz et al. 2005) 14.5 MdeA (J. Huang et al. 2004) 11.2 NorB (Ding et al. 2008) 16.0 NorC (Truong-Bolduc et al. 2006) 15.7 LmrS (Floyd et al. 2010) 14.5 Tet38 (Truong-Bolduc et al. 2013) 21.2   
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3.3.11 Putative SERAMS  Analysis of putative SERAMs in the S. hominis genome revealed the presence of two regions in all 11 genomes with sequence similarity to the conserved staphylococcal SERAM Ebh (Table 3.5). Ebh is encoded by only one gene, ebh, in 
S. aureus strains 8325, COL and USA300 whereas it is encoded by 2 separate genes, ebhA and ebhB in strains N315 and Mu50. The separation of ebh into two separate genes is proposed to have occurred as a result of a frame shift mutation (Clarke et al. 2002). Furthermore, a truncated form of ebh is found in 
S. aureus strain Newman which lacks the transmembrane domain of the protein and has a length of 7021 bp (Cheng et al. 2014). EbhA is the C-terminal portion of Ebh, a giant extracellular matrix binding protein. The ebhA gene of S. aureus is homologous to the Emb of Streptococcus defectivus (Manganelli & van de Rijn 1999) (Clarke et al. 2002), Emb has in turn been shown to be responsible for extracellular matrix binding of the species in chemical mutagenesis studies (Tart & van de Rijn 1993).   In the S. hominis strains, SK119 and VCU122 region 1 was 6.5 kb in size, less than the equivalent region in the other strains where it was between 7.1-7.8 Kb. Region 1 was present as a single open reading frame in strains SK119, ZBW5 and the J31 PacBio assembly. Further analysis showed that this protein contained an LPXTG-like cell wall sorting signal. Furthermore, this reading frame has an average identity of 27.6% with S. defectivus Emb. Multiple protein sequence analysis also showed 15.6% identity with S. hominis EbhA, 15.49% identity with S. hominis EbhB, 18.4% identity with the S. epidermidis RP62A Ebh homologue and 16.02% identity with the S. warneri Ebh homologue.  Although this S. hominis protein with similarity to EbhA was found in the search for the LPXTG-motif, it is possible that this binds to the bacterial cell with an alternative cell surface binding mechanism as is the case for Ebh. Ebh and its S. 
epidermidis homologue, Embp, are known to be lacking an LPXTG binding motif and interact with the cell in a sortase-independent manner.   
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Table 3.5 The protein ID and length of the genomic loci with similarity to Ebh in 11 S. 
hominis genomes. Total lengths were calculated by summing the individual lengths of the open reading frames. Protein IDs in bold indicate proteins identified in the LPXTG analysis. 
Ebh similarity region 1 
Genome Protein ID Overlapping reading 
frames\separation of reading 
frames 
Total length 
kb B10-PB 01102, 01103  7.2 C80-PB 01051, 01052  7.1 J6-PB 01024, 01025  7.4 J11-PB 01025, 01026  7.2 J23-PB 01021, 01022  7.3 J27-PB 01023, 01024 01023, 01024 7.7 J31-PB 01026, 01027  7.2 I4-PB 01022, 01023  7.3 SK119-PB 01009  6.5 VCU122-PB 01028*, 01029, 01030, 01031 01029, 01030 6.5 ZBW5-PB 01062  7.6 J31 pacbio assembly 01043  7.8 
Ebh similarity region 2a and 2b  Underlined protein IDs in region 2 denote proteins in the sub region 2a. 
Genome Protein ID Overlapping reading frames Total length 
kb B10-PB 01564, 01587 (reading frames separated by 16,545 bp) 10.5 C80-PB 01518, 01545 (reading frames separated by 17,019 bp) 10.6 J6-PB 01500, 01501, 01503, 
01504, 01505* 01503, 01504, 01505 6.4 J11-PB 01503, 01504, 01505, 01506, 01507* 01505, 01506, 01507 14.2 J23-PB 01499, 01500, 01501, 01502, 01503  13.8 J27-PB 01502, 01503, 01504, 01505, 01506, 01507, 01508 01505, 01506 13.9 J31-PB 01510, 01511, 01512, 
01513* 01510, 01511, 01512, 01513 6.0 I4-PB 01506, 01507, 01508, 01509, 01510, 01511  13.6 SK119-PB 01487 01510 (reading frames separated by 17,517 bp) 10.6 VCU122-PB 01515, 01539 (reading frames separated by 15, 357 bp) 10.5 ZBW5-PB 01545, 01566 (reading frames separated by 14,298 bp) 10.6 J31 pacbio assembly 01534  15.1 
* the rest of the open reading frame was indicated through lack of stop codons, but no protein coding sequence predicted. 
  105 
Ebh region 1 in seven of the eleven isolates consists of 2 adjacent reading frames of ~4.1 kb and ~3.1kb with similarity to Ebh proteins. With three S. 
hominis isolates these genes were fused into one reading frame, and in the remaining isolate the gene was fragmented into four open reading frames (Table 3.5). In the isolates where region 1 was present as a single open reading frame the locus was found as part of the signal peptide analysis of the LPXTG motif-containing proteins. Further investigation of the open reading frames of the remaining 8 isolates revealed a signal peptide in the N terminal-associated open reading frame of the region. Disparity between the Illumina and PacBio assembly of the J31 isolate, along with the overlapping reading frames of J27 and VCU122 is evidence that the separated reading frames may in fact be a sequencing artefact, which the longer PacBio reads have been able to resolve the locus more effectively than the Illumina sequencing method. Alternatively, there may be divergence at this locus within S. hominis as is observed in S. 
aureus.  The LPXTG-motif containing protein in region 1 was found by BLAST analysis to have similarity with Mrp or SasC in the isolates ZBW5, VCU122, SK119, K8 and C80. Mrp is known to be a protein homologous to Ebh in S. aureus and implicated in meticillin resistance through modification of cell wall peptidoglycans (Wu & De Lencastre 1999). SasC was also discovered in S. 
aureus as part of a search for LPXTG-motif containing proteins and was found to have an N-terminal domain important in cell aggregation (Schroeder et al. 2009). SasC also exacerbated the biofilm forming capabilities of S. carnosus upon plasmid-encoded expression of the surface protein. Mrp and SasC share two domains, DUF1542 and a motif found in various architectures (FIVAR motif) both found in other cell surface proteins, significantly Ebh and its S. 
epidermidis homologue Embp (Schroeder et al. 2009).  Region 2 is split into two sub regions, 2a and 2b (Table 3.5). Region 2a consists of an ORF containing an LPXTG-motif. In 7 of the 11 isolated this locus was adjacent to 2-6 additional open reading frames with similarity to Ebh. In the remaining 4 isolates the LPXTG protein was separated by between 14.3 and 
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17.0 kb from Ebh similarity region 2b. The PacBio assembly of the J31 genome was different from each of these groups with both region 2a and 2b being located as a single ORF.   There are several possible explanations that might account for this potential sequence discrepancy. The first is that there is indeed sequence divergence at this locus and two different loci occur. All open reading frames with similarity to Ebh at this locus may have been a single open reading frame in the evolutionary past and mutation events such as insertion of mobile genetic elements might have resulted in the locus becoming fragmented into several ORFs. Insertion of genetic material following an early gene fragmentation event may have resulted in the group of isolates where region 2a and 2b became separated. Good evidence against this possibility is, again, the disparity at this locus between the Illumina and PacBio assemblies of the J31 genome. The PacBio assembly indicates that regions 2a and 2b are fused whereas the Illumina assembly suggests a fragmented locus. As PacBio reads are longer than illumina reads (10kb vs 250bp) fewer reads are required to span a genomic region such as this. Due to the declining quality of sequence data at the ends of reads it is possible that there are sequencing errors within a potentially very large open reading frame traversed by multiple reads such as this one, which could affect gene calling and result in the appearance of multiple shorter open reading frames. Assembly errors could result in the spatial separation of region 2a and 2b in the isolates B10, C80, VCU122 and ZBW5, or alternatively the gene fusion in the PacBio assembly of J31. Validation by Sanger sequencing of these particular genomic regions could be used to clarify the genome structure.  Multiple sequence alignments were generated with the protein sequences of the J31 PacBio assembly of region 2, S. aureus strain Newman EbhA and EbhB, the putative S. warneri Ebh homologue and S. epidermidis Ebh homologue. Region 2 shares 30% identity with the S. warneri putative Ebh homologue, 34% identity with S. epidermidis RP62A Ebh homologue and 29.6% identity with S. aureus Newman EbhB. Region 2 also showed 18.1% identity with S. defectivus Emp 
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which is consistent with the 18.54% identity with S. epidermidis Ebh and the 19.12% identity found in both Newman and S. warneri.  Region 2 from the J31 PacBio assembly was analysed for the presence of transmembrane domains. None were found which is consistent with the S. 
warneri Ebh homologue which was also found not to contain transmembrane domains.  S. aureus Newman was also found to carry a truncated Ebh without transmembrane domains, however it was localised to the cell surface despite this truncation (Cheng et al. 2014). Localisation of Ebh in S. aureus was revealed to follow the expected pattern for proteins containing a YSIRK-motif signal peptide (Cheng et al. 2014). The putative S. hominis Ebh homologue similarly contains such a signal peptide. Furthermore a SasC/Mrp/FmtB cellular aggregation domain was also observed supporting findings that Ebh has a role in cell aggregation and biofilm formation. It was proposed that S. epidermidis Embp, the Ebh homologue, is involved primarily in tolerance to the osmotic pressures encountered on the skin and that its role in cell aggregation may be through cell-to-cell adhesion (Linnes et al. 2013).    Although Ebh proteins represent some of the largest open reading frames in the 
S. hominis genome their length falls far short of S. aureus Ebh and S. epidermidis Embp ORFs which are around 30 kb in length with strain dependent variation observed. There is no open reading frame of this length in any of the S. hominis genomes.  Despite questions about the genome organisation at these loci the presence of proteins with similarity to Ebh suggest that S. hominis secretes proteins capable of binding to the host extracellular matrix. This would be expected as it is thought that a range of adhesins and MSCRAMMs, such as wall teichoic acid, IsdA and ClfB, are required at different stages of epithelial colonisation by S. 
aureus (Burian et al. 2010), although this theory has not been explored in other species of staphylococci.  
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3.3.12 YSIRK sequence motif The YSIRK motif is located within the signal peptide of some LPXTG containing proteins and localises these proteins near the cell division septum (Carlsson et 
al. 2006). This results in a ring pattern of distribution around the cell (Cheng et 
al. 2014). In S. aureus it is known that expression of surface protein display (spdABC) genes is required for the trafficking of these proteins to the correct cell wall compartment (Frankel et al. 2010). Surface proteins lacking the YSIRK motif by contrast are localised to the cell poles (Schneewind & Missiakas 2012).   In S. hominis this YSIRK motif was conserved and was present in ShsB and the N terminus of both Ebh regions 1 and 2. 
 
3.3.13 Ica locus and IS256 insertion sequence The presence of icaA and IS256 are proposed to be markers of S. epidermidis invasiveness due to their involvement in biofilm production (Kozitskaya et al. 2004). Chromosomally encoded IS256 in conjunction with the ica genes is important, particularly as IS256 is thought to alter gene expression of the ica locus resulting in loss of the biofilm-positive phenotype. Reversible insertion and excision of IS256 into either icaA or icaC results in inactivation of these genes (Ziebuhr et al. 1999).Their presence or absence is used to inform clinical decisions regarding treatment of blood cultures positive for CoNS, which are often regarded as contamination due to their commensal lifestyle and ubiquitous distribution on human skin. Importantly, however, diversity in the pathways of biofilm formation has been shown in S. epidermidis with only 60% of biofilm-forming isolates testing positive for the presence of ica genes (Conlan 
et al. 2012). There is also evidence to support biofilm production in S. hominis (Mendoza-Olazarán et al. 2013), (Christensen et al. 1983), (Jones et al. 1992). The increasing involvement of S. hominis in clinical disease, its potential for forming a biofilm and the reported lack of icaA gene suggests a need for a wider strategy to assess invasiveness in CoNS involving a panel of markers which represent the more complex story of biofilm formation in the staphylococci. To examine further the genetic potential for biofilm formation in S. hominis the 
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available genomes were examined for both the ica gene locus as well as other genetic factors implicated with biofilm formation in staphylococci. 
 The ica gene locus was not observed in any of the S. hominis in this study. This is in accordance with reported data which also failed to identify icaABCD genes in 
S. hominis (de Silva et al. 2002). IS256 was observed in the ZBW5 multidrug resistant isolate, however without the presence of the ica genes, biofilm phenotype phase variation is unlikely to occur via IS256 in this strain. Despite the absence of the ica locus, all seven isolates sequenced in this study were found to have biofilm forming capabilities (Figure 3.7) indicating that this capability is independent of PIA/PNAG synthesis.   
Figure 3.7 Biofilm forming capabilities of the S. hominis isolates sequenced in this 
study. S. aureus SH100 and S. epidermidis RP62A were used as positive controls as they are both known to produce a strong biofilm. Absorbance of all test wells were normalised against a methyl blue treated control well containing only BHI supplemented with  glucose, without the presence of bacteria. 
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Other staphylococcal genes known to be involved in adherence and accumulation of biofilms include S. epidermidis Embp, the accumulation factor Bhp, and the murein hydrolase Atl. Bioinformatic analysis using psi-BLAST did not reveal the presence of a Bhp homologue with its characteristic Ig repeat regions among the surface proteins (Cucarella et al. 2001) (Lasa & PenadEs 2006) encoded in any of the S. hominis genomes. As described in detail previously, two regions showing similarity to Ebh, the S. aureus homologue of Embp, were found in all 11 isolates of S. hominis. Furthermore, putative CWA proteins which may have the capability to bind host ECM and cells were found in the S. hominis genomes. This suggests that S. hominis has the potential to initiate attachment to host proteins, the first stage of in vivo biofilm formation. 
 The biofilms formed by the biofilm-positive strains in this study were observed predominantly at the air-liquid interface with biofilm formation evident to a much lesser extent at the liquid-solid interface. Air-liquid interface biofilms are produced in the significant clinical pathogens Pseudomonas aeruginosa (Friedman & Kolter 2004) and Salmonella typhimurium (Römling et al. 2000)  among others. This mechanism differs from the S. epidermidis and S. aureus strains tested which form biofilms predominantly at the liquid-solid interface. It is worth noting that a range of growth media, the presence of plasma proteins and environmental conditions were not tested with S. hominis and there remains the possibility that the Ica-independent biofilm formation of this species might be dependent on particular environmental cues.    The ability to form a biofilm is not only considered to be a predictor of invasiveness, it has also been suggested that biofilm production may influence the ability of a bacterial species to colonise alternative niches. This is particularly clinically relevant since biofilms provide bacterial species with the opportunity to seed new sites with infective doses of cells (Hall-Stoodley & Stoodley 2005).    
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3.3.14 Antibiotic resistance profile, associated transposons and insertion 
sequences There is evidence to suggest that the antibacterial resistance profiles of the resident skin flora may have important diagnostic worth in the hospital setting. Obolski et al (2014) found the resistance profiles of CoNS contaminating blood cultures to be effective predictors of the resistance profiles, as well as specific antibiotic resistance, of the infecting organism (Obolski et al. 2014).   Predicted bacitracin resistance was conserved across all 11 isolates of S. hominis in this study with bacA universally present (Table 3.6); this gene was found to be chromosomally encoded in all isolates. BacA is an undecaprenyl pyrophosphate phosphatase and dephosphorylates undecaprenyl pyrophosphate, or UPP (C55-PP), which is the precursor for undecaprenyl phosphate or UP (C55-P), a lipid integral to synthesis of peptidoglycan and lipopolysaccharide in Gram-negative bacteria. It is a carrier lipid which facilitates transport of hydrophilic precursors through the hydrophobic cell membrane where they are externally polymerised.  Dephosphorylation of UPP occurs after each round of teichoic acid synthesis to make the lipid carrier UP available for the transport of further hydrophilic intermediates (Ghachi et al. 2004). Bacitracin is a cyclic polypeptide antibiotic whose bactericidal capabilities come from its ability to sequester the UP precursor, UPP, to prevent it from functioning as a lipid carrier thus disrupting wall teichoic acid synthesis. Approximately 80% of the reservoir of undecaprenol in the staphylococcal cell is present in the form of the free alcohol UP-OH (Higashi et al. 1970). It was suggested that this constitutes a pool of UP undecaprenol available to restock the supplies of UP should this be required (Ghachi et al. 2004). It has been shown, however controversially (Ghachi et al. 2004), that BacA possessed isoprenol kinase activity when plasmid encoded in E. coli (Cain et al. 1993) and it was also suggested that BacA may have undecaprenol kinase capabilities in S. 
aureus (Chalker et al. 2000) and functions to phosphorylate UP-OH and replenish the pool of UP under the condition of its sequestration by bacitracin (Yoshida et al. 2011).   
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Table 3.6 S. hominis antibiotic resistance profiles. The genes responsible for resistance to the antibiotics are listed are shown for each strain.  
Strain B10 C80 J6 J11 J23 J27 J31 I4 SK119 VCU122 ZBW5 
Bacitracin baca baca baca baca baca baca baca baca baca baca baca 
Penicillin bl2a-pc  bl2a-pc bl2a-pc bl2a-pc bl2a-pc bl2a-pc bl2a-pc   bl2a-pc 
MLS* msra msra       msra msra ermc 
Streptogramin a         vgaa   
Macrolide mphc        mphc mphc  
Fusaric acid  fusb          
Tetracycline          tetK tetk 
Bleomycin           ble 
Lincomycin           lnua 
Beta lactams           meca 
Methicillin           mecr1 
Isepamicin           aac6ie 
Netilmicin           aac6ie 
Tobramycin           aac6ie 
Amikacin           aac6ie 
Sisomicin           aac6ie 
Dibekacin           aac6ie 
Tobramycin           aadd 
Kanamycin           aadd 
*MLS resistance is resistance to macrolides, lincosomides and streptogramin A 
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Penicillin resistance was predicted in 8 of the 11 isolates through the presence of a type A beta-lactamase (Table 3.6). The beta-lactamase found in the S. hominis isolates was blaZ, known to confer resistance only to penicillin. Studies have shown that BlaI, the repressor of blaZ and MecR1, which in turn is the repressor of mecA, are homologous proteins which are capable of interacting to form heterodimers. It is proposed that these heterodimers bind with reduced affinity to the mecA promoter which results in reduced repression of mecA and the full expression of the meticillin resistance phenotype (Arêde et al. 2013). This is particularly significant in this study since mecA, mecR1 and blaI were all present in the genome of S. hominis isolate ZBW5.  Aminoglycoside resistance is conferred by the gene aacA-aphD and a copy was predicted in the genome of ZBW5 (Table 3.6). This gene is carried on the staphylococcal transposon Tn4001 found on composite phage as well as the SCCmec transposable element (Rouch et al. 1987) (Kinnevey et al. 2014). On this transposon the aacA-aphD resistance determinant is also flanked by the IS256L and IS256R sequences. The gene aacA-aphD encodes an aminoglycoside modifying enzyme (AME) and is also harboured on the transposon Tn4100 in S. 
aureus, which is similar to Tn4001 however it contains a similar insertion sequence IS257 in place of IS256 (Culebras & Martínez 1999) and Tn4031 in S. 
epidermidis. In S. hominis strain ZBW5 however aacA-aphD was not found to be flanked by IS256, however a single copy of IS256 was found to be present in the genomic region predicted to be an intact phage at the coordinates 2253755-2328024 (Table 3.9). The amino glycoside resistance gene falls within this phage region, indicating that it is phage encoded.  In addition to the presence of aacA-aphD (coordinates 2296616-2299055), PBP2A and meticillin resistance regulatory elements (coordinates 2255726-2257854) were also observed in the same region of the genome along with several genes considered to be markers of the SCCmec element. A putative cassette chromosome recombinase with 93.7% identity to S. aureus ccrC2 was found downstream of the putative SCCmec element. The IS431 insertion sequence is found on all types of SCCmec elements identified (International 
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Working Group on the Classification of Staphylococcal Cassette Chromosome Elements (IWG-SCC) 2009) and a copy of this sequence was found in the vicinity of the mec element in S. hominis ZBW5. The insertion sequence IS256 is associated with Tn4001 found on SCCmec type IV (Chlebowicz et al. 2010) and this IS element was found between the mec element and aacA-aphD. There is also evidence to show that mecA has been isolated from phage DNA from environmental samples (Colomer-Lluch et al. 2011) and to a lesser extent human faecal samples (Quirós et al. 2014). The presence of an SCCmec element similar to the type IV cassette could explain the genome region described here which contains both phage proteins and genes associated with SCCmec. Alternatively this may be a poorly resolved area of the genome sequence which contains multiple mobile elements. It is known that these elements are difficult to resolve where some sequencing technologies are used (Steinig et al. 2015).  This analysis does however present strong evidence that aminoglycoside resistance and meticillin resistance are both carried on mobile genetic elements in S. hominis. This provides additional evidence that S. hominis might donate antibiotic resistance determinants to other staphylococcal species, and also potentially acquire them through horizontal gene transfer (Strasheim et al. 2013).   Another important resistance phenotype is resistance to macrolides, lincosomides and streptogramin B (MLS). MLS resistance was predicted in 5 of the 11 isolates of S. hominis through two different pathways, ermC in strain ZBW5 and msrA in strains B10, C80, SK119 and VCU122 (Table 3.6). The gene responsible for MLS resistance was found immediately adjacent to those responsible for macrolide resistance in strain B10. These genes were located with an adjacent transposase gene immediately up and downstream indicating that they may be associated with a mobile genetic element such as a transposon. In strain SK119, these genes are also found in an area of the genome where transposases and plasmid-associated genes are also present. This is also true of the gene, vgaA, responsible for streptogramin resistance in this strain. In strain VCU122, MLS, macrolide and tetracycline resistance determinants are all 
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located immediately adjacent to each other. A transposase is also found adjacent to these resistance genes and they are found near to plasmid-associated genes. Similarly in strain C80, MLS resistance determinants reside in an area of the genome where plasmid and transposon-associated genes are present. As previously discussed, sequences of mobile genetic elements such as plasmids and phage are difficult to assemble and therefore genes associated with these MGEs often cluster at the end of genomes. This appears to be the case for the S. 
hominis genomes in this study, with the exclusion of the PacBio assembly of S. 
hominis strain J31. The presence of MLS and streptogramin A resistance genes in this unresolved area of the genome indicates that these genes may also be carried on a mobile genetic element.  MLS antibiotics are increasingly being prescribed as an alternative to meticillin as a response to meticillin resistance. An increased incidence of MLS prescription has likely selected for increasing levels of MLS resistance. MLS resistance phenotypes are complex and an understanding of their genetic basis is vital to correctly inform antibiotic therapy choices. MLS resistance attributable to ermC, as in the case of strain ZBW5, renders the use of first line antibiotics erythromycin and clindamycin ineffective. Resistance conferred by 
msrA however does not result in clindamycin resistance and so leaves this first line treatment available (Steward et al. 2005). The isolate SK119 was also predicted to contain an additional efflux pump to msrA which confers resistance to streptogramin A. Although the proteins encoded by the two loci are similar they do display divergent drug specificities (Chesneau et al. 2005) thought to be mediated by the C-terminus of the protein (Jacquet et al. 2008).   The fusidic acid resistance gene fusB was present in only 1 isolate, C80 (Table 3.6), where the gene is located near to plasmid and transposon-associated genes. FusB confers fusidic acid resistance in a highly unusual manner for antibiotic resistance by binding to elongation factor G and stalling the ribosome thus halting protein synthesis (Verbist 1990). FusB binds to the elongation factor via a zinc binding domain at a C-terminal site, the fusidic acid binding site is located at the N-terminus. Due to this spatial disparity in binding sites it was 
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hypothesised that steric hindrance of fusidic acid binding by FusB was unlikely. FusB causes destabilisation of the ribosome:elongation factor:GDP complex in the presence of fusidic acid which allows translation and therefore protein synthesis to continue (Cox et al. 2012). 
 
3.3.15 Mobile genetic elements 
3.3.15.1 Plasmids  Experimental data suggest that S. hominis J31 contains at least three plasmids. This is confirmed by PacBio sequence data with four of the five contigs obtained predominantly showing BLAST hits to staphylococcal plasmids. Further evidence to support that these contigs represent S. hominis plasmids is the presence of replication proteins on these contigs and indications from the initial PacBio sequence analysis that these contigs represent circular pieces of DNA (section 2.3.3). Each of the putative plasmid contigs are also indicated to be circular due to the annotation of similar gene fragments at both ends of the contigs (Table 3.7a-d).   
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Table 3.7a  The genes associated with plasmid contig 1. BLAST revealed similarity to Staphylococcus 
warneri SG1 plasmid clone pvSw5 genomic sequence. Query coverage- 20%, E-value- 0, Identity- 99% Gene name Gene product Plasmid annotation 
czcD_1 Cadmium  2C cobalt and zinc/H(+)-K(+) antiporter plasmids_00004 
czcD_2 Cadmium  2C cobalt and zinc/H(+)-K(+) antiporter plasmids_00005 
czcD_3 Cadmium  2C cobalt and zinc/H(+)-K(+) antiporter plasmids_00006 
 Glutaredoxin 3 plasmids_00007 
csoR_1 Copper-sensitive operon repressor plasmids_00008 
copA_1 Copper-exporting P-type ATPase A plasmids_00009 
copZ_1 Copper chaperone CopZ plasmids_00010 
 Hef nuclease plasmids_00013 
mobA_1 DNA strand transferase plasmids_00017 
 Integrase core domain protein plasmids_00020 
 YolD-like protein plasmids_00023 
 Putative transposase DNA-binding domain protein plasmids_00025 
soj Sporulation initiation inhibitor protein Soj plasmids_00027 
 anaerobic benzoate catabolism transcriptional regulator plasmids_00030 
 Replication initiation factor plasmids_00034 
spsB Signal peptidase IB plasmids_00035 
msbA Lipid A export ATP-binding/permease protein MsbA plasmids_00042 
 ABC-2 family transporter protein plasmids_00043 
 Pentapeptide repeats (8 copies) plasmids_00045 
yidC Membrane protein YidC plasmids_00047 
bin3_1 Putative transposon Tn552 DNA-invertase bin3 plasmids_00048 
 ABC-type enterochelin transport system  2C ATPase component plasmids_00050 
 Integrase core domain protein plasmids_00053 
ywrO General stress protein 14 plasmids_00055 
zwf Glucose-6-phosphate 1-dehydrogenase plasmids_00057 
gnd 6-phosphogluconate dehydrogenase  2C decarboxylating plasmids_00058 
pgi Glucose-6-phosphate isomerase plasmids_00059 
 3-hexulose-6-phosphate synthase plasmids_00060 
hxlB 3-hexulose-6-phosphate isomerase plasmids_00061 
hxlR HTH-type transcriptional activator hxlR plasmids_00062 
 Integrase core domain protein plasmids_00063 
immR HTH-type transcriptional regulator immR plasmids_00065 
 Integrase core domain protein plasmids_00066 
czcD_4 Cadmium  2C cobalt and zinc/H(+)-K(+) antiporter plasmids_00068 
 Glutaredoxin 3 plasmids_00069 
csoR_2 Copper-sensitive operon repressor plasmids_00070 
copA_2 Copper-exporting P-type ATPase A plasmids_00071 
copZ_2 Copper chaperone CopZ plasmids_00072 
ydaF_2 Putative ribosomal N-acetyltransferase YdaF plasmids_00074  Putative DnaQ family exonuclease/DinG family helicase plasmids_00076  Hef nuclease plasmids_00077 
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Table 3.7b Genes associated with plasmid contig 2. BLAST revealed similarity to 
Staphylococcus epidermidis ATCC 12228 plasmid pSE-12228-04, complete sequence. Query coverage- 28%, E-value- 0, Identity- 95% Gene name Gene product Plasmid annotation 
bin3_2 Putative transposon Tn552 DNA-invertase bin3 plasmids_00078 
 Putative ATP-binding protein involved in virulence plasmids_00079 
bmrA_1 Multidrug resistance ABC transporter ATP-binding/permease protein BmrA plasmids_00082 
 Conjugal transfer protein TrbA plasmids_00083 
mobA_2 DNA strand transferase plasmids_00089 
 Polar chromosome segregation protein plasmids_00093 
lrpC HTH-type transcriptional regulator lrpC plasmids_00095 
 Putative integral membrane protein plasmids_00097 
ecsA_1 ABC-type transporter ATP-binding protein EcsA plasmids_00099 
 ABC-type transport system involved in multi-copper enzyme maturation  2C permease component plasmids_00100 
bin3_3 Putative transposon Tn552 DNA-invertase bin3 plasmids_00102 
 putative ATP-binding protein involved in virulence plasmids_00103 
bmrA_2 Multidrug resistance ABC transporter ATP-binding/permease protein BmrA plasmids_00106  Conjugal transfer protein TrbA plasmids_00107       
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Table 3.7c Genes associated with plasmid contig 3. BLAST revealed similarity to S. 
saprophyticus subsp. saprophyticus MS1146 plasmid pSSAP1 complete genome. Query coverage- 16%, E- value- 0, Identity- 98% Gene name Gene product Plasmid annotation 
drrA_1 Daunorubicin/doxorubicin resistance ATP-binding protein DrrA plasmids_00119 
 Divergent AAA domain protein plasmids_00120 
nisC Nisin biosynthesis protein nisC plasmids_00127 
 Thiopeptide-type bacteriocin biosynthesis domain protein plasmids_00128 
apr Subtilisin plasmids_00129 
pepA Lantibiotic Pep5 precursor plasmids_00130 
fabG 3-oxoacyl-[acyl-carrier-protein] reductase FabG plasmids_00132 
ecsA_2 ABC-type transporter ATP-binding protein EcsA plasmids_00133 
 ABC-type transport system involved in multi-copper enzyme maturation  2C permease component plasmids_00134 
bin3_4 Putative transposon Tn552 DNA-invertase bin3 plasmids_00135 
ydgH Putative membrane protein ydgH plasmids_00136 
opuAC Glycine betaine-binding protein precursor plasmids_00137 
 Putative dihydroxyacetone kinase regulator plasmids_00138 
 Glyoxalase-like domain protein plasmids_00139 
 MepB protein plasmids_00140 
 Transcriptional repressor DicA plasmids_00142 
drrA_2 Daunorubicin/doxorubicin resistance ATP-binding protein DrrA plasmids_00147  Divergent AAA domain protein plasmids_00148  Type 2 lantibiotic biosynthesis protein LanM plasmids_00156  Type 2 lantibiotic biosynthesis protein LanM plasmids_00157  Thiopeptide-type bacteriocin biosynthesis domain protein plasmids_00159  Thiopeptide-type bacteriocin biosynthesis domain protein plasmids_00160   
  
Table 3.7d Genes associated with plasmid contig 4. BLAST revealed similarity to S. 
epidermidis CH plasmid pSepCH complete sequence, Query coverage-100%, E-value- 0.0, Identity 99% Gene name Gene product Plasmid annotation  Replication protein plasmids_00163 
qacC_1 Quaternary ammonium determinant C plasmids_00164 
 Replication protein plasmids_00166 
qacC_2 Quaternary ammonium determinant C plasmids_00167  Replication protein plasmids_00170 
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BLAST hits (99% identity, 100% query coverage) of plasmid contig 4 to the S. 
epidermidis plasmid pSepCH and the presence of qacC suggest the presence of a 
qacC group plasmid (Table 3.7d). Plasmid contig 3 carries putative lantibiotic bacteriocin biosynthesis genes and Blast revealed high sequence identity to the epicidin gene cluster of plasmid pCH01 (Heidrich et al. 1998) and the S. warneri plasmid pPI-1 known to encode the nukacin biosynthesis gene cluster (Aso et al. 2005) (Table 3.7c). The nuk operon genes of the S. warneri plasmid were not found in the S. hominis J31 genome, however.  S. warneri strain ISK-1 harbours a 
qacC plamid, pPI-2(Aso et al. 2005). S. epidermidis strain CH has the qacC plasmid pSepCH metioned above plus the epicidin encoding plasmid pCH01 discussed above. The putative lantibiotic biosynthesis cluster in S. hominis J31 has a conserved gene synteny when compared to the epicidin biosynthesis gene cluster of S. epidermidis (Figure 3.8). Gene product identity is between ~80-93%. The similarity observed between the homologous S. epidermidis lantibiotics epicidin and pep5 was 68-75% (Heidrich et al. 1998). The S. hominis lantibiotic biosynthesis gene products have 55-58% identity to the pep5 operon gene products. Upstream of the eci operon in S. epidermidis BN 280 lies the transposon Tn4003 associated with the insertion sequence IS257 (Heidrich et al. 1998). In S. hominis J31 the tranposase for Tn552 is present. Tn552 is however also associated with IS257 (Sidhu et al. 2002). Furthermore the plasmid gene 
drrA has BLAST similarity to a bacitracin ABC transporter of S. simulans. The presence of pSepCH and pCH01 in S. epidermidis CH, pPI-1 and pPI-2 in S. 
warneri ISK-1 plus the presence of a putative lantibiotic biosynthesis plasmid and qacC plasmid in S. hominis J31 could suggest that these two plasmids often occur together.    
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S. hominis was described as a  bacteriocin producer (Santos Nascimento et al. 2005) however the gene cluster found in the strain J31 in this study contrasts with earlier studies. Wilaipun et al identified a homologue of the S. warneri encoded lantibiotic nukacin ISK-1 which was designated nukacin KQU-131 (Wilaipun et al. 2008). Another study detailed the sequence of yet another lantibiotic encoded by S. hominis dubbed hominicin (Kim et al. 2010). Hominicin was found to be a type I lantibiotic of 21 amino acids in length, without similarity to other antimicrobial peptides and which does not contain thioether bridges in its structure (Kim et al. 2010). The two analogous peptides pep5 and epicidin are both around 30 amino acids in length and both contain a similar pattern of thioether bridges (Heilmann 2011). Given the high degree of sequence identity between the epicidin biosynthesis pathway genes and the homologous operon observed in S. hominis it may be extrapolated that a similarly structured peptide would be expected to result from it. It is documented that other species of staphylococci, including S. epidermidis and S. 
aureus, can encode multiple lantibiotic bacteriocins (Santos Nascimento et al. 2005). Perhaps then the S. hominis pan-genome encodes a repertoire of different bacteriocins.   
Figure 3.8 Lantibiotic biosynthesis operon. Representation of the synteny of the epicidin gene cluster in S. epidermidis BN280 and the lantibiotic biosynthesis gene cluster of S. hominis J31. The numbers indicate the number of amino acids comprising the genes and the arrow denotes the direction of transcription. The numbers in italics indicate the % identity between the residues in each gene product. 
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Lantibiotics are synthesised by the ribosome as two precursors; an N-terminal leader and a C- terminal propeptide which is modified by lanthionine synthase enzymes. LanC is the lanthionine synthase responsible for the post translational modification of type A(I) lantibiotics and is the synthase encoded by the S. 
hominis genomes in this study. Nukacin ISK is a type A(II) lantibiotic encoded by 
S. warneri and its constitutive pre-peptides are post translationally modified by LanM lanthionine synthase (Nagao et al. 2005).   The epicidin gene cluster does not have an associated TCS or ABC transporter, however expression in S. carnosus of only the epicidin gene cluster is sufficient to result in expression of the lantibiotic epicidin. It is hypothesised that a chromosomally-encoded transporter fulfils the function of exporting the lantibiotic in S. epidermidis. In S. hominis the presence of a putative bacteriocin ABC transporter encoded on the same plasmid as the lantibiotic synthesis operon suggests that this may not be the case in S. hominis strain J31.  Genes involved in metal ion resistance were also found to be encoded on plasmid contig 1 in S. hominis (Table 3.7a). Divalent cations such as zinc, iron and nickel are required for the growth and replication of bacteria and play catalytic (Sabala et al. 2014) as well as structural roles (Krishna et al. 2003) within proteins at nanomolar concentrations. Heavy metal ions are often added to feed stocks to reduce gastrointestinal diseases in livestock and as a result heavy metal resistance is widespread among livestock-associated strains of bacteria (Cavaco et al. 2010). Consequently heavy metal resistance mechanisms have evolved and are often found encoded by plasmids in addition to being found on the chromosome. czc genes are found on the chromosome in S. aureus (Poston & Hee 1991) (Kuroda et al. 1999) and the genomes of the S. hominis isolates in this study. Additional czc and czr genes are also found on plasmid contig 1 which is consistent with the previous observation of cadmium/zinc2+ resistance via a different mechanism on the pI258 plasmid of S. aureus (Ye et al. 2005). Heavy metal resistance has often been found to coexist with resistance to certain antibiotics and often on the same plasmid, this may not the case in this study since J31 contains only two probable antibiotic resistance factors one of 
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which is chromosomally encoded, the other appears phage-associated. There are however several putative multidrug ABC transporters present on the plasmid contigs that may represent uncharacterised pathways of antibiotic or biocide resistance in staphylococci.  
3.3.15.2 Conservation of plasmid genes among S. hominis strains To better understand how these plasmids were conserved across S. hominis strains an OrthoMCL analysis was performed to cluster the plasmid genes with any orthologous genes across the rest of the isolates.  171 proposed plasmid genes from the 4 putative plasmid contigs were grouped into 113 clusters of orthologous genes. The reduced number of clusters in comparison to genes would be expected in this analysis, not only due to the presence of families of similar genes such as those encoding replication proteins on multiple plasmids, but also due to the sequencing artefact of duplication of genes at the beginning and ends of the plasmid contigs. The presence or absence of these plasmid clusters of genes was then examined in the S. hominis genomes (Figure 3.9). All putative plasmid-encoding contigs were conserved across the similar isolates J6, J11, J23, J27, J31 and also K8 with more than 80% of gene clusters present in each isolate, with the exception of the small contig 4 which contained only 4 clusters.  
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Contig 1 Contig 2 Contig 3 Contig 4 
Figure 3.9 Conservation of plasmid associated genes The percentage of gene clusters from each putative plasmid contig determined by OrthoMCL present in the 11 S. hominis strains. Low percentage of plasmid gene clusters is indicated by white, a high percentage is indicated in red.   
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Of these sequences, contig 2 is proposed to encode a plasmid with a possible drug resistance efflux pump and was the most widely conserved with 8 strains sharing more than 50% of the genes clusters found on this contig (Figure 3.9).  Contig 3 is proposed to be a lantibiotic biosynthesis plasmid and is conserved only among the most similar isolates with the Liverpool “J” and K8 isolates posessing the nisC gene and sharing over 80% of the gene clusters. Strain C80 shares 50% of the gene clusters of plasmid contig 3 but does not contain the lantibiotic biosynthesis operon.  
3.3.15.3 Transposable elements Transposable elements and insertion sequences are ubiquitous features of prokaryotic genomes. They are credited as a source of expanded genome plasticity due to their involvement in recombination between sections of genomes and their facile and frequent mobilisation between species (Mahillon & Chandler 1998). One meta-analysis, however, disputed this claim and found no correlation between the number of IS sequences and the frequency of recombination across a range of species (Pál & Papp 2013). Transposons contain genes directing their insertion and excision and this is not discriminate,  occuring on the chromosome, plasmids or even within other transposable elements. These elements can undergo homologous recombination with other transposable elements thus forming novel structures (Roberts et al. 2008). Insertion sequences are short sections of DNA, which carry only the genes required for their mobilisation. Movement of transposable elements and insertion sequences into a new genomic location can be traumatic for the local architecture resulting inactivation or upregulation of genes in the vicinity. In general, insertion events are considered to be detrimental to the host genome, a consideration corroborated by the finding that larger genomes contain the highest frequency of insertion element and the lowest density of essential genes thus reducing the risk of a fatal insertion event (Touchon & Rocha 2007).  They can, however produce beneficial mutations that increase fitness which is one theory as to why selection maintains them within a genome despite their huge potential for deleterious effects (Fehér et al. 2012). 
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 In S. hominis, as with most other species of bacteria, the presence of several families of insertion sequences was detected (Table 3.8). The insertion sequence families IS1182 and IS6 were conserved across all isolates in this study. The insertion sequence IS257, an IS6 family insertion sequence also known as IS431, is conserved across all S. hominis isolates in this study. This insertion element is frequently associated with antibiotic resistance genes and carries a promoter region able to drive expression of drug resistance genes such as tetA more strongly than the native promoter in S. aureus (Simpson et al. 2000). Among human-associated staphylococci IS257-like insertion sequences of the IS6 family such as IS257, IS431 and ISSau10 were revealed to play a role in the integration of a multitude of smaller mobile genetic elements into larger mobile genetic elements or into the chromosome itself (Schwarz et al. 2011). Plasmid encoded ermC, for example, was shown to integrate into the chromosome in an IS257-dependent manner (Diep et al. 2006). Collectively, the IS6 family were described to be closely linked with the integration of resistance genes into the staphylococcal genome (Schwarz et al. 2014).  IS256, as previously discussed, is a marker for clinical invasiveness in S. 
epidermidis due to its association with the icaADBC gene locus and multidrug resistance (Yao et al. 2005) (Montanaro et al. 2007). This insertion sequence was identified in the multidrug resistant isolate, S. hominis ZBW5. The IS3 family and the IS30 family of insertion sequences were also present in the isolates B10, J31, SK119 VCU122 and ZBW5 (Table 3.8). The Insertion sequences present in the S. hominis isolates have origins in a range of staphylococcal species as well as being present in other genera of bacteria highlighting the capacity of IS elements to be agents of genetic diversity and genome plasticity and their effective lateral transfer capability.  
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Table 3.8 Summary of the insertion sequences present across the S. hominis isolates  
Genome IS family IS family origin B10 IS1182 S. aureus, S. epidermidis, S. 
haemolyticus  IS6 S. aureus  IS3 S. aureus J6 IS6 S. aureus  IS1182 S. aureus, S. epidermidis, S. 
haemolyticus J11 IS6 S. aureus  IS1182 S. aureus, S. epidermidis, S. 
haemolyticus J23 IS6 S. aureus  IS1182 S. aureus, S. epidermidis, S. 
haemolyticus J27 IS6 S. aureus  IS1182 S. aureus, S. epidermidis, S. 
haemolyticus J31 IS30 S. aureus  IS1182 S. aureus, S. epidermidis, S. 
haemolyticus  IS3 S. aureus  IS6 S. aureus SK119 IS1182 S. aureus, S. epidermidis, S. 
haemolyticus  IS3 S. aureus  IS6 S. aureus VCU122 IS1182 S. aureus, S. epidermidis, S. 
haemolyticus  IS3 S. aureus  IS6 S. aureus ZBW5 ISL3 S. haemolyticus  IS256 S. aureus, E. faecealis  IS6 S.aureus  IS1182 S. epidermidis 
 
 
3.3.15.4 Bacteriophages in the S. hominis genome 
 Bacteriophages were identified using the PHAST phage finder program  which assigns putative phage regions as intact, questionable or incomplete prophages according to criteria, including the number of coding sequences in the region, and the presence of characteristic phage genes such as tail and tape measure proteins (section 3.2.9). Several intact, questionable and incomplete prophage (Table 3.9) were found across the isolates of S. hominis. 
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Table 3.9 Summary of the prophage present in the S. hominis isolates. Incomplete phages were those with a completeness score below 60, questionable phage were those with a completeness score between 60 and 90. Complete phages were those with a score above 90. 
Isolate 
genome 
Genome 
position 
Region 
length 
Phage 
completeness 
Designation Possible phage  B10 83326-131512 48186 140 Intact Staphylococcus phage StB20 (NC_019915)  295758-315091 19333 70 Questionable Clostridium phage phiMMP04 (NC_019442)  1506131-1532195  26064 88 Questionable Staphylococcus phage PT1028 (NC_007045) C80 43650-64723  21073 30 Incomplete Staphylococcus phage PT1028 (NC_007045)  269721-308532 38811 50 Incomplete Staphylococcus phage PT1028 (NC_007045)  512225-536746 24521 150 Intact Lactobacillus prophage Lj965 (NC_005355)  1486948-1522307  35359 81 Questionable Staphylococcus phage PT1028 (NC_007045) J31 (PacBio assembly) 389028-402406  133378  20 Incomplete Staphylococcus phage phiRS7 (NC_022914)  1362133-1380156  18023 20 Incomplete Staphylococcus phage PT1028 (NC_007045)  1781926-1810085  28159  40 Incomplete Invertebrate iridescent virus 30 (NC_023611)  2217429-2238965  21536 40 Incomplete Cyanophage Syn30 (NC_021072) J6 374212-387475  13263 20 Incomplete Staphylococcus phage phiRS7 (NC_022914)  1330793-1348816  18023 20 Incomplete Staphylococcus phage PT1028 (NC_007045)  1749977-1778136  28162 40 Incomplete Invertebrate iridescent virus 30 (NC_023611) J11 374213-387492  13279 20 Incomplete Staphylococcus phage phiRS7 (NC_022914)  1330589-1348612  18023 20 Incomplete Staphylococcus phage PT1028 (NC_007045)  1749634-1777793  28159 30 Incomplete Invertebrate iridescent virus 30 (NC_023611) J23 374048-387311  13263 20 Incomplete Staphylococcus phage phiRS7 (NC_022914) 
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 1330889-1348912  18023 20 Incomplete Staphylococcus phage PT1028 (NC_007045)  1749653-1777812  28159 30 Incomplete Invertebrate iridescent virus 30 (NC_023611) J27 373945-387213  13268 20 Incomplete Staphylococcus phage phiRS7 (NC_022914)  1331029-1349052  18023 20 Incomplete Staphylococcus phage PT1028 (NC_007045)  1750132-1778291  28159 30 Incomplete Invertebrate iridescent virus 30 (NC_023611) I4 374220-387635  20 Incomplete  Staphylococcus phage phiRS7 (NC_02291)  1331466-1349489  20 Incomplete  Staphylococcus phage PT1028 (NC_007045)  1749754-1777913  40 Incomplete Invertebrate iridescent virus 30 (NC_023611)  2201825-2242040  109 Intact Enterococcus phage phiX174 (NC_001422) SK119 1323456-1337222  13766 20 Incomplete Staphylococcus phage PT1028 (NC_007045)  1459791-1496741  36950 88 Questionable Staphylococcus phage PT1028 (NC_007045) VCU119 1472455-1490085  17630 20 Incomplete Staphylococcus phage PT1028 (NC_007045) ZBW5 502486-517216  14730 150 Intact Staphylococcus phage CNPH82 (NC_008722)  1341869-1367471  25602 10 Incomplete Staphylococcus phage vB_SepiS-phiIPLA7 (NC_018284)  1494188-1515035  20847 30 Incomplete Staphylococcus phage PT1028 (NC_007045)  1787353-1806571  19398 30 Incomplete Invertebrate iridescent virus 30 (NC_023611)  2253755-2328024  74269 140 Intact Staphylococcus phage StB20 (NC_019915) 
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An incomplete phage with homology to the staphylococcal phage PT1028 was found at a chromosomally conserved location across all of the isolates. In those isolates where Ebh similarity regions were separated by between ~14 and ~17 kb (B10, C80, SK119, VCU122, ZBW5 Table 3.5) the PT1028 incomplete phage was found to be in the intervening region (Figure 3.10 A). In the isolates found to have an intact Ebh similarity region 2 (J6, J11, J23, J27, J31, K8, Table 3.5) the PT1028 incomplete phage was found upstream of this region (Figure 3.10 B). The length of the questionable PT1028 phage, however do not fit within the base range separating region 2a and 2b for the strains B10, C80 SK119 and ZBW5 indicating that the boundaries of the questionable and incomplete phage may not be accurate. However, this data does suggest that the separation of Ebh regions 2a and 2b in the strains B10, C80, SK119, VCU122 and ZBW5 may have been a result of a phage insertion, and that the phage genome may have subsequently decayed thus the designation as a questionable phage.   The intact phages were examined in detail, and the gene content investigated (Table S1). B10 phage 1 and ZBW5 phage 5 are intact prophages with homology to the staphylococcal phage STB20. Nucleotide sequence alignment of the B10 and ZBW5 phages revealed 62% and 64% identity with STB20 respectively, and 62% identity to one another. As previously mentioned aacA-aphD was found to be within the annotation of ZBW5 intact phage 5 however, despite the high degree of sequence identity between the B10 phage 1 and ZBW5 phage 5, aacA-
aphD is absent from the    
 131 
 annotation of B10 phage 1. This is consistent with the analysis of antibiotic resistance genes (Table 3.6).  ZBW5 phage 5 also showed 68% sequence identity to StB27 (Accession number JN700519). Mauve alignment showed a region conserved between ZBW5 phage 5 and STB27 (Figure 3.11). Investigation of the gene content of this region using ACT revealed the presence of essential phage proteins such as the tail tape measure protein, and other structural proteins. The ZBW5 phage 5 also has an extended length of 74,269 bp in comparison to the 40071 bp of the phage STB27 (Figure 3.12).  
 The genes present in these additional bases include cargo genes such as the 
mecR1 gene for meticillin resistance. The mecR1 gene is often present in conjunction with the ACME element, which contains an arginine deiminase  
Figure 3.10 Schematic representation of the two possible structures of ebh 
region 2. Structure A is present in isolates B10, C80, VCU122 and ZBW5. Structure B is present in isolates J6, J11, J23, J27, J31, I4 and SK119  
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  gene. 67.9% of methicilin-resistant S. epidermidis strains carry ACME (Barbier et al. 2011), however only one copy of the arcA gene encoding an arginine deiminase was found in the ZBW5 genome, and this gene was not within the annotation of phage 5. The SCCmec element is mobilised mecR1 in conjunction with the ACME element which in turn introduces an additional copy of arcA to the genome. As previously discussed (section 3.3.14) the mecR1 gene is present in ZBW5 on a genomic element similar to SCCmec IV. A study by Scharn et al revealed that smaller SCCmec elements, such as type IV elements, can be mobilised by transduction, and that rearrangements and deletions in the SCCmec element can occur as a result (Scharn et al. 2013).    
Figure 3.11 Mauve alignments of ZBW5 phage 5 with STB20 and STB27. The ZBW5 genome region annotated as the intact phage 5 by PHAST was aligned to the complete sequences of the phages STB20 and STB27.  
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  Although not found within the annotation of this phage (Table S1) the loci responsible for tobramycin and kanamycin resistance, bleomycin resistance and streptrogramin a resistance in the ZWB5 multidrug resistant isolate were all found at the boundary of intact prophage region 5 (Figure 3.13) . The attR site, however is annotated a further 5,875 bases upstream of this (Table S1). This is further evidence that this region is not well resolved as attL and attR sites would be expected to flank the boundaries of a phage location. 
Figure 3.12 Artemis genome alignments between ZBW5 phage 5, STB27 and 
STB20. The yellow arrow indicates the position of the gene mecR1, the purple arrow indicates the position of the aacA-aphD gene.     
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Figure 3.13 Boundary of the annotated ZBW5 phage 5. The nucleotide highlighted yellow marks the  bioinformatically annotated boundary of the genome region annotated as phage 5. The genes responsible for bleomycin (ble), streptogramin A (ermC) and tobramycin and kanamycin (knt) resistance are shown adjacent to the phage region.  
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3.4 Conclusion 
 This research study aimed to take advantage of developments with next generation sequencing technologies to interrogate S. hominis as a species. The data derived due to the increased resolution of newer technologies such as PacBio sequencing is able to increase the resolution and accuracy to better understand potential gene traffic between genomes.  Specifically, it can better resolve structures of phage and plasmids than earlier technologies such as 454 and Illumina (Jørgensen et al. 2014). The addition of several more S. hominis genomes to those publically available has allowed the investigation of the S. 
hominis pan-genome and a wider understanding of the complement of genes present within the species. The S. hominis pan-genome was found to be open and contain ~1879 genes and be expanding at a rate of 41 news genes per each genome added. It is expected that the size of the pan-genome will fall as new genomes are sequenced and analysed.  Greater than 60% of the pan-genome comprises accessory genes, yet only 17% of the genome of each strain is accessory genome. The large pool of accessory genes indicates that S. hominis may occupy a range of niches and overcome the specific obstacles to survival found there such as diverse community composition requiring adaptability.  The accessory genome is often associated with the presence of mobile genetic elements and for this reason emphasis was placed on characterising the repertoire of plasmids, phage, insertion sequence and transposons in the S. 
hominis genomes. All of the 11 genomes carried mobile genetic elements, some of which are associated with virulence in S. aureus, for example aminoglycoside and meticillin resistance. A putative SCCmec element was found in the genome of ZBW5, adding further evidence that CoNS have donated this MGE to S. aureus where it has acted as a virulence factor. The observed presence in the S. hominis isolates of biofilm forming capabilities, carotenoid production, a suite of CWA proteins, including putative MSCRAMM-like proteins and SERAMS, some of which are classical S. aureus virulence factors, invites further investigation of the roles of these genes in distinct backgrounds. Better understanding of their 
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role as survival factors may offer new perspectives on their role in staphylococcal virulence. 
 The diversity of antibiotic resistance determinants observed in this study, and their association with mobile genetic elements suggests that on skin S. hominis represents an important source of transferable antibiotic resistance. The expanded antibiotic resistance profile of the multidrug resistance isolate ZBW5 was possibly accounted for in the main by a single phage with homology to the StB20 staphylococcal phage. Spread of this phage to successful clones, as was seen in the case of the introduction of the PVL phage into the USA300 epidemic clone (Thurlow et al. 2012), could result in an increase in infection caused by S. 
hominis.   Not only has the mobilome been found to be a source of an expanded repertoire of genes, but also a potential for divergent profile of phenotypes. The ST1028 incomplete prophage was found to insert into two alternative genomic locations. One of these locations was between two fragments of a gene shown to have similarity to the giant ECM binding protein Ebh, which has been shown to be sufficient for maintaining a biofilm in S. epidermidis (Christner et al. 2010). The “J” isolates of S. hominis were all shown in this study to have the capability to form an air interface biofilm. These isolates also had the ST1028 prophage inserted upstream of the gene similar to Ebh.    
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4.1 Introduction 
4.1.1 Interspecies comparative genomics The field of comparative genomics is primarily centred upon comparing multiple DNA sequences and there have been numerous algorithms developed to meet the needs of different types of comparative genomic analyses. The field took roots in the late 1970s with the completion of the first two whole genomes, the phages ϕX174 and MS2, however with limited available sequence data and two largely unrelated sequences this was a stilted beginning (Koonin & Galperin 2013). One of the early published comparative genomic studies, a comparison of the Epstein-Barr virus and varicella-zoster virus, dealt with many of the themes integral to comparative genomics such as genome architecture, conservation and prediction of genes (Davison & Taylor 1987).   The field evolved and perhaps the best known and most ubiquitously used alignment tool, BLAST, was developed to allow rapid searching of the growing databases of protein and nucleotide sequences on a desktop computer (Altschul 
et al. 1990). From this beginning there followed BLASTZ, the first algorithm geared towards whole genome alignments with reasonable computational requirements and timescales (Mullikin 2014) (Schwartz et al. 2003). This algorithm was adapted for the purpose of comparing larger mammalian genomes from the web based PipMaker, a workbench which allowed comparisons of complete or incomplete genomes, with the aim of coding sequence and regulatory element prediction in mammalian and bacterial genomes (Schwartz et al. 2000). Today there is an array multiple genome alignment software publically available, such as Mauve (Darling et al. 2004), the Artemis Comparison Tool (ACT) (Carver et al. 2005) and the Integrative Genomics Viewer (IGV)(Robinson et al. 2011), which cater variously to the different requirements, questions and approaches explored in comparative genomics studies.   These tools facilitate mining the wealth of genome sequence data publically available in the wake of high throughput next-generation sequencing, which has 
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led comparative genomic studies to become a commonplace means of both asking specific questions and addressing broad themes. For example, Burgess-Herbert & Euling used comparative genomics for the latter purpose to assess the effects of extrapolating the potential impact of certain chemicals from one species to another, with particular emphasis on extrapolating the effects of pharmaceuticals from model organism to humans (Burgess-Herbert & Euling 2013). Their approach is also pertinent, however, when the human microbiome is considered. Understanding the interspecies comparative genomics of the pathogenic S. aureus relative to beneficial resident staphylococci, such as S. 
hominis, S. haemolyticus and S. epidermidis could help to extrapolate the effects of interventions across species. This kind of approach may help to develop interventions to clear S. aureus from the skin or manipulate its microflora without affecting the desirable members of the community.   Interspecies comparative genomics of other microbial communities have been carried out with the hope of gathering information that might allow the manipulation of these coummunities for the benefits of human health and prevention of disease. Kaoutari et al for example used comparative genomics to describe the diversity of carbohydrate active enzymes in the genomes of gut resident microbial species, noting that these microbial enzymes aid in the digestion of some of the complex polysaccharides in our diet, thus showing a healthy gut microbiome is integral to human health (Kaoutari et al. 2013). Comparative genomics has also been used to assess the integrity and safety of the food chain; Papadimitrou et al used comparative genomics to assess the risk of the Streptococcus macedonicus in fermented dairy products, given that it is part of the Streptococcus bovis/Streptococcus equinus complex implicated in endocarditis and colon cancer in humans (Papadimitriou et al. 2014).   
 
4.1.2 Staphylococcal whole genome sequencing The genus Staphylococcus comprises 51 species with 27 subspecies. The species of this genus have a broad host range with specialists colonising non-human primates (Tong et al. 2015), dolphins (Varaldo & Kilpper-Bälz 1988) and fermented food products (Probst et al. 1998). The genus continues to expand 
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with next generation sequencing technologies aiding the refinement of speciation for closely related staphylococci, such as S. argenteus and S. 
schweitzeri which are indistinguishable from each other and S. aureus at their 16S locus (Tong et al. 2015). At the time of writing over 4400 strains of S. aureus had been sequenced with over 4200 of these genomes publically available in a range of formats from scaffolds to complete genomes, including the important USA300 community-acquired MRSA strain (Diep et al, 2006).    The prolific sequencing of this notorious pathogen has increased understanding of many aspects of its genomic content, such as the acquisition of vancomycin resistance phenotypes which eliminate the availability of this last line antibiotic from the treatment of MRSA (Kos et al. 2012).  More recently it was used to investigate the efficacy of employing whole genome sequencing as a means of determining these resistance phenotypes (Lee et al. 2015). Clinically relevant timescales for high-throughput whole genome sequencing have allowed the interrogation of the genomes of infection isolates and aided understanding of outbreaks of MRSA and its transmission in real time (Köser et al. 2012). Large scale sequencing studies have also begun to unravel the basis for the broad host range of S. aureus through their power to estimate timelines of host jumps and the genetic mechanisms for these events (Spoor et al. 2013) (Lowder et al. 2009) (Lowder & Fitzgerald 2010) (Viana et al. 2015).   Complete genomes have also been finished and published for 8 other staphylococcal species, including 9 strains of S. epidermidis, which represents the most common pathogen associated with infection of implanted medical devices. In total, the genomes of 44 species of the Staphylococcus genus have been sequenced, with 27 of these being available publically (Zakour et al, 2008 & data compiled from NCBI and GOLD online database). Although individual isolates, or small cohorts of isolates have been sequenced for most of the species in the genus it is still unclear to what extent these species interact and share genetic information with one another. These interactions are important in the context of human health and disease since several species of staphylococci, 
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S. epidermidis, S. hominis, S. haemolyticus among them, are known to be dominant members of the human skin microflora.   
4.1.3 Features of staphylococcal genomes To understand the interactions between staphylococcal genomes we must first understand the structure of the genomes themselves. Sequencing of multiple species of staphylococci elucidated broad similarities among the genomes. There is a conservation of genome size and synteny of hypothesised core genes in S. haemolyticus, S. epidermidis and S. aureus which was proposed following the sequencing of the first S. haemolyticus genome (Takeuchi et al. 2005). The presence of an oriC environ thought to represent the source of much of the divergence between staphylococcal species was proposed by Takeuchi et al in 2005. The described orfX region is near to the oriC origin of replication and this region serves as an integration site for multiple staphylococcal cassette chromosomes (SCCs). This region of the genomes is often observed to contain strain specific genes and genes associated with niche adaptation acquired through horizontal gene transfer (Hiramatsu et al. 2014) (Harrison et al. 2013).   Genome plasticity appears to be important to the success of staphylococci within their niche. This was revealed by the extensive sequencing of S. aureus and S. epidermidis, whose pan genomes comprise 37% and 56% strain specific genes respectively (Kelly 2013). In addition to SCCs, other mobile genetic elements such as plasmids, phages and transposons were identified across the staphylococci (Takeuchi et al. 2005) (Kuroda et al. 2005) and contribute to diversity; most frequently these elements contribute virulence factors (Moon et 
al. 2015) and generate resistance profiles to antibiotics and heavy metals, as highlighted in the study of the S. hominis genome in chapter 3 of this thesis. Non-pathogenic species of staphylococci were shown to contain fewer MGEs; the food grade species S. carnosus for example, was shown through comparative genomic studies to contain fewer MGEs than other members of the genus (Rosenstein & Goetz 2010). Not only does the non-pathogenic S. carnosus contain a comparatively low amount of MGEs it also has a smaller amount of repeat sequences, which may suggest fewer recombination events and thus 
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reduced genomic diversification (Aras et al, 2003). The low frequency of repeat sequences in the S. carnosus genome suggests it is less plastic than that of species such as S. haemolyticus, S. epidermidis and S. aureus. This supposed lack of genome plasticity of S. carnosus may be explained by its selection from a restricted niche within a starter culture (Rosenstein & Friedrich 2010) or spontaneously fermented foods (Anon 2008). Despite its limited plasticity and generally regarded as safe (GRAS) status, S. carnosus does contain genes with homology to S. aureus virulence genes. One possible explanation of this may be that genes classified as virulence factors and contributing to disease in pathogenic staphylococci might be involved in environmental survival mechanisms in other species. The non-pathogenic bacterium Wolinella 
succinogenes, which has a primary niche in the bovine rumen, shares multiple homologous genes with Campylobacter jejuni and Helicobacter pylori (Baar et al. 2003). Strikingly it harbours genes having homology and synteny with pVir, an important Campylobacter virulence plasmid (Bacon et al. 2000). This observation led to the suggestion that the virulence factors were involved in maintaining symbiosis between W. succinogenes and its host (Baar et al. 2003).   The arginine catabolic mobile element (ACME) and the SCCmec element represent evidence of interactions between staphylococci and the exchange of genetic material. It was proposed that the ACME element spread through horizontal gene transfer from S. epidermidis to S. aureus. This inheritance has been well-characterised and it was revealed that the recombinase required for recombination of the SCCmec element into the genome is hijacked by ACME (Miragaia et al , 2009).   Although several studies suggest that carriage of ACME in disease isolates of S. 
aureus does not affect virulence (Montgomery et al, 2009), a role with respect to colonisation has been speculated since ACME carriage does influence fitness with respect to skin colonisation (Diep et al, 2006). A role as a fitness determinant as opposed to a virulence factor is also supported by the presence of ACME in the genomes of other commensal staphylococci, such as S. 
haemolyticus (Pi et al, 2009). Further evidence for ACME increasing survival on 
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the skin can be gleaned from the presence of an arginine deiminase pathway in 
Streptococcus pyogenes that promotes survival in a low pH environment (Holden et al, 2006).   A recent comparative genomic analysis of a large cohort of S. aureus and S. 
epidermidis isolates revealed that the two species rarely undergo homologous recombination with one another, but that there is a high degree of commixing mobile genetic elements between the two species. Recombination within each species appears to differ with isolates of S. epidermidis recombining more frequently than isolates of S. aureus.  
4.1.4 Staphylococcal two component systems  Two component systems (TCSs) allow many prokaryotes to interact with their environment and react to the presence of stimuli. These two component systems comprise: a sensor histidine kinase which typically spans the cell membrane and interacts with the external environment; interaction with its target molecules resulting in conditional autophosphorylation; a response regulator, which is typically an intracellular protein that interacts with the histidine kinase sensor and is phosphorylated. The role of a two component system is to change the behaviour of a cell to compensate for changing environmental conditions, therefore it is to be expected that the internal regulator is often a DNA-binding protein which can effect altered gene expression (Stock et al. 2000).   TCSs are present across bacterial genomes to varying degrees and absent from certain species, such as Mycoplasma genitalium. For particular bacteria these systems comprise relatively large proportions of the genome, for example 
Synechocystis sp of which 2.5% of the total genome is accounted for by TCSs (Kolar 2012). The S. aureus genome contains 16 TCSs with target genes from an array of functional groups. Although TCSs are widespread across prokaryotes, there is one particular family specific to the Firmicutes, those containing an intramembrane-sensing histidine kinase (IM-HK). This family of HKs are smaller than those found in other species of bacteria and have a small, 25 amino 
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acid linker region between their two 400 amino acid transmembrane helices. Due to their minimal extracellular presence they were thought to sense signals occurring within the cell membrane (Mascher 2006).  Subsequent research has recently suggested alternative mechanisms of action (Mascher 2014).   This relatively small Firmicutes family of histidine kinases can be divided into two subgroups. The first, HPK7, is defined by an additional transmembrane protein required to effect the downstream response. A well-studied member of this family of HKs is LiaS which is part of the LiaFSR three component system of 
B. subtilis. In the staphylococci, a well-studied example is the VraFSR system (Mascher 2006). This IM-HK is proposed to indirectly sense antibiotics by responding to the resulting cell membrane damage (Rietkötter et al. 2008). The second subgroup of IM-HK is HPK3i, which is defined by the presence of an associated ABC transporter. Research has shown that the histidine kinase itself does not play a direct role in sensing the stimulus which activates this class of two component system. Rather, it is binding of the substrate to the cognate ABC transporter (Rietkötter et al. 2008) and a possible physical interaction between the TCS and ABC transporter (Falord et al. 2012) that activates the TCS to upregulate the ABC transporter and consequently remove the substrate from the cell. This second family of IM-HK TCSs has therefore been shown to respond directly to the presence of antibiotic. Examples of this subgroup of IM-HK TCS are the GraXSR system which is present across the staphylococci and the well-studied BceRS system of B. subtillis.   The GraRS TCS of S. aureus has been examined in detail. GraRS is part of a global regulation network responsible for resistance to cationic antimicrobial peptides (CAMPs) (section 3.3.9.9). GraXSR regulates the expression of DltABCD and MprF which both alter the S. aureus surface charge to evade electrostatic interaction-mediated interaction with CAMPs (Falord et al. 2011). Furthermore, the autolysin SsaA that is also involved in cell wall homeostasis is upregulated by GraRS. Transcriptionally, ssaA is regulated by the essential TCS WalKR (Delaune et al. 2011). In addition to these loci VraSR expression is controlled by GraXSR (Meehl et al. 2007). The GraRS regulated protein SdrH belongs to the 
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serine aspartate repeat (SDR) family of proteins in S. aureus; cell wall-associated proteins which contain serine-aspartate tandem repeats located at the C-terminal of the protein. Several members of this SDR protein family interact with the host extracellular matrix, for example SdrG of S. epidermidis which binds to fibrinogen (Ponnuraj et al. 2003). Differential regulation of multiple protein families demonstrates the complexity of TCS regulatory networks and highlights the challenges involved in deciphering their interconnected roles.  An orthologous TCS to GraRS was described in S. aureus and designated BraRS and NsaRS by two different groups concurrently (Hiron et al. 2011) (Blake et al. 2011). Blake et al discovered the role of the uncharacterised protein SAOUHSC_02955 in lantibiotic resistance through an evolution based approach where resistance to nisin was selected by serial passage in sub-MIC concentrations of the lantibiotic. This approach, and subsequent genome sequencing of the evolved isolate revealed two SNPs, one of which was associated with the gain of function and was located in the putative sensor histidine kinase SAOUHSC_02955, thus it was designated NsaSR or nisin susceptibility-associated sensor regulator (Blake et al. 2011).   Hiron et al revealed that the same TCS was characteristic of the Bce-like family of IM-HKs which are involved in cationic antimicrobial peptide resistance, and that analysis of gene mutants showed that lack of the TCS resulted in increased susceptibility to bacitracin. The TCS was thus designated BraSR for bacitracin resistance-associated sensor regulator. Susceptibility of the knockout mutant to a panel of antibiotics was investigated, however only a decrease in MIC for bacitracin and the lantibiotic nisin was observed  (Hiron et al. 2011). BraRS binding sites were discovered upstream of braDE and vraDE , two ABC transporter genes induced in the presence of bacitracin, but not in a braRS mutant. The BraDE and VraDE transporters were shown to play different roles in antibiotic resistance. BraDE contributes to the detection of nisin and bacitracin and subsequent signal transduction via BraRS, whereas VraDE is more directly involved in detoxification (Hiron et al. 2011).    
 146 
A later study by Kolar et al showed that braRS (nsaRS) transcription was upregulated by the presence of multiple antibiotics such as ampicillin, phosphomycin and nisin. An allelic replacement mutant of braS (nsaS) altered the transcription of 245 genes in a transcriptomic analysis (Kolar et al. 2011). This study revealed multiple effects of loss of BraRS (NsaRS) function in S. 
aureus, such as effects on biofilm formation, regulation of cellular transport and responses to anaerobic conditions. The size of the reported regulon may be an overestimate due simply to the overlapping circuitry reporting stimuli at the cell surface and a more detailed study is certainly required to map the regulon more precisely.  The potential complexity of the BraRS regulon indicates that, although multiple TCSs in Firmicutes detect damage and changes in the cell membrane, there are still others with more diverse functions. The well-studied Agr quorum sensing system involves AgrC, as the histidine kinase, and AgrA, as the DNA binding response regulator (Koenig et al. 2004). Still other TCSs deal with the toxicity of metal ions such as HssRS which regulates the expression of the efflux pump HrtAB (Stauff et al. 2007). Although the TCSs of S. aureus are well studied and the mechanisms of action and global regulons are being unravelled, it is unclear to what extent these TCSs are distributed throughout the genus. 
4.1.5 Chapter Aims In recent times, efforts have been made to understand the genetic aspects of the staphylococci which make them successful as infective agents. As described, S. 
epidermidis and S. aureus represent two major, but distinct human pathogens, consequently work has been focused on the genomes of these two species to uncover mechanisms relating to disease. In this chapter the study sought to use interspecies comparative genomics to investigate how S. hominis relates to other members of the Staphylococcus genus. Furthermore the study sought to investigate the ways in which members of this genus broadly differ and resemble one another in their mechanisms to thrive in their niche and within their communities. Particular emphasis was given to exploring mechanisms which might pertain to being successful skin residents.    
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4.2 Methods 
4.2.2 Analysis of orthologous gene content across the staphylococci A representative genome from all staphylococci sequenced at the time of analysis was either retrieved from the NCBI FTP (ftp://ftp.ncbi.nlm.nih.gov/) site or sequenced as part of this study. Complete genomes were used as far as possible, however where only draft genomes were available NCBI scaffolds were reordered against an appropriate reference using the perl script written by Dr Roy Chaudry (CGR). The base set of strains used in the analysis is described in Table 4.1. The genomes were annotated using PROKKA (version 1.5.2) to ensure coherent annotation. OrthoMCL with the parameters stated above was used to cluster the orthologous proteins.   
Table 4.1 List of base strains for the OrthoMCL analysis. All genomes were retrieved from NCBI or sequenced as part of this work, the draft or complete nature of the genome is indicated. 
Species Strain Accession Draft/complete 
S. arlettae CVD059 Uid175126 Draft 
S. aureus Newman Uid58839 Complete 
S. capitis SK14 Uid55415 Draft 
S. carnosus TM300 Uid59401 Complete 
S. cohnii (this work) PRJEB10525 Draft 
S. delphini 8086 Uid199664 Draft 
S. epidermidis ATCC_12228 Uid57861 Complete 
S. equorum Mu2 Uid169178 Draft 
S. haemolyticus (this work) PRJEB10525 Draft 
S. hominis J6 (this work) PRJEB10524 Draft 
S. intermedius NCTC_11048 Uid199665 Draft 
S. lentus F1142 Uid200144 Draft 
S. pettenkoferi VCU139 Uid180074 Draft 
S. lugdunensis HKU09 Uid46233 Complete 
S. pseudintermedius HKU10 Uid62125 Complete 
S. saprophyticus ATCC_15305 Uid58411 Complete 
S. simiae CCM_7213 Uid77893 Draft 
S. simulans (this work) PRJEB10525 Draft 
S. vitulinus F1028 Uid200114 Draft 
S. warneri SGI Uid187059 Complete 
S. xylosus (this work) PRJEB10525 Draft   
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The python script Table_alt_cluster-1.py was used to create a table describing the presence or absence of each OrthoMCL cluster within each genome. This table was then converted to a data matrix using the statistical package R and a heatmap was generated from the matrix.  To control for gross strain specific effects on the clustering this step was repeated after substituting with the strains described in Table 4.2 for an alternative species strain from Table 4.1. All permutations were carried forward and used in subsequent steps of the analysis.  
Table 4.2 List of alternative strains. Strain substitution was used to rule out strain specific effects in species as a driver for the OrthoMCL clusters and their genetic basis. 
Species Strain Accession Draft/complete 
S. aureus USA300 Uid58555 Complete 
S. epidermidis RP62A Uid57663 Complete 
S. hominis J11 (this work) PRJEB10524 Draft 
S. pseudintermedius ED99 Uid162109 Complete 
S. saprophyticus CCM_833 (this work) PRJEB10567 Draft  
4.2.3 Identifying the drivers of OrthoMCL group formation The R library randomForest was used to investigate the genetic basis directing the formation of each of the OrthoMCL groups. The output from the script 
Table_alt_cluster-1.py was edited to designate each species from the analysis as either belonging to the cluster being investigated or not belonging to the cluster. This information was then used as the input data for the randomForest analysis. The output analysis was summarised using the variable importance plot function and the mean square error resulting from the permutation of each variable and was used as the measure of importance. Clusters were mapped back to the genome and the annotation and protein sequence for a species representative from each cluster were retrieved. Protein sequences were then used to search the NCBI BLAST database to confirm the PROKKA genome annotation. Outputs from substituted strains for each cluster were compared and the genes conserved in the variable importance analysis for all combinations of strains within a cluster were collated and carried forward for subsequent analysis.  
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Artemis (version 14.0.0)was used for genome interrogation (Rutherford et al. 2000) and BLAST and CLustalW2 (http://www.ebi.ac.uk/Tools/msa/clustalw2/) were used to perform sequence alignments.  
4.2.4 Investigating the diversity of loci associated with CAMP resistance in 
the staphylococci 
 The BraR, BraS, GraR and GraS protein sequences were retrieved from the relevant genomes in the analysis and protein sequence alignments were carried out using ClustalW2.  All neighbour-joining trees were generated using Geneious global alignment with the Blosum62 cost matrix followed by the geneious tree builder and a consensus tree based on 1000 bootstrap repitions (Geneious version 8.1.7).    
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4.3 Results and Discussion 
4.3.1 Analysis of orthologous gene content across the staphylococci The orthologous gene content of one genome from each of the available genomes of sequenced staphylococcal species was analysed using OrthoMCL, which groups orthologous genes (homologues separated by speciation) from across the different species into clusters. The number of shared orthologous clusters between the different species’ genomes was represented as a heatmap (Figure 4.1). The output from this analysis revealed the assembly of three groups of species with high numbers of shared orthologous clusters. The cladogram accompanying the heatmap also reinforced these three groups which were therefore labelled as A, B and C. In addition to these three groups, there were also several pairs of species which showed a high degree of shared orthologous clusters of genes, and branched together in the cladogram. These pairs of strains were S. aureus and S. simiae, S. simulans and S. carnosus, and S. 
lentus and S. vitulinus.  The effect of substituting alternative strains of individual species and rerunning the OrthoMCL analysis was investigated and did not affect the three groups of staphylococci (Supplementary figures).  The similarity and grouping of the species S. simulans and S. carnosus in the cladogram is to be expected as S. carnosus was originally identified as S. simulans. The percentage DNA similarity between the type strain of S. simulans was found to be more similar to S. carnosus (32-39%) than to any other species in the genus; this is observed with the homologous gene content of the two species which cluster together in the OrthoMCL heatmap, and group together in the cladogram (Figure 4.1). The phenotypic differentiation of S. carnosus as a species from S. 
simulans is based upon the ability of S. carnosus to produce acetoin, and its inability to ferment sucrose, lactose and maltose, whereas S. 
simulans can ferment these sugars. Futhermore, S. carnosus can be differentiated from all other staphylococci by its strongly positive growth in high salt concentrations (Schleifer & Fischer 1982).  
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Figure 4.1 Heat map representation of the presence of clustered orthologous proteins across the 
staphylococci. Presence is indicated on a colour scale from red (high) to white (low). A high number of shared clusters of orthologous proteins is indicated by red colouration and few shared clusters is indicated by white. The three major groups of species observed in the analysis are highlighted by coloured lines;  Group A is indicated in blue, B is indicated in green and C is indicated in purple.   
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S. lentus and S. vitulinus would also be expected to cluster together in the OrthoMCL analysis as these species comprise two of the four species in the 
Staphylococcus sciuri group, the other two species being S. sciuri and S. pulvereri (Stepanovic et al. 2003). These species are considered to be primarily animal species, however colonisation in humans and isolation from clinical samples has been observed (Nagase et al. 2002). The S. sciuri group are differentiated from other staphylococci as they are positive for cytochrome c oxidase activity. This aspect of their genome makes them the most closely related group of staphylococci to the micrococci (Kwok & Chow 2003).  The largest, although least well-defined, group was comprised of S. epidermidis, 
S. capitis, S. warneri, S. haemolyticus, S. hominis, S. lugdunensis, S. pettenkoferi, S. 
aureus and S. simiae. This set was designated as group A (Figure 4.1). It was noted that group A contained the species that most commonly occur on the human skin (Kloos 1980). The likelihood of a strain-dependent effect structuring the output was investigated by substituting S. epidermidis, S. hominis and S. aureus with alternative strains (Table 4.2). The same structure of groups was observed in each of the instances of switching strains indicating that there was a robustness to this output independent of strain choice (Supplementary figures).  Within group A, S. aureus and S. simiae were most similar to one another and branch together in the cladogram.  S. aureus and S. simiae belong to the the S. aureus group of staphylococci, which includes only these two species. Investigation of Staphylococcus phylogeny using only core genes revealed the clustering of S. aureus and S. simiae (Suzuki et al. 2012). In the analysis by Suzuki et al, however, this grouping broke down upon hierarchical clustering based on whole genome content (Suzuki et al. 2012), whereas in this present study branching of both S. aureus and S. simiae was observed based on orthologous gene content of the whole genome. It is to be noted that the methodologies and strain sets used by the two studies differed. It was decided to include the species S. aureus and S. simiae within group A for subsequent comparative analyses, since by taking into account both the cladogram and the heatmap these two species are more related to the other species within group A than those outside of it. Downstream analysis, however, involved investigating 
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the genetic basis driving the groups of species. Inclusion of S. aureus in group A, which also contains those frequent members of the human skin microbiome, such as S. epidermidis, S. hominis and S. haemolyticus, could reveal important similarities between S. aureus and the skin resident species; exclusion of S. 
aureus from group A would result in these similarities being missed. Equally, inclusion of S. aureus and S. simiae in group A would result in differences from the skin resident species S. epidermidis, S. hominis and S. haemolyticus being missed. Therefore group A was also divided into two subgroups, A1 and A2. A1 contained the species in group A without the inclusion of S. aureus and S. simiae. A2 contained included only these two. Downstream analysis was carried out first with only subgroup A1 and then expanded to include subgroup A2; the analysis of both subgroups together is discussed simply as group A.   A second, smaller group of species from the cladogram/heatmap was comprised of S. equorum, S. arlettae, S. cohnii, S. saprophyticus and S. xylosus; this was designated as group B. A common lifestyle identified in the group B species is their association with animal and meat products plus the presence of novobiocin resistance (Devriese et al. 1985) (Bannerman et al. 1991) (Schleifer 
et al. 1984). Furthermore, commonalities in the compositions of their cell walls was observed (Schleifer et al. 1984).   A third species group was comprised of S. pseudintermedius, S. delphini and S. 
intermedius and was labelled as group C.  This set of organisms has previously been designated the S. intermedius group, or SIG, and is known to cause infection in companion animals and equids, with the emerging antibiotic resistance in this group of organisms representing a clinical veterinary concern (Stull et al. 2014). Routine speciation within this group is difficult due to the high degree of sequence identity at their 16S locus (Slettemeås et al. 2010).  To investigate the genetic basis directing the formation of these groups of species (A, B and C) the randomForest package was used in R. This analysis employs the randomForests algorithm of Leo Breiman for classification (Breiman 2001). This algorithm ranks the importance of variables, in this case 
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OrthoMCL clusters, for their contribution to the presence of groups A, B and C based on a forest of trees generated from these variables.  A variable importance plot of each random forest was generated which plots the scaled importance of the variables in order of importance from the top of the plot to the bottom. The measure of importance used here was %IncMSE, which refers to the mean squared error resulting from the permutation of the variables. Permuting an important variable will result in a large mean squared error, with decreasing importance of variables resulting in decreasing mean squared error. Variables are found on the y-axis and their importance score on the x-axis, an example plot is included (Figure 4.2).  The OrthoMCL clusters representing each variable were then examined and mapped back to the genome of a publically available reference for each cluster and the PROKKA annotation of each protein coding sequence was verified using BLAST. This was repeated for each group and for each of the strains used to verify the presence of the three clusters (Table 4.2). The genes conserved in the variable importance analysis between substituted strains are discussed in the following sections.   
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Figure 4.2 Variable importance plot output from investigation of the genetic basis for 
group A. This variable importance analysis is based upon a randomForest analysis with 1000 trees for the base strain set. The 30 most important variables from the randomForest analysis are found on the y-axis, their importance is found on the x-axis. Increasing importance is described as increasing mean squared error resulting from the permutation of the variable in the randomForest analysis.  
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4.3.1.1 Clusters driving formation of group A Four of the clusters whose presence is important in defining group A are proteins in sequential genomic locations (epi_02134, epi_02135, epi_02136, epi_02137). Two of these clusters represent a TCS sensor/regulator with similarity to GraSR (Table 4.3a). PROKKA annotated these proteins as sensor histidine kinase (GraS) and glycopeptide resistance associated protein R (GraR). The genomes of the organisms in group A were revealed to contain 2 loci annotated by PROKKA as GraSR, except in the case of S. pettenkoferi which contained only one locus annotated as GraRS. Bioinformatic analysis revealed that in the included S. aureus genomes the locus identified by the randomForest analysis shared ~100% sequence identity to SA2417/SA2418 of S. aureus HG001, which was shown by Hiron et al to encode a TCS associated with resistance to nisin and bacitracin (Hiron et al. 2011). Further investigation of this locus revealed that it was present only in the genomes of group A species of staphylococci, and absent from the rest of the genomes included in the OrthoMCL analysis. This locus is explored further in section 4.3.3.1  The remaining two adjacent clusters (epi_02134, epi_02135) positively associated with formation of group A constitute an ABC transporter composed of two subunits with 98% and 99% sequence identity, respectively to the SA2415 and SA2416 ABC transporter proteins, designated as BraD/BraE (Hiron 
et al. 2011) was also observed. These proteins were annotated by PROKKA as FtsX-like permease family protein and macrolide export ATP binding/permease protein MacB. This locus is absent in staphylococci outside of group A. The ABC transporter genes were reported to be co-transcribed as an operon separately from braRS. Furthermore, the ABC transporter BraDE is induced in the presence of bacitracin and nisin and this inducible expression is controlled by BraRS (Hiron et al. 2011).  The absence of two clusters which represent multidrug ABC transporters (sap_00398, sap_00399) is also important in defining group A. Multidrug ABC transporters mobilise a range of cytotoxic molecules across the cell membrane. One well-characterised example is the ABC transporter SAV1866 from S. aureus 
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which is used as a model in the study of multidrug ABC transporters (Dawson & Locher 2006) (Velamakanni et al. 2008). ABC transporters can also act as sensors in some families of TCS (Rietkötter et al. 2008). Together with the absence of these clusters of ABC transporter proteins the presence of a separate cluster representing a different ABC transporter in group A contributes to the variable importance analysis (epi_00394). This cluster was found by BLAST similarity to be a bacitracin ABC transporter . The importance of a differential repertoire of ABC transporters associated with survival from antimicrobials may indicate the importance to speciation of adaptation and responses to the arsenal of antibiotics produced by the members of the communities in their different niches in order to compete for resources.   The contribution of the absence of succinate semialdehyde dehydrogenase NADP+ (sap_00201) from group A staphylococci may indicate differences in the metabolism of glutamate and responses to certain environmental stressors in organisms inside of group A and those outside of group A. Glutamate is involved in multiple metabolic processes across the tree of life. In bacteria the enzyme glutamate dehydrogenase catabolises glutamate, which plays a role in acid tolerance. Succinate semialdehyde dehydrogenase is involved in catabolism of γ-aminobutyrate, a product of  glutamate dehydrogenase activity (Feehily & Karatzas 2013). This pathway is proposed to have a role in oxidative stress or glutamate metabolism. Redundancy in succinate semialdehyde dehydrogenases across species of bacteria has been shown; E. coli for example encodes two such enzymes, whereas Pseudomonas syringae encodes three isozymes (Donnelly & Cooper 1981) (Buell et al. 2003). Different succinate semialdehyde dehydrogenases can have different requirements for the cofactor NAD(P) (Zhu 
et al. 2010).   The absence of a cluster representing UDP-glucose 4-epimerase (sap_00643) from group A organisms is supported by known species differences in carbohydrate metabolism.  UDP-glucose 4-epimerase is an enzyme of the Leloir pathway for metabolising lactose and galactose. This 
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Table 4.3a Proteins driving formation of group A. PROKKA annotation was found by mapping clusters from the variable importance analysis to the S. epidermidis genome in the case of “present” clusters and the S. saprophyticus genome in the case of the “absent clusters”. The PROKKA locus tag is indicated in brackets. BLAST similarity was found by searching the protein against the NCBI BLAST database. 
PROKKA annotation BLAST similarity 
Presence FtsX like permease family protein (epi_00394) Bacitracin ABC transporter Hypothetical protein (epi_00430) Hypothetical protein Hypothetical protein (epi_00538) Hypothetical protein Putative distant relative of cell wall associated hydrolases (epi_00542) Hypothetical protein Hypothetical protein  (epi_01643) Hypothetical protein Staphylococcal accessory regulator U (epi_01831) Hypothetical protein Regulatory protein soxS (epi_01832) AraC family transcriptional regulator Hypothetical protein (epi_01980) Abortive infective protein Hypothetical protein (epi_02055) Hypothetical protein Hypothetical protein (epi_02098)) Cell wall surface anchor protein Hypothetical protein (epi_02108) Hypothetical protein FtsX like permease family protein (epi_02134) ABC transporter permease Macrolide export ATP binding/permease protein MacB (epi_02135) bacteriocin ABC transporter ATP-binding protein Sensor histidine kinase GraS (epi_02136) Sensor histidine kinase Glycopeptide resistance associated protein R (epi_02137) PhoB family transcriptional regulator 
Absence  Succinate semialdehyde dehydrogenase NADP + (sap_00201) Succinate-semialdehyde dehydrogenase Putative membrane protein putative toxin regulator (sap_00203) PTS sugar transporter subunit IIC Putative multidrug resistance ABC transporter ATP binding/permease protein YheI (sap_00398) multidrug ABC transporter ATP-binding protein Putative multidrug resistance ABC transporter ATP binding/permease protein YheH (sap_00399) Multidrug ABC transporter ATP-binding protein UDP-glucose 4-epimerase (sap_00643) UDP-glucose 4-epimerase L-lactate utilization operon repressor (sap_00760) transcriptional regulator Glutamate aspartate carrier protein (sap_01003) sodium:dicarboxylate symporter L-serine dehydratase beta chain (sap_01607) serine dehydratase subunit beta Hypothetical protein (sap_02162) serine dehydratase subunit beta 
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pathway is catalysed by β-galactosides. It is known that S. aureus cannot utilise this pathway, instead it metabolises lactose and galactose via a different mechanism catalysed by phospho-β-galactosidase (Bissett & Anderson n.d.).  
4.3.1.2 Clusters driving formation of group A1. The absence of the OrthoMCL clusters which encode genes of the fad operon is perhaps the most striking difference between group A1 and the rest of the species analysed (Table 4.3b). The fad genes, fadA, fadD, in S. aureus encode the proteins of the fatty acid degradation pathway. These genes were down-regulated in response to linoleic acid (Kenny et al. 2009). The indicated importance of the of the absence of the fatty acid metabolism pathway (sap_02495, sap_02494, sap_02493, sap_02491)  from group A1 species indicates that fatty acid metabolism occurs differently in the two groups. Notably this operon is also absent from S. simulans, which is closely related to S. 
carnosus that does encode the fatty acid metabolism pathway. S. epidermidis was found to carry a gene annotated as fadD by PROKKA (epi_00312). This gene encodes a long chain fatty acid CoA ligase, as does S. saprophyticus fadD 
(sap_02494). The protein sequences of the two genes however show only 20% sequence identity with one another. The S. epidermidis fadD is found next to a gene encoding an Acetyl-CoA acetyltransferase, in S. saprophyticus the adjacent gene is an Acyl-CoA dehydrogenase, short-chain specific (sap_02493).  
 Differences in the histidine biosynthesis operon were also important in defining the subgroup A1. The histidine operon contains eight genes and is similar in structure and function to that of S. typhimurium (KLOSS & PATTEE 1965). Absence of the genes sap_00436, sap_00437, sap_00438, sap_00439, sap_00440, sap_00441, sap_00442, sap_00443 and sap_00444 was shown to be important. Upon investigation, S. epidermidis was revealed to encode 7 of the 8 genes of the histidine operon; only hisC  was missing. A homologue of the gene sap_00444 encoding a regulator was also present. The S. epidermidis histidine biosynthesis operon was also included in the OrthoMCL clusters, with 8 of the 9 genes of the non-group A1 species. 
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Table 4.3b Proteins driving formation of group A1. PROKKA annotation was found by mapping clusters from the variable importance analysis to the S. epidermidis genome in the case of “present” clusters and the S. saprophyticus genome in the case of the “absent clusters”. The PROKKA locus tag is indicated in brackets. BLAST similarity was found by searching the protein against the NCBI BLAST database. PROKKA annotation BLAST similarity 
Presence 
Hypothetical protein (epi_02098) Cell wall surface anchor protein 
FtsX like permease family protein 
(epi_02134) 
ABC transporter permease Hypothetical protein (epi_01465) Hypothetical protein Hypothetical protein (epi_00207) Hypothetical protein Hypothetical protein (epi_00829) Hypothetical protein Hypothetical protein (epi_02277) Hypothetical protein Hypothetical protein (epi_01534) Hypothetical protein Staphylococcal secretory antigen ssaA2 precursor (heamolyticus_00353) Hypothetical protein 
Absence 
Na + /dicarboxylate symporter 
(sap_00900) 
Na  + /dicarboxylate symporter 
Putative ring cleaving dioxygenase 
mhqO (sap_00404) 
Glyoxalase Oxidoreductase YdhF (sap_02092) Aldo/keto reductase 
Phosphoribosyl ATP pyrophosphatase 
(sap_00436) 
phosphoribosyl-AMP cyclohydrolase  
Imidazole glycerol phosphate synthase 
subunit HisF (sap_00437) 
imidazole glycerol phosphate synthase 1-5 phosphoribosyl-5 [ 5 phosphoribosylamino methylideneamino] imidazole 4 carboxamide isomerase (sap_00438) 
1-(5-phosphoribosyl)-5-[(5-phosphoribosylamino)methylideneamino] imidazole-4-carboxamide isomerase 
Imidazole glycerol phosphate synthase 
subunit HisH 2 (sap_00439) 
imidazole glycerol phosphate synthase 
Imidazoleglycerol phosphate 
dehydratase (sap_00440) 
imidazoleglycerol-phosphate dehydratase 
Histidinol dehydrogenase (sap_00442) histidinol dehydrogenase 
ATP phosphoribosyltransferase 
(sap_00443) 
ATP phosphoribosyltransferase catalytic subunit  
ATP phosphoribosyltransferase 
regulatory subunit (sap_00444) 
ATP phosphoribosyltransferase Histidinol phosphate aminotransferase (sap_00441) histidinol-phosphate aminotransferase  Butyrate-acetoacetate CoA transferase subunit A (sap_02495) acetyl-CoA transferase Long chain fatty acid-CoA ligase (sap_02494) long-chain fatty acid--CoA ligase Acyl CoA dehydrogenase-short chain specific (sap_02493) glutaryl-CoA dehydrogenase 3 ketoacyl CoA thiolase (sap_02491) acetyl-CoA acetyltransferase  Formate channel 1 (sap_00605) formate/nitrite transporter  
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Investigation of the S. haemolyticus genome revealed that the histidine biosynthesis operon was not present in the genome. This indicates that this inability to produce histidine may be important in defining group A1. Despite this, S. epidermidis may not produce histidine due to the lack of the hisC gene from the histidine operon.  The presence of the staphylococcal secretory antigen was important to defining group A1. The S. epidermidis SsaA protein was not however present in the OrthoMCL cluster with the rest of the group A1 species. Investigation of the genome of S. saprophyticus demonstrated the presence of an ssaA gene, however this was evidently sufficiently diverged from that of the group A1 species, excluding S. epidermidis, that they did not cluster together in the OrthMCL analysis. SsaA was isolated from S. epidermidis strain NCTC 11047 and shares homology with SceB from S. carnosus. The protein is antigenic and patients with 
S. epidermidis endocarditis showed elevated levels of antibodies to the protein (Lang et al. 2000).   The presence of the gene product designated as BraD in the analysis above is important in defining group A1 though S. simiae and S. aureus  are both also present in this OrthoMCL cluster. The inclusion of these species in the group-defining clusters is also the case for a hypothetical protein with BLAST similarity to a cell wall surface anchor protein (epi_02098). The presence of group A2 species in important “presence” clusters such as these, and conversely the presence of group A2  species in important “absence” clusters indicated that groups A1 and A2 can not easily be separated. These clusters which hinder separation of the two clusters are highlighted in bold (Table 4.3b). As a consequence of this basis for the formation of group A, it will be discussed as a whole henceforth.   
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4.3.1.3 Clusters driving formation of group B  The presence of an OrthoMCL cluster representing a transcriptional repressor contributes to defining group B (Table 4.4, xylosus_02454). This transcriptional regulator was annotated by PROKKA as a lactose operon repressor in S. xylosus and catabolite control protein A in S. saprophyticus. The ccpA gene was first discovered in B. subtillis and its product is known to regulate the utilisation of alternative sugars in the absence of glucose (Faires et al. 1999). The lactose operon repressor inhibits the expression of genes of the lac operon that encodes proteins involved in lactose metabolism. Loss of DNA binding of the Lac repressor in the presence of lactose allows transcription of the lac operon.  An orthogolous cluster corresponding to farnesyl diphosphate:farnesyl transerase (xylosus_00489), otherwise known as squalene synthase (SQS), is involved in defining group B. SQS is an alternative pathway for the biosynthesis of carotenoid pigments in certain bacteria, such as species of  Methylomonas, a methanotrophic Gram-negative bacterium (Tao et al. 2005). In S. aureus the dehydrosqualene synthase CrtM converts farnesyl diphosphate (FPP) to dehydrosqualene (Furubayashi et al. 2014) replacing this SQS activity in carotenoid production. In Methylomonas, no crtM locus is detected, instead sqs is present and encodes an enzyme that exhibits low dehydrosqualene synthase activity (Tao et al. 2005). Furubayashi et al determined that in a synthetic pathway  E. coli SQS and the S. aureus carotenoid desaturase CrtN function together to synthesise the carotenoid pigment staphyloxanthin (Furubayashi et 
al. 2014). The putative SQS from S. saprophyticus has 13.24% identity to S. 
aureus CrtM and 28% identity with squalene synthase from Methylomonas. Despite the presence of the alternative squalene synthase, the group B staphylococci S. xylosus and S. arlettae do encode CrtM in their genomes, along with the crtPQN genes. In contrast to the S. hominis genomes discussed however, an acetylesterase (crtO) is present in the S. xylosus and S. arlettae genomes. This  glysocyl-4,4’-diaponeurosporenoate acetyltransferase shows 42% and 39% identity to   
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Table 4.4 Proteins important in defining group B. PROKKA annotation was found by mapping clusters from the variable importance analysis to the S. xylosus genome in the case of “present” clusters and the S. epidermidis genome in the case of the “absent clusters”. The PROKKA locus tag is indicated in brackets. BLAST similarity was found by searching the protein against the NCBI BLAST database. 
PROKKA annotation BLAST similarity 
Presence   Lactose operon repressor (xylosus_02454) Transcriptional regulator Hypothetical protein (xylosus_02429) Hypothetical protein Hypothetical protein (xylosus_02133) Hypothetical protein Hypothetical protein (xylosus_02128) Hypothetical protein Hypothetical protein (xylosus_02121) Hypothetical protein Hypothetical protein (xylosus_01818) Hypothetical protein 3 demethyl-ubiquinone 3 methyltransferase (xylosus_01429) SAM-dependent methyltransferase 2 dehydropantoate 2 reductase (xylosus_01388) Transcriptinal regulator Glucokinase (xylosus_01379) Transcriptional regulator Na +/dicarboxylate symporter (xylosus_01326) Anion transporter Hypothetical protein (xylosus_01105) Transporter protein HTH type transcriptional repressor glcR (xylosus_01104) Transcriptional regulator Hypothetical protein (xylosus_01043) Membrane protein Hypothetical protein (xylosus_00825) Hypothetical protein Osmoprotectant binding protein (xylosus_00598) Glycine/betaine ABC transporter substrate-binding protein Hypothetical protein (xylosus_00536) Hypothetical protein Farnesyl diphosphate:farnesyl transferase (xylosus_00489) Phytoene synthase Elastin binding protein ebpS  (xylosus_00325) Elastin-binding protein Ebps Hypothetical protein (xylosus_00257) Hypothetical protein Hypothetical protein (xylosus_00177) Hypothetical protein Putative BCR/YitT family (xylosus_00036)  Hypothetical protein 
Absence   Hypothetical protein (epi_02082) Hypothetical 
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USA300 crtO in S. xylosus and S. arlettae respectively. It is unknown if the carotenoid operon is functional in these species.   2-dehydropantoate 2-reductase (xylosus_01388), an oxidoreductase involved in the synthesis of pantothenate, contributes to the variable importance analysis and associates with group B species. Pantothenate is a precursor for the biosynthesis of coenzyme A. There is evidence of intraspecific variation in pantothenate biosynthesis, including at loci encoding 2-dehydropantoate 2-reductase (Aakra et al. 2007). According to KEGG pathway annotation 2-dehydropantoate 2-reductase is involved in the biosynthesis of secondary metabolites.  Other clusters that contribute to the definition of cluster B include an osmoprotectant (glycine/betaine ABC transporter substrate, xylosus_00598) binding protein. Osmoprotectant transporters can uptake substrates such as glycine-betaine from the environment to maintain cytoplasmic osmolarity. The presence of a protein which binds these substrates indicates a protein with a role in managing the osmotic stress response (Kuroda et al. 2004). In addition, a protein with sequence identity to the elastin binding protein EbpS (xylosus_00325), an integral membrane protein present in several staphylococcal species, was present in the variable importance analysis. EbpS is discussed in detail in chapter 3 (section 3.1.4.3). The presence of EbpS as a separate OrthoMCL cluster in the group B organisms suggests that this protein is sufficiently diverged in these organisms that it might no longer represent an orthologue of EbpS in S. aureus. Finally, the presence of another hypothetical protein with BLAST similarity to a membrane protein was also found to be importance in the definition of group B.   
4.3.1.4 Clusters driving formation of group C A putative glycosyltransferase with similarity to TagX (sap_02141)was absent from group C comprising SIG species: S. pseudintermedius, S. delphini and 
S.intermedius (Table 4.5). Certain glycosyl-transferases incorporate N-acetylglucosamine into surface molecules, such as wall teichoic acids. TagX 
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however was shown not to be involved in the glycosylation of wall teichoic acids (Winstel et al. 2014). Glycosyltransferases are also involved in glycosylation and therefore reducing the immunogenicity of other surface proteins (Hazenbos et 
al. 2013); this could be the function associated with TagX.   The presence of a second cluster which represents a D-Ala-teichoic acid biosynthesis protein (inter_00088) with 45% identity to Streptococcus sanguis DltX was shown to be important in defining group C. This may imply that the SIG staphylococci have an alternative pathway for modifying their cell wall teichoic acids with D-alanine. It is known that there is redundancy in the tag genes of staphylococci, even on an intraspecific basis (Winstel et al. 2014), therefore it may be possible that there are also differences in cell wall modifications via other pathways.  The presence of a macrolide export ABC transporter protein (inter_02006) is important in defining group C. A BLAST search revealed similarity to a bacteriocin ABC transporter. Bacteriocins are narrow spectrum antibiotics produced by bacteria to inhibit the growth of competitors (Riley & Wertz 2002). The presence of a bacteriocin transporter protein in the importance analysis suggests that SIG species have evolved resistance to the toxic antimicrobials secreted by the community in their niche as canine and equid colonisers. The fact that it was shown to be important in defining group C shows that it is distinct enough from the bacteriocin transporter involved in defining group A (epi_00394) that it is in a separate OrthoMCL cluster.    Two clusters found to represent glutamyl specific endopeptidases (inter_00008, inter_00009) with identity to S. aureus V8 serine protease were also found to be important in defining group C. V8 protease has similarity to S. 
aureus exfoliative toxins (Ladhani 2003) and has been shown to cause epidermal barrier dysfunction in nude mice (Hirasawa et al. 2009).    
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Table 4.5 Proteins important in defining group C. PROKKA annotation was found by mapping clusters from the variable importance analysis to the S. intermedius genome in the case of “present” clusters and the S. saprophyticus genome in the case of the “absent clusters”. The PROKKA locus tag is indicated in brackets. BLAST similarity was found by searching the protein against the NCBI BLAST database. 
PROKKA annotation BLAST similarity 
Presence  V8 like Glu specific endopeptidase (inter_00008) Glutamyl-endopeptidase V8 like Glu specific endopeptidase (inter_00009) Glutamyl-endopeptidase D Ala teichoic acid biosynthesis protein (inter_00088) D-Ala-teichoic acid biosynthesis protein Yip1 domain protein (inter_00369) Hypothetical protein Hypothetical protein (inter_00749) Possible membrane protein DoxX (inter_01836) DoxX family protein Macrolide export ATP binding/permease protein MacB (inter_02006) Amino acid ABC transporter permease Hypothetical protein (inter_02256) Hypothetical protein Hypothetical protein (inter_02629) Hypothetical protein 
Absence  Aspartokinase 2 (sap_01421) Aspartokinase ii Putative glycosyltransferase tagX (sap_02141) Teichoic acid biosynthesis protein 
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4.3.2 Diversity across the staphylococci at loci associated with CAMP 
survival 
4.3.2.1 Intramembrane histidine kinase sensor : response regulator 
systems As described above, the presence of a two component sensor regulator was shown to be important in the definition of group A, and that this TCS in the strains of S. aureus analysed had ~ 100% sequence identity to BraRS. The two component system identified in the random forest analysis as being important in defining group A will therefore be referred to as BraRS from this point.   Due to the presence of two homologous TCSs in the group A species, the sequence identity of GraRS, the conserved TCS, was investigated across groups A-C in this analysis. A high degree of identity, ≥77% (Table 4.6a), between the protein sequences of the GraR regulator was seen within the three groups with the highest identity of 97.9% among the organisms of group C. The identity between the groups fell to 66.7% indicating some degree of divergence in the GraR protein.   A neighbour joining tree was generated from an alignment of the GraR protein sequences (Figure 4.3).  The same clustering observed in the heatmap generated from the OrthoMCL analysis (Figure 4.1) was observed, with the labels A, B and C corresponding to the respective heat map groups. Notably S. 
pettenkoferi was observed to be an outlier in this analysis.   The sequence identity of the GraS sensor histidine kinase locus within the three groups was also investigated. This protein was shown to be less conserved than the regulator within each group A and B as the identity within these groups was 60.4% and 66%, respectively (Table 4.6a). GraS was more highly conserved in members of group C, with an identity of 88.2%. In comparison, the sequence identity between the groups A-C was 48.2% and lower than that observed for the GraR regulator protein.
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Figure 4.3 Neighbour-joining tree of the GraR protein. The basis of the tree is the alignment of the GraR protein sequence from all staphylococci included in the OrthoMCL analysis. A indicates group A strains from the OrthoMCL analysis heatmap, similarly B and C indicate groups B and C from the same analysis.  Bootstrapping using 1000 replicates was performed. 
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 A neighbour-joining tree was generated from an alignment of the protein sequences of GraS (Figure 4.4). Again, consistent with GraR, a clustering pattern in the heatmap generated from the OrthoMCL analysis was observed (Figure 4.1) with the exception of an increased tree branch length for S. lentus and S. 
vitulinus and indicating increased divergence of the GraS sensor histidine kinase across the different species. S. pettenkoferi was again observed as an outlier by not clustering with group A in this analysis.  The sequence identity of the BraR regulator protein sequence among the group A organisms was investigated (Table 4.6b).  Due to the fact that the GraRS proteins from S. pettenkoferi did not cluster with the rest of the group A organisms in the neighbour-joining trees, and that the GraRS annotated locus in this species was present in the OrthoMCL clusters representing BraRS in the rest of group A, this locus was included in the BraRS analysis. It was shown that the identity in the BraR protein sequence within group A was 77.1%. Identity of this protein with GraR in group B and C species was 39.6% and identity with GraR in group A was 44.34%.    
Table 4.6a Percentage identity in the GraRS TCS. Average % identity in the GraR and GraS within groups A, B and C as well as between all the groups was calculated from multiple sequence alignments of all protein sequences.   
Two component 
system 
identity within 
group A 
Identity 
within 
group B   
Identity 
within 
group C  
 
Identity between 
all groups  
GraR 77.3/87.8* 84 97.9 66.7 GraS 60.4/69.4* 66 88.2 48.2 
Table 4.6b Percentage Identity in the BraRS TCS. Average % Identity in the BraR and BraS within group A as well as % identity to GraRS was calculated from multiple sequence alignments of all protein sequences. 
 Identity within 
group A 
Identity to group B & C 
graRS 
Identity to group A 
Gra BraR 77.1 39.6 44.34 BraS 62.9 26.4 29.8 * % Identity within group A was also calculated excluding the outlier S. pettenkoferi 
 170 Figure 4.4 Neighbour-joining tree of the GraS protein. The basis of the tree is the alignment of the GraS protein sequence from all staphylococci included in the OrthoMCL analysis. A indicates group A strains from the OrthoMCL analysis heatmap, similarly B and C indicate groups B and C from the same analysis.  Bootstrapping using 1000 replicates was performed.  
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A neighbour-joining tree based on the alignment of the BraR protein was generated (Figure 4.5). The clusters present in the heatmap generated from the OrthoMCL analysis were observed and clear divergence between the orthologues BraR and GraR was identified.  Sequence identity of the BraS protein sequence within group A was found to be 62.9% (Table 4.6b). Identity of BraS to GraS in groups B and C and group A was 26.4% and 29.8% respectively indicating increased divergence from the GraS homologue compared to the regulator protein. A neighbour-joining tree was generated based on the alignment of the BraS protein sequence from group A and the GraS protein sequences from groups B and C (Figure 4.6). Groups B and C clustered together however the clustering of group A broke down with increased branch lengths in this cluster representing increased divergence of the BraS protein sequence compared to the GraS protein sequence. S. lentus and 
S. vitulinus were also observed to cluster with the group A genomes indicating identity between their GraS protein sequence and the BraS protein sequence. Despite this, the sequences of the S. lentus and S. vitulinus GraS protein share only an average 26.5% identity with the group A BraS proteins.  It is clear that the process of responding to cationic antimicrobial peptides in the staphylococci is complex, highlighted by the level of divergence observed between species in the two TCSs GraRS and BraRS. This divergence indicates that the TCSs are under strong selection pressures, which is unsurprising as cationic peptides are constantly present in their host environment. The first point of interest to note is the presence of only one of the two TCSs in S. 
pettenkoferi. Due to the fact that the TCS shows higher percentage identity to BraRS and S. pettenkoferi was observed as an outlier in the neighbour-joining tree based on the GraRS protein sequences (Figures 4.6, 4.7 ), it appears that this singular TCS is BraRS. This raises questions about the  evolution of BraRS in the group A organisms.
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Figure 4.5 Neighbour joining tree of graR and the orthologous BraR proteins. The basis of the tree is the alignment of the BraR protein sequence from group A organisms with the GraR protein sequence from non-group A organisms from the OrthoMCL analysis.  The labelled  A, B and C refer to the groups A,  B and C defined in the same analysis. Bootstrapping using 1000 replicates was performed.  
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Figure 4.6 Neighbour joining tree of GraS and the orthologous BraS proteins. The basis of the tree is the alignment of the BraS protein sequence from group A organisms with the GraS protein sequence from non-group A organisms from the OrthoMCL analysis.. The labelled  A, B and C refer to the groups A,  B and C defined in the same analysis. Bootstrapping using 1000 repetitions was performed.  
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One explanation could be that a gene duplication of GraRS in one of the group A species and then subsequent divergence of the BraRS system from GraRS; this duplicated system may have then been spread through the rest of group A by horizontal gene transfer. S. pettenkoferi presents a challenge to this paralogue hypothesis, however, due to the presence of only BraRS. There are two possibilities which might explain the presence of only one of the TCSs; S. 
pettenkoferi  could have either lost graRS following acquisition of braRS, or S. 
pettenkoferi never acquired braRS, but rather its braRS evolved from an ancestral graRS. The other group A organisms may then have acquired braRS from S. pettenkoferi as an additional TCS to graRS.  Regardless of the origins of the two TCSs, the presence of sequence variation both among and between GraRS and BraRS suggests that these systems evolved to confer resistance to the variety of cationic antimicrobial peptides with different structures and mechanisms of action present in the different niches to which the staphylococci are specialised. It is known that mutations in the TCSs alter resistance to a variety of antibiotics, particularly mutations in the gene encoding the sensor histidine kinase protein of both systems. It was shown that a mutation in graS leads to intermediate vancomycin resistance in MRSA (Howden et al. 2008), for example. Furthermore, Blake et al found a point mutation in braS to be responsible for increased resistance to the lantibiotic nisin (Blake et al. 2011).    The role of GraRS and BraRS in species of staphylococci inside and outside of group A is explored in further detail in chapter 5.   
4.3.2.2 Associated ABC transporters It was discussed that BceS-like intra-membrane histidine kinases do not act directly to sense the presence of antimicrobial peptides, but rather act as signal transfer molecules which activate the response regulator in the presence of the antimicrobial peptide substrate bound to the associated ABC transporter(Mascher 2014). Both GraRS and BraRS are members of this family of TCSs. Due to the importance of the ABC transporter to the functioning of 
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these TCSs the protein sequence of the ABC transporters associated with both BraRS and GraRS were retrieved from the genomes and investigated.  It was evident that the proposed ABC transporter associated with GraRS was not present in groups B genomes. S. pettenkoferi was only found to carry BraRS, however no ABC transporter was observed in the expected location adjacent to BraRS, or in the surrounding genomic region.  The ABC transporter associated with GraRS is VraFG (Meehl et al. 2007). A protein sequence alignment of the ABC transporter adjacent to the GraRS locus with the protein sequences of VraFG from S. haemolyticus strain JCSC1435 and 
S. aureus strain Z172 was carried out. Intraspecies variation was low with the S. 
aureus VraF from this analysis sharing 93% identity with S. aureus Z172, and S. 
haemolyticus VraF from this analysis sharing 99.6% identity with S. 
haemolyticus JCSC1435. An average of 68.3% identity was observed at the putative vraF locus among all species (Table 4.7). Identity within the groups was higher with group A organisms sharing 79% identity, group B organisms sharing 85.3% identity and group C sharing 96.8% identity. Noticeably, vraF was not observed to be adjacent to GraRS in group B organisms. Instead vraF, and indeed vraG are located elsewhere on the chromosome.    
Table 4.7 % sequence identity in the VraFG ABC transporter. Average % identity in the VraF and VraG within groups A and C as well as between the groups was calculated from multiple sequence alignments of all protein sequences.   
Two component 
system Identity within group A Identity within group B Identity within group C   Identity between all groups VraF 79 85.3 96.8 68.3 VraG 61.9 65.2 88 47.5   
 176 
A neighbour-joining tree based on the protein sequence alignment of VraF was generated (Figure 4.7). Groups A, B and C clustered together. The length of S. 
hominis VraF however is 275 amino acids compared to 253 amino acids for the protein sequence of the rest of the group A VraF. Despite this, in the protein sequence alignment S. hominis showed 73.7% identity with the rest of the group A VraF protein sequences.   Intraspecies variation in the VraG protein sequence was also low with the S. 
aureus VraG from this analysis sharing 90% identity with S. aureus Z172, and S. 
haemolyticus VraG from this analysis sharing 100% identity with S. haemolyticus JCSC1435. Identity between all species in the VraG protein sequence was 47.5%, and 88%, 65.2% and 61.9% identity for groups A, B and C respectively. Again, no vraG gene was observed adjacent to the graRS locus in group B species, the protein was located in the same location as the putative vraF. A neighbour-joining tree based on the protein sequence alignment of VraG was also generated (Figure 4.8) and Groups A, B and C clustered together (Figure 4.8).  As discussed in section 4.3.2.1 an ABC transporter was identified in group A which was proposed to be BraD/BraE. The sequence identity at this locus between the genomes in group A was investigated. The organisms of group A were shown to share 68.4% identity in their BraD protein sequences, and a much reduced  38.9% identity in their BraE protein sequences.  In the genomes where VraFG was encoded there is a high degree of protein sequence identity, indicating that the ABC transporter is well-conserved among the species. This conservation is higher for VraF than it is for VraG, for example identity of VraF between all groups is 68.3% and 47.5% for VraG. Notably BraD is also more highly conserved than BraE showing 68.4% identity compared to 38.9% identity.   The divergence of BraRS and GraRS  may be as a result of the adaptation of the ABC transporter sensors to different antimicrobial peptides. As the ABC transporters evolved, the histidine kinase may have also evolved in such a way 
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that it was still able to receive and transfer this signal to the response regulator. The reduced divergence of the response regulators may be explained by the fact that they are the part of the system most isolated from the external environment and the changing stimuli.  
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Figure 4.7 Neighbour joining tree of VraF. The basis of the tree is VraF protein sequence alignment from all genomes. The labeled A. B and C indicate groups A and C from the OrthoMCL analysis. Bootstrapping using 1000 replicates was performed.  
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Figure 4.8 Neighbour joining tree of VraG. The basis of the tree is a VraG protein sequence alignment.. The labeled A, B and C indicate groups A, B and C from the OrthoMCL analysis.  Bootstrapping using 1000 replicates was performed.  
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4.4 Conclusion An investigation of the genetic basis directing formation of the three groups of staphylococcal species based upon shared orthologous clusters (Figure 4.1) highlighted several common themes. Many of the genes driving formation of the clades were associated with metabolism, such as the absence of UDP-glucose 4-epimerase from group A. Differences in resistance to antimicrobial peptides were also suggested by the different repertoirs of ABC transporters among the three groups. Other proteins have roles in mediating the cell’s interaction with external stimuli such as the proposed presence of a divergent D-Ala-treichoic acid biosynthesis protein in group C and an alternative version of EbpS in group B. Finally proteins involved in survival of hostile conditions in the host niche, such as osmotic stress, were identified.  The presence of genes with these functions in the importance analyses investigating the genetic basis of groups A, B and C indicate that species groups may be defined by metabolism, response to antimicrobial peptides and interaction with the host.  Interestingly, differences in fatty acid metabolism were found to differentiate S. epidermidi, S. capitis, S. 
warneri, S. haemolyticus, S. hominis, S. lugdunensis  and S.pettenkoferi from the rest of the species of Staphylococci in the analysis. Excluding S. lugdunensis and 
S. pettenkoferi, this group contains the staphylococci associated with the human skin microbiome. How these species interact with fatty acids on the skin may therefore impact on their successful skin colonisation.  The ability to compete for nutrients, resist the antimicrobial peptides produced by the host and other members of a community and survive the hostile conditions of the host niche are all pre-requisites for success as part of a microbial community. As each of the three groups were comprised of species isolated from similar hosts and niches (4.3.2) it makes sense that the genetic basis behind each group involves functions important in niche specialisation.   One important aspect of niche diversity is the antimicrobial peptides community members both encounter and produce. One would therefore expect diversity in the mechanisms with which the different groups resist these antimicrobial peptides due to strong selective pressures. Diversity was shown 
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in this analysis although the forces that directed these differences are unclear. Diversity was observed at the GraRS locus both within and between the three groups of species investigated, which is central as the common antimicrobial sensor in almost all Staphylococcus species.  The broad host range of S. aureus presents questions regarding the suggestion that genes involved in niche specialisation may be involved in creating the basis for the three groups discussed in this analysis. S. aureus has been isolated from a variety of hosts including cattle, chickens and rabbits. The presence of BraRS in the animal S. aureus strains RF122 (Bovine associated) ED98 (poultry associated) and ERS400835 (rabbit associated) was investigated. The BraRS TCS was found to be present and have 100% protein sequence identity to BraRS from human-associated strains. The associated ABC transporter similarly shared 98% identity with human-associated strains.   In the model laid out by Mascher for the mechanism of action of BceS-like IM-HK systems the antimicrobial peptide is sensed by its binding to an additional protein shown to be the ABC transporter (Rietkötter et al. 2008). This signal is then transferred to the TCS which functions to alter gene expression within the cell to confer resistance to the stimulus. It has been shown that increased resistance to antimicrobials and antibiotics is frequently conferred by changes in the histidine kinase (Cui et al. 2009) (Blake et al. 2011). Furthermore, the largest amount of protein sequence variation in the two TCSs discussed in this chapter is observed in the histidine kinase. This protein is proposed to function as a signal transfer protein between the external signal input from the ABC transporter and the response regulator inside the cell (Mascher 2014).   When the cognate ABC transporters for BraRS and GraRS were investigated the largest amount of protein sequence diversity was observed among VraG and BraE. These proteins function as ABC transporter membrane permeases. It may be expected that these proteins exhibit less sequence identity than the ATP-binding domains VraF and BraD as conservation of the ABC domain in these permeases is important in defining them as ABC transporters (Higgins 2001).  
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 The clustering pattern of the concatenated housekeeping protein sequences is observed for all TCSs and ABC transporters investigated (Figures 4.7-4.12). The neighbour joining tree of the concatenated protein sequences of a panel of housekeeping genes showed that S. aureus and S. simiae cluster with group A.   Finally, the clustering pattern within group A observed in the the GraS (Figure 4.4) TCS neighbour joining trees does not follow that of the well-conserved housekeeping gene panel (Figure 4.9) in that GraS of S. lugdunensis does not cluster closely with that of S. hominis and S. haemolyticus as is the case for the housekeeping genes as well as BraRS, GraR and VraFG.
 183 Figure 4.9 Neighbour joining tree of housekeeping genes. The basis of the tree is the concatenated protein sequences of the housekeeping genes aroE, gmk, pta and tpi. The labelled A, B and C indicate groups A, B and C from the OrthoMCL analysis. Bootstrapping using 1000 repetitions was carried out.  
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Chapter 5 
Experimental evolution of Staphylococcus hominis, 
Staphylococcus saprophyticus and Staphylococcus 
aureus with type-A (i) lantibiotic nisin selection. 
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5.1 Introduction 
5.1.1 Biosynthesis, structure and function of nisin  Nisin is a type-A(i) lantibiotic produced by Lactococcus lactis. This peptide antibiotic is active against a range of Gram-positive bacteria, including S. aureus and species of Bacillus and Clostridium (Delves-Broughton et al. 1996).  Type A lantibiotics are so called due to the inclusion of the unusual thioether amino acids lanthionine or methyllanthionine in their structure (Bauer & Dicks 2005). Their biosynthesis also follows an unusual route in that a precursor peptide is ribosomally synthesised as a prepeptide comprised of a C-terminal propeptide and an N-terminal leader peptide. The C-terminal propeptide is post-translationally modified and the leader peptide is cleaved in the final stage of nisin biosynthesis to release the active lantibiotic.  The structure of the leader peptide is important to the classification of nisin as a type A(I) lantibiotic. Leader peptides in this group are hydrophilic, contain multiple charged amino acids and are highly conserved (McAuliffe et al. 2001).  The nisin biosynthesis gene cluster encodes the protein activities required for the post-translational modifications for maturation of nisin. Of these, nisB encodes a hydrophilic protein of around 100 amino acids in length. Membrane localisation of the proteins has been shown by the presence of hydrophobic domains within these relatively large proteins and their presence in the same centrifugation fraction as membrane vesicles in L. lactis (Engelke et al. 1992). Experiments show NisB is a dehydratase which converts Ser33 in the propeptide to didehydroalanine (Dha)(Sen et al. 1999). Dehydration of the hydroxyl serine residue in the propeptide by the membrane-associated cyclase, NisC couples a cysteine residue to the dehydrated serine, thus forming a thioether (Li et al. 2006). The NisB and NisC proteins form an unstable lantibiotic synthase complex with a putative peptide translocator protein NisT. The ratio of the three proteins in the complex is one molecule of NisB to two molecules each of NisC and NisT (1:2:2) (McAuliffe et al. 2001).   Before nisin can exert its antimicrobial activity the leader peptide must be cleaved and the mature, active lantibiotic translocated across the cell 
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membrane. Cleavage of the leader peptide occurs through the proteolytic action of the peptidase NisP, a 682 amino acid extracellular protein (McAuliffe et al. 2001) (Siegers et al. 1996). Inactivation of the lantibiotic biosynthesis peptidase, epiP, showed that the protein is not essential to the production of a mature, functional lantibiotic peptide, suggesting that an alternative peptidase can compensate for the loss of epiP (Geissler et al. 1996). Conversely, the peptidase responsible for the leader protein cleavage of the Pep5 lantibiotic was shown to be essential for the production of mature and fully functional Pep5 (Meyer et al. 1995).  The NisT translocator is an ABC transporter, which exports nisin out of the cell. This transport is proposed to be mediated by the leader peptide and is reliant on the presence of active NisT. In the case of other lantibiotics, for example the aforementioned Pep5, the lantibiotic is still exported from the cell with reduced efficiency in the absence of the Pep5 translocator protein. This suggests that other ABC transporters encoded in the genome are able to compensate for the role of the lost Pep5 translocator (Meyer et al. 1995). This compensation is also observed with the lantibiotic epidermin (McAuliffe et al. 2001).  Lantibiotic biosynthesis is controlled by a TCS, NisKR, in response to changes in cell density, where nisin acts as a substrate for the sensor histidine kinase. The response regulator activates transcription of nisA in the presence of nisin, or NisA. Mutant nisin and nisin analogues can also induce the transcription of nisA (Kuipers et al. 1995). 
 The structure of nisin is characteristic of the type(I)-A lantibiotics, being composed of rigid lanthionine rings separated by areas of less rigidity. Nisin contains 5 lanthionine rings, and the N-terminal rings A and B are conserved in several lantibiotics within the same group including gallidermin (Wilson-Stanford et al. 2009). The basis of these lanthionine rings is the presence of thioether bridges. These thioether bridges are essential to the function of nisin since oxidation of the thioether moieties to sulfoxides results in the loss of its antimicrobial properties (Slootweg et al. 2014). 
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 The mode of action of this lantibiotic involves interaction of nisin with lipid II, in the cell membrane that results in pore formation. Studies revealed that lipid II enhances the capacity of nisin to form pores in membrane model systems (Breukink et al. 1999), and that the presence of lipid II is required for the formation of a stable pore (Wiedemann et al. 2004). Furthermore, the conserved N-terminal lanthionine rings of nisin have been shown to be the lipid II binding site. In the presence of lipid II the N-terminus of nisin adopts a cage-like structure, involving the first two lanthionine rings, A and B, around the pyrophosphate group of lipid II. The interaction between nisin and lipid II is enhanced by the formation of hydrogen bonds between the pyrophosphate group and the binding cage. The presence of this pyrophosphate moiety in both lipid I and lipid II explains the interaction of nisin with both molecules (Hsu et 
al. 2004).   In addition to the action of forming pores in the bacterial membrane nisin sequesters lipid II and removes it from its functional location thus blocking cell wall synthesis. This mode of action also results from the presence of the pyrophosphate cage created by the A and B lanthionine rings, thus other lantibiotics where this motif is conserved also exibit this action (Hasper et al. 2006).  
5.1.2 Biosynthesis, structure and function of type-A(I) lantibiotics 
produced by staphylococci Lantibiotic production in the staphylococci is dominated by the commensal species. Several of these antimicrobial peptides are type-A(I) lantibiotics. The type-A(I) lantibiotics can be further divided into three structural groups; the nisin group, the pep5 group and the epidermin group (Chatterjee et al. 2005). S. 
epidermidis produces two such antimicrobial peptides, Pep5 and epidermin. Pep5 was isolated from S. epidermidis strain 5, and its biosynthesis gene cluster contains the pepA structural gene, pepB, pepC and pepP which encode enzymes responsible for post-translationally modifying and processing the prepeptide, 
pepT which encodes the PeP5 translocator and pepI which, when expressed, 
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confers producer immunity (Meyer et al. 1995). Pep5 biosynthesis is encoded by the plasmid pED503 and the biosynthesis gene clusters is arranged 
pepTIAPBC (Meyer et al. 1995). A key structural difference in Pep5 is the N-terminally exposed didehydroaminobutyric acid following cleavage of the leader peptide. This is an unstable moiety which is quickly deaminated to form 2-oxobutyryl (McAuliffe et al. 2001). Like nisin, Pep5 is able to form pores in Gram-positive cell membranes (Kordel et al. 1988). Pep5 also weakens the cell wall by counteracting the inhibition of lytic enzymes, which regulate cell wall turnover, by their inhibitors that include teichoic and lipoteichoic acids (McAuliffe et al. 2001). In contrast to nisin, however, Pep5 has low affinity for the peptidoglycan precursor lipid II (Brötz et al. 1998). 
 Epidermin is produced, modified and transported by a gene cluster similar to that of Pep5 encoded by the plasmid pTu32 in the S. epidermidis strain Tü3298(Augustin et al. 1992) . The epidermin biosynthesis gene cluster contains the additional genes epiD and epiQ, encoding an oxidative decarboxylase (Bierbaum et al. 1996), and a regulator protein respectively (McAuliffe et al. 2001) (Götz et al. 2014); there is also a producer immunity gene cluster. Gallidermin, synthesised by S. gallinarum, is similar to epidermin and Pep5. The gallidermin biosynthesis cluster is organised as that of epidermin and is borne on a large plasmid. Regulation of epidermin and gallidermin occurs through the transcription of epiQ/gdmQ, which is not activated by mature lantibiotic, as is the case for nisin. The epiQ promoter which activates transcription of the epiP and epiQ operon is not itself controlled by EpiQ, therefore epidermin/gallidermin biosynthesis is not autoregulated (Götz et al. 2014). Expression of the additional epiD gene and its homologue gdmD, encoded in the epidermin and gallidermin biosynthesis clusters, structurally alters the mature lantibiotic peptide to contain an S-((Z)-2-aminovinyl)-D-cysteine modification that is lacking in nisin and Pep5 due to the absence of an epiD homologue (Götz et al. 2014).  Both epidermin and gallidermin are synthesised as prepeptides and their leader peptides are cleaved by the leader peptidase. EpiP and GdmP are both serine 
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proteases which contain a signal peptide which controls their secretion.  As is the case for nisin, the post-translocation processing of the prepeptide by the peptidase is essential for its maturation and function.  Due to the shorter length of epidermin and gallidermin compared to the well-studied nisin and Pep5, their mode of action is proposed to differ. The interactions with lipids I and II involved in murein synthesis is conserved, however epidermin and gallidermin interact differently with WTA precursors and these interactions may be the cause of bacterial killing by these two lantibiotics rather than pore formation (Hasper et al. 2006). Gallidermin is not able to form pores by interacting with lipid II, and in fact interaction of gallidermin with this molecule prevents pore formation by nisin in vitro (Müller 
et al. 2012). It is likely that the short lantibiotic peptides gallidermin and epidermin act by sequestering lipid II and preventing cell wall synthesis in this way (Hasper et al. 2006).  
5.1.3 Other lantibiotics produced by staphylococci The lantibiotic hominicin has been purified from S. hominis strain MBBL 2-9 and its structure contains those uncommon amino acids characteristic of the type-A(I) lantibiotics, however it has no thioether bridges integral to the lanthionine ring structures (Kim et al. 2010) of the type-A(I) lantibiotics. This implies that the mode of action of hominicin will not follow that of nisin; that is it will not interact with lipid II through a pyrophosphate cage structure.   Nukacin ISK-1, a type-A(II) lantibiotic, was isolated from S. warneri strain ISK-1 and its propeptide is similar to lacticin type lantibiotics. The nukacin ISK-1 biosynthesis operon appears to be comprised of a structural gene, nukA, a modification enzyme expressed from nukM and a response regulator (Sashihara 
et al. 2000). The ring structures characteristic of type-A(I) lantibiotics are also present in nukacin ISK-1 and ring A was shown to act as a lipid II binding site (Islam et al. 2012). Interaction of nukacin ISK-1 with the target membrane is due to electrostatic interactions mediated by three N-terminal lysine residues. Mutation of these residues was shown to attenuate the antimicrobial activity of 
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nukacin (Asaduzzaman et al. 2006). Variants of nukacin are produced by other staphylococci.  Nukacin 3299 was isolated from S. simulans involved in bovine mastitis in Brazil. The lantibiotic was originally known as simulancin 3299, however gene sequencing of the structural gene revealed 100% identity with nukA of the nukacin ISK-1 biosynthesis cluster. Similar to other lantibiotic biosynthesis clusters the nukacin 3299 biosynthesis cluster is plasmid encoded and this isolate demonstrated a wider range of host producer (Ceotto et al. 2010).  
S. hominis also produces a nukacin variant. Nukacin KQU-131 is produced by S. 
hominis KQU-131, which was isolated from fermented fish. The lantibiotic prepeptide has 3 differing amino acid residues when compared to nukacin ISK-1: 1 in the leader peptide and 2 in the mature lantibiotic. The three lysine residues proposed to be important in membrane interaction are conserved, and the two amino acid changes in the mature lantibiotic are found in the last lanthionine ring of the structure(Wilaipun et al. 2008).   As well as the type-A(I) lantibiotics epidermin and Pep5, S. epidermidis produces several other lantibiotics; epicidin 280, epilancin K7 and epidermicin NI01. Epidermicin was the most recently characterised of the three and is a type-(II) lantibiotic. S. epidermidis strain 224 encodes the epidermicin NI01 biosynthesis cluster on a plasmid (Sandiford & Upton 2012). Epilancin K7 is a type-A lantibiotic, and contains the characteristic thioether bridges. Unlike the type-A(I) lantibiotics discussed, however, the peptidase associated with the epilancin K7 biosynthesis cluster does not carry an export signal, implying that it acts inside the producer cell. Epilancin K7 may therefore be exported as a mature lantibiotic peptide. The exposure of the N-terminus, cleaved of its leader peptide, to the cytoplasm could be the reason for the unusual modification of the first residue of the lantibiotic (van de Kamp et al. 1995). Finally, Epicidin 280 is produced by S. epidermidis BN 280. Both the lantibiotic peptide and its biosynthesis cluster exhibit a high degree of similarity to Pep5. Differences in structure of the biosynthesis cluster are however present as the ABC 
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transporter associated with high yields of Pep5 was absent, and an additional modification gene, epiO was found. The epicidin gene cluster was present on the larger plasmid pCH01. The lack of an associated transporter and evidence from Pep5 that deletion of the dedicated Pep5 transporter reduces, but does not abolish the production of the lantibiotic, suggests that an alternative transporter may export epicidin. Finally, strains which produce Pep5 or epicidin 280 exhibit cross immunity to the two peptides (Heidrich et al. 1998). This suggests that bacteria within niche communities producing similar bacteriocins might exhibit cross immunity to one another’s antimicrobial peptides.  
5.1.4 Producer immunity to lantibiotics The mechanism of L. lactis immunity to the lantibiotic nisin is well understood. Several proteins are involved in immunity to nisin; the ABC transporter encoded by nisFEG and the membrane bound immunity protein NisI. This is also true of epidermin, gallidermin and nukacin immunity which also utilise this two factor resistance. Pep5, epilancin and epicidin immunity each require only one immunity peptide; PepI, EciI and ElxI respectively (Alkhatib et al. 2012). The ABC transporter involved in the immunity to nisin is in addition to the transporter responsible for the translocation of the peptide out of the cell. NisF is the nucleotide binding domain of the transporter, located on the cytoplasmic side of the cell membrane and the intramembrane subunits are NisE and NisG (Alkhatib et al. 2012). This transporter architecture is characteristic of importers however this ABC transporter expels unmodified nisin from the membrane before the occurrence of pore formation. Interaction of the ABC transporter with its substrate is mediated by the C- terminus of nisin, including the last lanthionine ring (Alkhatib et al. 2014). Expression of this ABC transporter occurs in the presence of nisin as a result of the phosphorylation of the histidine kinase NisK by the regulator protein NisR.  NisFEG contributes only around 20% of immunity to nisin, the remainder is contributed by the NisI immunity protein. NisI is a lipoprotein which contains an N-terminal cell wall anchor motif, however this cell wall anchoring is inefficient and around 50% of the lipoprotein is secreted into the extracellular 
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space (Koponen et al. 2004). This family of protein is poorly understood and does not share a great degree of similarity with other proteins; the hydrophobic N-terminal region is however shared with other lantibiotic immunity peptides such as PepI, which gives Pep5 producer strains of S. epidermidis resistance. A 21 amino acid portion of NisI provides specificity of other immunity peptides to nisin, and is responsible for most of the immunity against nisin conveyed by NisI (Takala & Saris 2006). Similarly the C-terminus of PepI is responsible for Pep5 immunity in S. epidermidis (Hoffmann et al. 2004). NisI is suggested to sequester aggregates of nisin to prevent them from interacting with the producer cell membrane. This ability to interact with nisin is not dependent on being anchored to the cell wall, therefore the NisI secreted into the extracellular space may also have a role in producer immunity (Koponen 2004) (Takala et al. 2004). Furthermore, NisI secreted into the extracellular space is present in a ~1:50 ratio with aggregated nisin further enhancing activity of the lantibiotic against producer strains in vitro (Koponen et al. 2004).  
5.1.5 Experimental evolution and its role in elucidating antimicrobial 
resistance Evolution of resistance to antibiotics by bacteria is one of the most significant problems facing medicine. Understanding the potential for resistance to new antibiotics and the mechanisms of emerging resistance to current antibiotics is required to develop effective, future proof antimicrobials. Experimental evolution is one method that has been used to investigate the potential for resistance to newly discovered antimicrobials, and also to infer information about the mechanism by which this resistance may have occurred.   Acquired antimicrobial resistance has been explored in several ways, such as using clinical isolates from antibiotic resistant infections (Mwangi et al. 2007) (Howden et al. 2011) as well as experimentally evolved isolates (Renzoni et al. 2011) (Song et al. 2013).  There are advantages and disadvantages to both approaches. In an experimental evolution model the variables are tightly controlled so any variation in phenotype and genotype can be attributed to the antimicrobial under test. A model which uses clinical isogenic pairs of strains to 
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examine evolution of resistance instead, has the advantage of including host or community factors which might affect resistance. Such factors are synergistic effects of other antimicrobials or acquisition of resistance by horizontal gene transfer from community members. Regardless of the model used, minimum inhibitory concentration (MIC) assays are employed to identify the presence and understand the extent of antibiotic resistance developed.  Resistance to antimicrobial peptides often arises through mutations which may occur in a sequential fashion, that is one mutation may be necessary for the next to be acquired. Resistance to some groups of antibiotics, however, is the result of a single mutation, as is the case for rifamycin and quinolones (Toprak et al. 2012). In most laboratory systems of evolution this series of mutations is selected for by maintaining the mutant selection window, which requires the concentration of the antibiotic being used as the selection pressure to be continuously increased as mutations conferring resistance occur. The rate at which resistant mutants occur leading to the concentration of the antibiotic to be increased changes for each organism and antimicrobial (Drlica 2003).  Where resistance determinants are encoded by elements, which can be gained through horizontal gene transfer, the story is slightly different. Multidrug resistance plasmids carry resistance determinants to a broad range of antimicrobials and these plasmids represent a fitness cost for the host bacteria in the absence of the selective pressure of antibiotics. This has been investigated through laboratory evolution of mixed populations of E. coli comprised of organisms with and without plasmid-encoded resistance to antimicrobials introduced as a selection pressure. It was shown that the levels of antibiotics required to maintain these resistant determinants, especially where multiple selection pressures for multidrug resistance plasmids are present, are far below the levels of MIC and may be found in certain environments such as hospital settings and agriculture (Gullberg et al. 2014).    
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5.1.5 Chapter aims The staphylococci live in complex communities as part of the skin microbiota. To compete for resources such as space and nutrients the members of these communities employ an arsenal of weapons such as the production of lantibiotic bacteriocins. Data from chapter 4 led to the hypothesis that the way in which different groups of staphylococci combat these lantibiotics may be different through the divergence of the graRS operon and the presence of an additional orthologous operon, braRS between groups of species. BraRS has previously been shown to be important in lantibiotic resistance in S. aureus. Since the involvement of BraRS in nisin resistance has thus far only been investigated in the pathogenic species S. aureus the first aim of this chapter was to determine if this involvement extended to those other commensal species of staphylococci bearing the braRS operon. The responses of strains of S. hominis and S. aureus to the type-A(I) lantibiotic nisin were therefore compared using experimental  evolution with analysis of resulting SNPs to understand if nisin resistance in the two species occurs through similar mechanisms.     A further aim of this chapter was to use this experimental evolution model to investigate if species without BraRS evolved resistance to nisin to the same extent as those species which carry braRS. The resulting SNPs in the evolved populations were analysed to understand any differences in the pathways to increased nisin resistance in the two groups. To this end the evolution of the 
braRS-positive species S. hominis and S. aureus to nisin was compared with that of the braRS-negative species S. saprophyticus.  
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5.2 Methods 
5.2.1 Preparation of nisin stock solutions For all experiments where preparation of nisin stocks was required, master stocks were prepared at 20, 2 and 0.2 mg/mL in 10mM sodium citrate at pH 3 and stored at 4 °C and allowed to reach room temperature before use. 
5.2.2 Minimum inhibitory concentration assay A microtiter plate method was used with doubling dilutions of a nisin stock solution prepared at 2X the highest concentration required in sodium citrate and diluted to the appropriate concentration using BHI.  Concentrations were then diluted 1 in 2 with bacterial suspension. The final concentrations used are found in Table 5.1. Optical densities of overnight cultures of each strain tested were adjusted to OD600 0.2 ± 0.005 and 100 μL was used to inoculate the microtiter plates. The lowest concentration with an optical density ≤ to that of the initial optical density was taken to be the minimum inhibitory concentration (MIC).  With thanks to Dr Miriam Korte-Berwanger, University of Bochum, for kindly providing the Staphylococcus saprophyticus strains used in this study.      
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  Table 5.1 Concentrations of nisin used in the nisin MIC assay. All concentrations given in μg/mL. 
S. aureus S. hominis S. saprophyticus (excluding strain 349) S. saprophyticus strain 349 500 50 500 50 400 40 400 40 300 30 300 30 250 25 250 25 200 20 200 20 150 15 150 15 125 12.5 125 12.5 100 10 100 10 75 7.5 75 7.5 62.5 6.25 62.5 6.25 50 5 50 5 37.5 3.75 37.5 3.75 31.25 3.125 31.25 3.125 25 2.5 25 2.5 18.75 1.875 18.75 1.875 15.625 1.5625 15.625 1.5625 12.5 1.25 12.5 1.25 9.375 0.9375 9.375 0.9375 7.8125 0.78125 7.8125 0.78125 6.25 0.625 6.25 0.625 4.6875 0.46875 4.6875 0.46875 3.90625 0.390625 3.90625 0.390625 3.125 0.3125 3.125 0.3125 2.34375 0.234375 2.34375 0.234375 1.953125 0.1953125 1.953125 0.1953125 1.5625 0.15625 1.5625 0.15625 1.171875 0.1171875 1.171875 0.1171875 0.9765625 0.09765625 0.9765625 0.09765625 0 0 0 0 
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5.2.3 Experimental evolution and selection Experimental evolution was carried out using a microtiter plate method. Plates were set up with doubling dilutions of nisin (prepared as described in section 4.2.1) in triplicate across the microtiter plate. Concentrations used for experimental evolution are shown in Table 5.2. The initial stock solution concentration of nisin used for each strain was selected based on the results of the MIC assay and produced a set of doubling dilutions which encompassed the MIC value observed. For S. aureus and S. saprophyticus this initial stock concentration was 60% 0.02 g/10mL. For S. hominis this was 0.002 g/10mL. Sodium citrate control plates were set up using the same method but omitting nisin so the control experiment reflected the concentration of sodium citrate in the nisin experiment. All plates were incubated static at 37 °C. The first plates were inoculated with OD600 0.2 bacteria for the first passage and bacteria from the well with the highest concentration of nisin which supported growth consistent with the control after 24 or 48 hours was passaged forward to the next plate. All wells of subsequent passages were inoculated with a 1:1000 dilution of the bacteria passaged forward. This passaging was repeated to a terminal concentration of 10 000 μg mL-1 of nisin or for a period of 12 days. Strains were stocked in 20% glycerol after each passage. The T0 time point was also stocked as a comparator strain.   
   
Table 5.2 Concentrations of nisin used in the experimental evolution. All concentrations are given in μg/mL, percentages refer to a starting stock prepared from a percentage dilution of the master stock. well 60% 0.2 100% 0.2 60% 0.02 100% 0.02 60% 0.002 100% 0.002 2 3000 5000 300 500 30 50 3 1500 2500 150 250 15 25 4 750 1250 75 125 7.5 12.5 5 375 625 37.5 62.5 3.75 6.25 6 187.5 312.5 18.75 31.25 1.875 3.125 7 93.75 156.25 9.375 15.625 0.9375 1.5625 8 46.875 78.125 4.6875 7.8125 0.46875 0.78125 9 23.4375 39.0625 2.34375 3.90625 0.234375 0.390625 
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Time points for sequencing were selected by using the highest concentration of nisin where each of the three independent biological replicates reached the same level of nisin resistance. Stocks from each time point were streaked on BHI agar and incubated overnight at 37 °C . Clones from each repeat were selected and cultured once more without nisin by inoculating 10 mL of BHI with the clones and incubating at 37 °C with shaking at 200 rpm overnight. Increased MICs were then confirmed by altering the MIC assay described above to include the end point MIC and clones with MICs similar to each other and the end point MIC were selected.  This process was repeated for the corresponding control time point for each of the three species.  
5.2.4 Analysis of nisin selection SNPs DNA was extracted from clones selected from each experimental and control repeats from the method described above using the protocol described (section 2.2). 30 ng of DNA from each of five selected clones was pooled in a volume of 55 µL to make up the 150 ng of DNA required to make Illumina Truseq DNA libraries with an insert size of 350 bp. In addition to three separate clone pools, a single clone was selected for sequencing from the clones used to constitute the pools. Single clones were selected on the basis of the highest DNA quality. The single clones and the T0 isolates were also sequenced using Illumina Truseq nano DNA libraries with 350 bp inserts. Single clones were not sequenced from the control pools. DNA quality checking was carried out according to the protocol outlined in (section 2.3) and libraries were constructed by the CGR, University of Liverpool, according to the protocol laid out in (section 2.5  Sequencing reads were trimmed and quality checked using the method from (section 2.6). T0 comparator strains were assembles using VelvetOptimiser (Victoria Bioinformatics Consortium) with Kmer sizes from 19 to 99 and Velvet version 1.2.06 (Zerbino & Birney 2008). Annotation was carried out using 
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PROKKA (Victoria Bioinformatics Consortium). The PacBio assembly of S. 
hominis strain J31 was used as the comparator assembly for this strain.   Good quality filtered reads from experimentally evolved pools and single clones were then aligned to the relevant comparator strains using the BWA, a Burrows-Wheeler aligner (H. Li & Durbin 2009), packages aln and sampe version 0.5.9-r16. SAM files were converted to bcf (binary variant call files) files with samtools which could then be used for SNP calling using the mpileup package. The bcf output file from mpileup was then converted to vcf (variant call format) files and quality filtered. This pipeline was run from the shell script 
SNP_analysis.sh. For pools of clones this quality filtered vcf file along with the mpileup output without base data generated from SNP_analysis.sh were then used to further filter the SNPs to include only those present in 33.33% of reads, which equates to the SNP being present in more than one clone. This further filtering was achieved using the script significant_snps.sh.   
5.2.5 Modelling proteins containing SNPs Potential protein domains were identified by aligning the amino acid sequences to Protein Data Bank archive (PDB) and the Conserved Domains Database (CDD) using HHPred (Söding et al. 2005) as well as searching the Pfam protein families database (Finn et al. 2014). Proteins, excluding membrane proteins and those with predominantly coiled coil structures, were then modelled using the alignment from HHPred. The structures were explored, and figures generated using The Pymol Molecular Graphics System v 1.7.4.4 (Schrödinger, LLC).      
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5.3 Results and discussion 
5.3.1 Intraspecies variation in susceptibility of staphylococci to the 
lantibiotic nisin To select strains with a representative baseline susceptibility to nisin the MIC of a panel of S. aureus, S. hominis and S. saprophyticus strains was investigated. A high degree of intraspecies variability was observed for S. aureus (Figure 5.1) and S. saprophyticus (Figure 5.2) with the nisin MIC ranging from 31.25 to 125 
μg/mL for both species. The MIC of S. aureus agrees with work by Hiron et al who found the nisin MIC of strain HG001 to be >128 μg/mL (Hiron et al. 2011). These results however differ significantly from those of Blake et al who found that the nisin MIC of SH1000 was 4 μg/mL. Their study does not, however, give details of the method used, and the work presented here used a method similar to that of Hiron et al. Differences in MIC method may therefore account for some of the variation between the experiments. Little intraspecies variation was observed among the isolates of S. hominis (Figure 5.3) tested, which ranged from 12.5 to 15 μg/mL.  The mean MIC was determined for all three species and an isolate as close as possible to that value was selected for experimental evolution. Type strains of all three species were also included for experimental evolution (Table 5.3).   
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Table 5.3 Summary of nisin MICs for S. aureus, S. saprophyticus and S. hominis. End point nisin MICs represent the MIC following experimental evolution in the presence of nisin. Species Average MIC 
(μg/mL) Isolates Starting MIC (μg/mL) End point MIC (μg/mL) 
S. aureus 66.04 171 50 10000 
  SH1000 100 10000 
S. saprophyticus 71.72 CCM883 62.5 10000 
  349 40 750 
S. hominis 14.58 type 12.5 375 
  J31 15 375 
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Figure 5.1 Nisin MICs of a panel of S. aureus isolates. Strains A) 059 B) 171 C) 014 D) Mu50 E) SH1000 F) MSSA476. Error 
bars represent the standard deviation of a data set; the red line represents the optical density threshold for bacterial growth. 
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Figure 5.2 Nisin MICs of a panel of S. hominis isolates. Strains A) B10 B) I4 C) J6 D) J11 E) S. hominis type strain F) J31. 
Error bars represent the standard deviation of a data set; the red line represents the optical density threshold for bacterial 
growth.  
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Figure 5.3 Nisin MICs of a panel of S. saprophyticus isolates. Strains A) 349 B) 346 C) CCM883 D) 352 E) 409. Error bars 
represent the standard deviation of a data set; the red line represents the optical density threshold for bacterial growth. 
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5.3.2 Experimental evolution of S. aureus, S. hominis and S. saprophyticus 
in the presence of nisin. 
All strains selected for experimental evolution were serially passaged in 
triplicate with increasing concentrations of nisin using a microtiter plate 
method. Since the nisin was dissolved in sodium citrate, a control experiment 
was performed in parallel with evolution in the presence of nisin. In this control 
experiment cells were serially passaged in the equivalent concentration of 
sodium citrate present in the nisin plates. In this way SNPs selected by passage 
in the presence of sodium citrate could be distinguished from those selected 
from passage in the presence of nisin. 
 
Microtiter plates with doubling dilutions of nisin across the plate were used for 
the serial passages. A fresh plate was used for every passage and all dilutions of 
nisin were inoculated for every passage. An increase in resistance was taken as 
comparable growth of a strain to the wild type in a higher concentration of nisin 
than the previous passage. Strains were passaged once every 24-48 h. Stepwise 
increases in nisin MIC were observed for all strains tested.  No obvious pattern 
in the rate of resistance acquisition was observed between the species.  
 
Both strains of S. aureus exhibited ~100 fold increases in their nisin resistance 
(Figure 5.5). This is a greater fold increase in S. aureus resistance than that 
observed by Blake et al, however there are several differences in the strategies 
used for experimental evolution between experiments and so results can not 
easily be compared. Firstly it is not known if their serial passage was carried out 
in microtiter plates and small volumes, as is the case in this study, or if it was 
carried out in larger culture volumes such as flasks. MICs do not easily translate 
between plate-based methods and methods using larger culture volumes. The 
clinical isolates of S. saprophyticus 883 and 349 showed an 80 fold and 4.7 fold 
increase in nisin resistance respectively. Each of the S. hominis strains exhibited 
around 25-fold increases in their nisin resistance. 
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The choice of strains to sequence was relatively arbitrary (isolates sequenced 
are indicated by an asterisk in Figures 5.4 and 5.5): strains J31 and 171 were 
selected for sequencing post-evolution based upon both being recent skin 
isolates and therefore deemed to be more representative than the archive S. 
hominis and S. aureus type strains tested. To compare mechanisms of increased 
resistance to nisin across species with and without BraRS, the S. saprophyticus 
strain CCM883 was included for sequencing due to the fold change in nisin 
resistance being comparable to S. aureus and intermediate with S. hominis 
(Figure 5.6).
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Figure 5.4 Nisin MICs of evolved S. hominis strains A) J31 B) HT. Biological repeats are indicated by 
red, blue and green bars. Isolates selected for sequencing are indicated by asterisks.  
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Figure 5.5 Nisin MICs of nisin-evolved S. aureus strains A) SH1000 B) 171. Biological repeats are indicated by red, 
blue and green bars. Isolates selected for sequencing are indicated by asterisks.  
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Figure 5.6 Nisin MICs of nisin evolved  S. saprophyticus strains A) 349 B) 883. Biological repeats are 
indicated by red, blue and green bars. Clones selected for sequencing are indicated by asterisks.  
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5.3.3 Nisin selection SNPs in evolved strains 
T0 sequenced isolates were assembled and annotated according to the 
previously described method (chapter 2, Methods ). To identify SNPs present, 
reads from pooled samples and single clones evolved in nisin and the sodium 
citrate control pools were aligned to these T0 isolates in the case of S. aureus 
171 and S. saprophyticus CCM883, and to the PacBio assembly in the case of S. 
hominis J31. SNPs present in both the control pool and the nisin-evolved pools 
and single clones were discarded, as these SNPs are unlikely to be due to 
selection from the presence of nisin. Following this, proteins in which significant 
SNPs occurred were modelled from the sequences in the reference sample 
genome and the SNP was imposed upon the structure. SNPs most likely to be 
involved in resistance to nisin are SNPs present in all three pools of evolved 
clones. 
 
5.3.3.1 Nisin-selected SNPs of S. aureus 
The selection for increased nisin resistance in S. aureus 171 resulted in only 1 
SNP that was present in all three clone pools, and this SNP was located at 
chromosome position 1820274 in a gene encoding a hypothetical protein 
containing a transposase domain (Table 5.4a). This SNP was a non-synonymous 
point mutation within this domain resulting in the substitution of the amino 
acid leucine for proline. In addition, another SNP was present in more than one 
clone pool. A serine to threonine (S114T) amino acid change was caused by a 
base change at the chromosome position 2001512. This chromosome position is 
within a gene encoding a hypothetical protein of 120 amino acids in length. 
These 120 amino acids share 95% similarity with 120 amino acids of a larger 
(582 amino acids) S. aureus membrane-associated protein (accession 
GI486263885)  with some homology to a membrane-associated protein, which 
contains an MHC class II analogue protein (MAP) domain where the amino acid 
change is located. This protein domain is present in multiple extracellular 
matrix proteins and facilitates protein-protein interactions (Jönsson et al. 1995). 
Due to the low percentage of reads covering the position of this base change it is 
likely that only 1 or 2 of the clones in each pool contained the SNPs, however 
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due to its presence in multiple pools the base change occurred in multiple 
independent evolution experiments therefore suggesting that they may be 
important in nisin resistance. 
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Table 5.4a Non-synonymous, homozygous SNPs from nisin-evolved isolates of S. aureus strain 171. Pools were comprised of 5 clones from each 
experimental repeat, for example pool 1 corresponds to experimental repeat 1. Nisin MICs of clones in each pool were confirmed to ensure they were not 
significantly different. 
Prokka annotation Blast similarity Pools Chromosome position Base change Amino acid change % of reads 
rpoC DNA-directed RNA polymerase 
subunit beta 
3 523690 G -> T Ala448Ser 99.50980392 
femB femB 3 1323450 G -> A Arg215His 63.20754717 
phage terminase like 
protein 
Terminase 3 1491745 C -> G Gly240Ala 100 
greA greA 3 1625376 A -> T Leu76* 37.27272727 
hypothetical Hypothetical protein 1,2,3 1820274 A -> G Leu39Pro 39.83050847 
N/A  3 1820533 T -> A  34.82142857 
map-ND2C Hypothetical protein 2,3 2001512 A -> T Ser114Thr 34.7826087 
braS Two component sensor histidine 
kinase 
3 2627088 G -> A Thr175Ile 100 
hypothetical protein Membrane protein 2 615003 C -> T Gln57* 34.54545455 
hypothetical protein Transposase 2 1337527 T -> C Val37Ala 33.91304348 
hypothetical protein Hypothetical protein 2 1781422 A -> T Leu21His 33.48017621 
surface precursor 
protein 
Virulence-associated cell-wall-
anchored protein SasG 
1,2 2481387 A -> G Phe59Phe 34.09090909 
walK Sensor kinase walK 1 17119 A -> G His364Arg 100 
hypothetical_protein Hypothetical protein 1 272718 T -> C Asp23Asp 43.33333333 
hypothetical_protein Hypothetical protein 1 277837 C -> T Asp23Asp 34.21052632 
gltB_1 Glutamate synthase 1 437361 A -> T Gln797Leu 100 
rpoB DNA-directed RNA polymerase 
subunit beta 
1 520176 C -> T His506Tyr 100 
mraY Phospho-N-acetylmuramoyl-
pentapeptide transferase 
1 1103071 G -> A Val266Ile 100 
N/A  1 1821311 G -> T  35 
yurK Transcriptional regulator 1 1998279 C -> T Gly73Arg 100 
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Table 5.4b Non-synonymous, homozygous SNPs from nisin evolved clone of S. aureus strain 171. The S. aureus 171 single clone sequences was 
from pool 1 
Prokka annotation Blast similarity Chromosome position Base change Amino acid change 
walK Sensor protein kinase walK 17119 A -> G His364Arg 
gltB_1 Glutamate synthase 437361 A -> T Gln797Leu 
rpoB DNA-directed RNA polymerase subunit beta  520176 C -> T His506Tyr 
N/A  846611 A -> G  
mraY Phospho-N-acetylmuramoyl-pentapeptide transferase 1103071 G -> A Val266Ile 
msrR Regulatory protein msrR 1309845 G -> T Glu181* 
yurK Transcriptional regulator 1998279 C -> T Gly73Arg 
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Within each of the clone pools, SNPs were identified that were present in 100% 
of the reads covering their chromosomal location in a single pool indicating that 
the SNP was present in all five of the clones included in the pool. One of these 
SNPs was a G -> T base change at the chromosome position 523690 within rpoC, 
which resulted in an alanine to serine (A448S) amino acid change. Alanine and 
serine are structurally similar, however alanine is non-polar whereas serine is 
polar. This amino acid change is in domain 2 of the protein which contains the 
active site, furthermore the alanine to serine residue change appears to be 
within an NADFDGD motif. This motif is conserved across bacteria and functions 
to bind the magnesium ion within the active site via the three aspartate residues 
(Figure 5.7) (Cramer et al. 2001) (Zhang et al. 1999).  Since metal ions catalyse 
the active site, altering the magnesium ion binding motif may affect the 
efficiency of the polymerase, and therefore the rate or accuracy of transcription. 
Other studies have described mutations in the subunits of RNA polymerase as a 
result of selective pressures. For example, it has been observed that a mutation 
in rpoC causing a glutamate to aspartate amino acid change is involved in 
resistance of B. subtilis to cephalosporin (Lee et al. 2013). The location of this 
mutation however is in the DNA binding cleft of the protein.  
 
A second SNP in a gene encoding a transcription complex protein was identified 
with a C -> T mutation at chromosomal position 520176 in the rpoB gene. This 
SNP was present in 100% of reads covering the chromosome position from pool 
1 and the S. aureus 171 single clone which replaces a histidine with a tyrosine 
(H506Y). Histidine is a basic amino acid and tyrosine is aromatic and polar. This 
amino acid change is within domain 3 of the protein know as the fork domain 
which forms the border between the β and β’ domains. This domain is 
highlighted in yellow in the 3D model of the protein (Figure 5.8). Mutations 
within a 25 amino acid region of this domain of RpoB from E. coli are associated 
with slippage at the RNA-DNA hybrid during transcription which reduces the  
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Figure 5.7 3D model of S. aureus RpoC with the 
highlighted substitution Ala448Ser. Domain 2 is highlighted 
in yellow and the SNP-directed substitution Ala448Ser is 
highlighted in red. 
Figure 5.8 3D model of S. aureus RpoB with the highlighted 
substitution His506Tyr. Domain 3 is highlighted in yellow and 
the SNP-directed substitution His506Tyr is highlighted in red. 
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fidelity of transcription however the SNP does no fall within this region (Y. N. 
Zhou et al. 2013).  
 
Of key relevance to the current study, a further gene, braS, displayed 100% of 
reads from pool 3 with the presence of a SNP. The identified G -> A base change 
at chromosome position 2627088 resulted in a threonine to isoleucine (T175I) 
substitution. Threonine and isoleucine are structurally similar amino acids 
however the change from threonine to isoleucine replaces a polar residue with a 
non-polar one. Only a single protein domain is predicted in BraS from S. aureus 
171 by searching against the Pfam database and this is an ATP binding domain 
encompassing the residues 195 to 294. The SNP therefore does not occur within 
this domain. In a previous experimental evolution experiment by Blake et al, the 
amino acid change A208E was observed in the same histidine kinase but was 
positioned within the ATP binding domain (Blake et al. 2011). As previously 
discussed, BraRS is involved in resistance to nisin (section 4.1.4). Mutational 
assays of the BraRS TCS have shown that inactivation of the genes results in an 
increased susceptibility to nisin (Hiron et al. 2011). Due to the presence of this 
braS mutation in 100% of reads in pool 3 and the presence of the mutation in 
rpoC in 100% of reads covering this locus from pool 3, it is likely that these 
mutations occurred together in the clones constituting pool 3. 
 
In pool 1, 100% of reads covering a locus had a mutation at chromosome 
position 17119 which is within the gene walk, encoding the sensor protein of 
the essential TCS WalKR, also known as YycGF. The SNP results in a histidine to 
arginine (H364R) amino acid change within the PAS domain of the protein. The 
PAS domain is responsible for signal sensing within a sensor histidine kinase 
protein and is a diverse and flexible domain (Hefti et al. 2004). WalKR is integral 
to maintaining cell wall metabolism (Delaune et al. 2012) and mutations in the 
TCS are linked with resistance to vancomycin and daptomycin and an 
associated cell wall-thickening phenotype (Howden et al. 2011). The 
antimicrobial effects of nisin occur as a result of its interaction with cell wall 
intermediates including lipid I and lipid II, which results in sequestration of 
these intermediates and also pore formation which uses these intermediates as 
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docking molecules. A cell wall thickening phenotype that may result from 
mutation of WalKR could limit the ability of nisin to interact with these target 
molecules and therefore abrogate its effects.   
 
Pool 1 was the first pool during the experimental evolution to exhibit a large 
increase in nisin resistance (Figure 5.4a). A large overlap between the WalKR 
and GraRS regulatory networks has been suggested in S. aureus (Falord et al. 
2011). 
 
A point mutation in the large subunit of glutamate synthase was observed in 
pool 1 and the single clone sequenced from the encompassing experiment. 
100% of reads covering this locus report a base change A -> T which results in 
the amino acid change glycine to leucine (G797L) within a flavin 
mononucleotide (FMN) binding domain. This domain has a beta/alpha barrel 
structure and is one of the catalytic sites of glutamate synthase together with 
the amidotransferase domain and interacts with FAD or NADPH. The FMN 
binding site makes a GOGAT domain with the Fe-S cluster. This domain spans 
residues 806-1179 in Corynebacterium glutamicum (Beckers et al. 2001).  
Glutamate synthase involved in the production of D-glutamate which is a 
component of cell wall peptidoglycans. Of relevance, one study reported that the 
small subunit of glutamate synthase was upregulated in response to the 
presence of cell wall active antibiotics, including bacitracin (Utaida et al. 2003).  
 
A further gene involved in peptidoglycan synthesis also contains a SNP in both 
pool 1 and its single clone. mraY encodes a transferase which catalyses the 
formation of lipid I (Bouhss et al. 1999), a peptidoglycan precursor with which 
nisin is known to interact (5.1.1). This SNP results in the amino acid change 
V266I, which is often considered a functionally conservative replacement, 
indicating that this SNP might not alter MraY activity. 
 
Finally a C -> T base change in the yurK gene encoding a transcriptional 
regulator at the chromosomal location 1998279 results in a glycine to arginine 
(G73R) amino acid substitution. This transcriptional regulator is adjacent to an 
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ABC transporter gene, which it may regulate transcriptionally. ABC transporters 
are known to transport a range of substrates, including antibiotics such as nisin 
which is especially relevant here. Certain multidrug ABC transporters have been 
described with a broad substrate specificity (Poelarends et al. 2000).  
 
5.3.3.2 Nisin-selected SNPs of S. hominis 
Fewer nisin-selected SNPs were present in the S. hominis clone pools compared 
with those present in the S. aureus pools (Tables 5.4 and 5.5). No SNPs were 
present in all three pools. Only 1 SNP was present in more than one pool. An A -
> C base change at chromosome position 2211829 that resulted in an 
asparagine to histidine (N40H) amino acid change in a hypothetical protein with 
no Pfam protein domains found in the amino acid sequence. Since this SNP was 
only found in 35.8% of reads covering this locus, it is likely that it was present in 
just one of the clones. The fact that it was present in more than one pool, 
however, means that it arose independently in two nisin selection experiments.  
 
Several SNPs were present in 100% of reads covering their chromosomal 
location. A SNP in the zinc metalloprotease gene ftsH was present in 100% of 
reads covering its location in pool 2 indicating that the SNP was present in 
every clone. This SNP was also present in the sequenced single clone (Table 
5.5a). A C -> A base change at chromosome position 2172470 resulted in an 
aspartate to glutamate (D171E) amino acid change in the extracellular domain 
of the protein. Aspartate and glutamate are both structurally similar acidic 
amino acids and often considered functionally interchangeable. FtsH was found 
to play a role in osmotic stress and is required for the integration of penicillin 
binding proteins into the cell membrane. Its expression was found to be 
upregulated in response to cell wall active antimicrobials in S. aureus MRSA252 
(Overton et al. 2011). 
 
A SNP was present in 100% of reads covering the chromosome position 552630 
in pool 3 which resulted in an arginine to histidine (R135H) amino acid change 
in guanylate kinase, the gene product of gmk. This is perhaps somewhat unusual 
since gmk is included in the panel of housekeeping genes used in multi locus 
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Table 5.5a Non-synonymous, homozygous SNPs from nisin evolved isolates of S. hominis strain J31. Pools were comprised of 5 clones from each experimental repeat, for 
example pool 1 corresponds to experimental repeat 1. Nisin MICs of clones in each pool were confirmed to ensure they were not significantly different. 
Prokka annotation Blast similarity Pools Chromosome position Base change Amino acid change % of reads 
rpoB DNA-directed RNA polymerase subunit beta 1 41317 G -> T Asp1046Tyr 78.94736842 
graS Sensor histidine kinase 2 147503 C -> T Ser120Leu 42.12765957 
ftsH Zinc metalloprotease 2 2172470 C -> A Asp171Glu 100 
hypothetical  2,3 2211829 A -> C Asn40His 34.84848485 
N/A  2 2323889 A -> T  60 
gmk Guanylate Kinase 3 552630 G -> A Arg135His 100 
yurK Transcriptional regulator 3 1212777 G -> A Gln47* 100 
Table 5.5b Non-synonymous, homozygous SNPs from nisin evolved clone of S. hominis strain J31. The S. hominis J31 single clone sequences was from pool 2 
Prokka annotation Blast similarity Chromosome position Base change Amino acid change 
ftsH Zinc metalloprotease 2172470 C -> A Asp171Glu 
N/A  2189828 G -> T  
N/A (plasmid 
encoded) 
 2323889 A -> T  
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sequence typing due to the lack of selective pressure acting upon the genes and 
their resultant stable sequences (Chambers & DeLeo 2009).  
 
A C -> T base change in the gene graS at chromosome position 147503 
substitutes the amino acid serine with leucine (S120L). It is likely that this 
mutation was present in 2 clones in pool 2 due to the proportion of reads 
covering this location which carry the alternative base. As previously discussed 
graS encodes the sensor histidine kinase for the TCS GraRS which is involved in 
resistance to cationic antimicrobial peptides (section 4.1.4). S. hominis is part of 
the group of staphylococcal species which carry both braRS and graRS, 
therefore it is intriguing that experimental evolution with nisin resulted in SNPs 
in different homologous TCS in the species S. aureus and S. hominis which 
encode both GraRS and BraRS; a SNP was present in the sensor histidine kinase, 
braS in S. aureus pool 3. 
 
A base change of A -> T at chromosome position 2323889 was identified which 
is 31 base pairs upstream of a replication protein on the S. hominis J31 plasmid 
which carries the gene qacC. This gene encodes resistance to cationic 
compounds by exporting them from the cell in a proton-dependent manner, and 
has therefore been designated as encoding a multidrug resistance export 
protein (Paulsen et al. 1995). Notably, the plasmid carrying qacC, pSepCH in S. 
epidermidis CH occurs alongside the plasmid pCH01 encoding lantibiotic 
biosynthesis. In S. warneri strain ISK-1 a qacC plamid, pPI-2, and a lantibiotic 
biosynthesis plasmid, pPI-1 are both present (3.3.15.1).  
 
There were several  similarities between the nisin-selected SNPs that occurred 
in both S. aureus and S. hominis. Firstly, an amino acid change in rpoB was 
observed in each species resulting in a tyrosine residue. However, these two 
tyrosine residues are separated in both the amino acid primary structure and in 
the folded protein. The H506Y amino acid change in rpoB of S. aureus 171 is 
present in the fork region of domain three, whereas in rpoB of S. hominis J31 the 
SNP is found at chromosomal location 41317 (D1046Y) which falls in domain 
six known to be one of the dispensable regions of the protein where random 
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insertions are found in many bacterial species. Both domain 3 where the SNP is 
present in S. aureus and domain 6 containing the SNP in S. hominis are 
highlighted in Figure 5.9. Whether, given their somewhat proximal structural 
locality there is any similarity in functional outcome is unclear.  Secondly, a base 
change of G -> A at chromosome position 1212777 in the gene encoding 
transcriptional regulator YurK resulted in a truncation (N47*) of the protein at 
the amino acid residue glutamine 47. The amino acid sequence of this 
transcriptional regulator shares 75% sequence identity with yurK which was 
found to contain a SNP in pool 1 at chromosome position 1998279. In S. hominis 
the transcription factor is also adjacent to the same ABC transporter observed 
in S. aureus. The ABC transporters in the two species share 51.9% identity at the 
amino acid level. In S. aureus 171 the G73R substitution could have an 
abrogating consequence upon YurK activity to match the transcription 
termination effect of the SNP in S. hominis J31, but this would require further 
study. 
 
  
Figure 5.9 3D model of S. hominis RpoB with the highlighted 
substitution Asp1046Tyr. Domain 3 is highlighted in purple and 
domain 6 is highlighted in yellow. The SNP Asp1046Tyr is 
highlighted in red. 
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5.3.3.3 Nisin-selected SNPs of S. saprophyticus  
As observed with S. hominis, the number of SNPs resulting from evolution with 
nisin selection in S. saprophyticus was reduced when compared to S. aureus. No 
identical SNPs were present in all three pools, however SNPs were identified in 
the gene graS in all clones of all pools. Specifically, in pools 2 and 3 a G -> T base 
change at chromosome position 2069134 resulted in the presence of a serine 
residue in the place of an alanine residue (A160S), replacing a basic amino acid 
for a polar one (Table 5.6a). In pool 1 a base change at chromosome position 
2068987 substituted a glycine residue for a cysteine residue (G209C), replacing 
one polar residue with another. This is the only SNP present in the S. 
saprophyticus single clone (Table 5.6b) confirming it is important in the 
development of nisin resistance. Both of these residue positions are distinct 
from the amino acid change corresponding to the graS mutation in pool 2 of S. 
hominis. The S. saprophyticus A160S amino acid change appears to be in the 
same region of the GraS protein as the S120L amino acid change resulting from 
the graS SNP identified in S. hominis  pool 2, however the protein model created 
of GraS from S. hominis and S. saprophyticus was a low quality model therefore 
statements must be made with caution. The G209C residue change in S. 
saprophyticus GraS appears to be located within a separate protein domain.   
 
Other SNPs present in more than one pool include a C -> A base change at 
chromosome position 1537681 which results in an amino acid change from 
leucine to phenylalanine (L79F) in the transcriptional regulator CodY. This 
amino acid change from one non-polar amino acid to a more bulky non-polar 
residue occurs in GAF-like domain of the protein thought to be involved in GTP 
binding. The presence of a bulky amino acid in this domain may prevent GTP 
binding and thus attenuate the repressive effect of this regulator. In S. aureus 
CodY in known to be a global regulator which alters expression of virulence 
genes in response to nutrient availability, and deletion has been shown to 
enhance virulence in CA-MRSA (Montgomery et al. 2012). CodY may be involved 
in nisin resistance through multiple described mechanisms. For example, it may 
have a role in the breakdown of the peptide antibiotic through regulation of 
protease production, it may differentially influence the transcription of rpoB 
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Table 5.6a Non-synonymous, homozygous SNPs from nisin evolved isolates of S. saprophyticus strain 883. Pools were comprised of 5 clones from each 
experimental repeat, for example pool 1 corresponds to experimental repeat 1. Nisin MICs of clones in each pool were confirmed to ensure they were not 
significantly different. 
Prokka annotation Blast similarity Pools Chromosome position Base change Amino acid change % of reads 
codY Transcriptional regulator 2,3 1537681 C -> A Leu79Phe 100 
pitA Inorganic phosphate transporter 2,3 2066724 G -> A Ala195Val 100 
graS Sensor histidine kinase 2,3 2069134 G -> T Arg160Ser 100 
hypothetical hypothetical 2 140317 G -> T Val73Leu 38.46153846 
integrase core domain Transposase 2 912319 A -> G Lys160Arg 33.33333333 
marR family protein Transcriptional regulator 2,3 2136907 G -> A Thr62Ile 100 
hypothetical protein Transposase 1 911139 T -> A Met1? 71.42857143 
graS Sensor histidine kinase 1 2068987 C -> A Gly209Cys 100 
Table 5.6b Non-synonymous, homozygous SNPs from nisin evolved clone of S. saprophyticus strain 883. The S. saprophyticus 883 single clone 
sequences was from pool 1 
Prokka annotation Blast similarity Chromosome 
position 
Base change Amino acid change 
graS Sensor histidine kinase 2068987 C -> A Gly209Cys 
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which is implicated in nisin resistance in S. aureus and S. hominis by the results 
of this chapter, or it may alter gene expression of peptide transporters to export 
nisin from the cell (Somerville & Proctor 2009). Due to the fact that nisin 
activity occurs mainly at the cell surface, an increase in the transcription of 
extracellular proteases may be a mechanism by which resistance to nisin could 
occur. Furthermore, due to the presence of SNPs in rpoB in nisin-evolved strains 
of S. aureus and S. hominis it seems likely that there may be differential 
regulation of rpoB. 
 
A protein with similarity to the PitA inorganic phosphate transporter of E. coli 
was found to contain a nisin-selected amino acid change of alanine to valine as a 
result of a G -> A base change at chromosome position 2066724. Alanine and 
valine are structurally similar and non-polar. The S. aureus homologues of the 
pitAB (SAOUHSC_00669 and SAOUHSC_00670) transporter operon are part of 
the GraRS regulatory network, and bioinformatic analysis identified a WalR 
binding site upstream of S. aureus pitA (Falord et al. 2011). The PitA homologue 
in S. saprophyticus 883 showed 87.5% protein sequence identity with S. aureus 
SAOUHSC_00670 indicating that this protein may be the S. saprophyticus 
homologue and therefore part of the GraRS and/or WalKR regulons. 
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5.4 Conclusion 
 
In this chapter the capacity for S. aureus, S. saprophyticus and S. hominis to 
acquire resistance to the lantibiotic nisin was investigated. Specifically, the aim 
was to correlate nisin-selected resistance using experimental evolution with the 
resulting genome distribution of SNPs in the context of the graS and braS genes 
that are differentially present across the staphylococci. Each of the three 
staphylococcal species tested exhibited an increased nisin resistance with both 
strains of S. hominis developing a 25-fold increase and both strains of S. aureus a 
100-fold increase. There was variation in the final nisin MIC between the two 
isolates of S. saprophyticus experimentally evolved with nisin. S. saprophyticus 
strain 349 acquired a 4.7-fold increase in resistance whereas S. saprophyticus 
strain 883 exhibited an 80-fold increase in resistance. 
 
During the experimental evolution three experiments were run for each of the 
six strains in parallel.  Not all experiments exhibited equivalent fold increases in 
resistance or developed them at the same rate. Furthermore, when the SNPs 
from the pools of clones sequenced from each experimental repeat were 
examined, the repertoire of SNPs was different for each of the pools. This 
indicated that the development of nisin resistance in each parallel experiment 
occurred through different pathways and involved different genes, or 
combinations thereof. 
 
In the S. aureus nisin selection pool 3 clones contained a SNP in the braS gene. 
This gene was previously implicated in resistance to nisin (Kolar et al. 2011) 
(Blake et al. 2011). Despite this, pool 1 which did not contain a SNP in either 
braS or its regulator braR evolved resistance to nisin more quickly than pool 3. 
The SNPs found in pool 1 were found in walK, glutamate synthase and mraY. 
These genes are involved in peptidoglycan synthesis and turnover, and 
synthesis of lipid precursors known to be targets for the mechanism of action of 
nisin. This proposes an alternative strategy for nisin resistance whereby lipid 
precursors are synthesised at an increased rate to counteract the mechanism of 
nisin to sequester them.  
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In S. aureus and S. saprophyticus all three sequenced pools reached the same end 
point nisin MIC. This suggests that, although crucial SNPs in the evolution of 
increased nisin resistance may have occurred at different passage stages 
resulting in increased resistance occurring at different rates in each pool, all 
pathways in the different pools are ultimately effective in conferring nisin 
resistance in this experiment. This is not the case for S. hominis strain J31, 
however, since pool 3 is the only pool to show a 25-fold increase in nisin 
resistance. Therefore this pathway is most effective in conferring increased 
resistance to nisin in this species. The presence of a SNP in the yurK 
transcriptional regulator gene in 100% of reads covering the region in this S. 
hominis pool, and in S. aureus pool 1, implicates yurK and potentially the 
adjacent ABC transporter as being important in nisin resistance in both species. 
Intriguingly, a MarR family transcriptional regulator was implicated in S. 
saprophyticus nisin resistance in pools 2 and 3 which could be functionally 
equivalent to YurK. 
 
Results from all three species highlight the complex interplay between TCSs as 
SNPs were present in genes from the regulons of GraRS, BraRS and WalKR as 
well as within the genes encoding the TCSs themselves. The regulons of GraRS 
and BraRS are known to overlap, as are those of GraRS and WalKR. 
Furthermore, Hiron et al showed that deletion mutants of GraRS and BraRS 
resulted in increased susceptibility to nisin in S. aureus (Hiron et al. 2011). The 
fact that SNPs were present in walK and WalKR regulon genes in all three 
species supports the possibility that this TCS and its regulatory network may 
also be involved in nisin resistance in addition to GraRS and BraRS. Due to the 
potentially interconnected nature of the three TCSs, although SNPs were found 
in different genes in each of the species, it may be the case that many of the 
SNPs occurred within the same regulatory network of genes to produce 
somewhat equivalent resistance outcomes. 
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Chapter 6 
 
Conclusions and future work 
  
 228 
The aim of this thesis was the comparative study of the major human 
staphylococcal species to gain insights into their complement of available genes 
that make them successful at thriving on skin. To complete this aim, firstly 
sequencing of the genomes of those species not publically available was 
undertaken. Secondly, in order to enlarge the current knowledge of S. hominis, 
the second most common species colonising the human skin, and therefore 
allow comparison with the major skin coloniser S. epidermidis, as well as an 
exploration of the gene content of S. hominis as a species, a set of recent skin 
isolates of the latter species was sequenced. Thirdly, differential presence of 
genomic components in the major staphylococcal species was then investigated 
to elucidate new insights into human skin colonisation, with focus on two 
related TCS.  
 
6.1 Genome sequencing and annotation 
Over the course of this project, sequencing technologies have advanced such 
that the volume of genomic data has increased greatly. This has led to both 
benefits and drawbacks in scientific research.  
 
The volume of data has led to the development of the RefSeq database, which 
aims to reduce the redundancy of available information, and integrate data 
types such as transcriptomic, proteomic and annotation (Pruitt et al. 2012). 
Furthermore, sequencing of large strain sets has enabled pan-genome analyses 
which take into account the diversity and genetic complexity of a single species. 
For the staphylococci, large scale sequencing efforts and pan-genome analyses 
have been completed for S. aureus (Kelly 2013), (Méric et al. 2015) S. 
epidermidis (Conlan et al. 2012), (Kelly 2013) (Méric et al. 2015) and S. 
haemolyticus (Cavanagh et al. 2014). Until now no such analysis had been 
carried out for S. hominis. The S. hominis pan-genome is discussed below 
(section 6.2). 
 
The long read sequencing technology PacBio has enabled the sequencing and 
assembly of the S. hominis isolate J31 into five contigs. One of these contigs is 
proposed to encode the whole bacterial chromosome, and the other four are 
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proposed to encode plasmids. Discrepancies between the annotation of the 
Illumina-sequenced S. hominis J31 and the PacBio assembly indicate the need 
for localised Sanger sequencing of these regions of the genome to resolve coding 
sequence prediction (section 3.3.11).  One possible reason for these 
discrepancies is the reliance of this study upon computational methods of 
annotation. 
 
The process of computational functional predictions, and the reduced incidence 
of experimental verification of these functional predictions, has led to mis-
annotation of protein sequences and propagation of these errors in protein 
sequence databases. This project relies largely on such computational function 
prediction and protein sequence databases.  The presence of a TCS similar to 
that of BraRS in S. aureus, for example, was predicted by computational 
annotation in a group of species (section 4.3.3.1), and its identity explored and 
confirmed through bioinformatics analysis. Experimental confirmation of its 
function in species other than S. aureus, however was not performed except 
with the use of experimental evolution. 
 
6.2 The S. hominis pan-genome 
The main weakness of this pan-genome study is the restricted S. hominis strain 
set included in the analysis; it also highlights the advances in genomic study 
over recent years The largest published pan-genome sequencing efforts of S. 
aureus, S. epidermidis and S. haemolyticus involve 168, 139 and 134 genomes 
respectively. The pangenome analysis of S. hominis includes only 11 strains 
which falls far short of these numbers. Additionally, the Liverpool strains were 
sampled from a single geographic area, albeit the study volunteers migrated 
from different parts of the UK, and they worked in the same building and 
environment. This could be argued to have limited the diversity of the strains 
and therefore skewed results associated with the pan-genome, such as 
increasing the apparent number of strain-specific genes or reducing the 
apparent size of the pan-genome. The pan-genome of S. hominis was 
approaching closure at 11 genomes, meaning that few new genes were added to 
the pan-genome upon addition of each strain. With increased strain diversity it 
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is highly likely that the size of the S. hominis pan-genome would increase from 
3115 genes.  
 
The analysis of the S. hominis pan genome revealed the conserved presence of 
several genes proposed as virulence factors in S. hominis: shsA; braRS and 
stp1/stk1. The putative S. hominis cell wall-associated protein ShsA shares 16% 
protein sequence identity with S. aureus AdsA, previously known as SasH. ShsA 
is also predicted to share 5’-nucleosidase activity with AdsA, this enzyme 
mediates adenosine synthesis activity in S. aureus, which in turn reduces its 
killing by neutrophils. This function designates AdsA as a virulence factor of S. 
aureus. The two component system BraRS is associated with virulence 
phenotypes in S. aureus, such as biofilm formation and resistance to 
macrophage killing (Kolar 2012), despite its presence in the non-pathogenic 
species S. hominis among others. Finally, the serine/threonine kinase Stp1/Stk1 
is also associated with virulence in a mouse model due to reduced survival in 
the kidney of an stk1 mutant (Débarbouillé et al. 2009).  
 
Virulence, by definition, is the degree of pathogenicity of an organism, and in 
turn the definition of pathogenicity is the ability to cause disease. If genes 
labelled as virulence factors, or as being able to cause virulence phenotypes, are 
also present in non-pathogenic backgrounds such as those discussed above it 
could be argued that they play a role as a survival factor. Genes with roles in 
evading the host immune system, or antibiotic resistance, or adhesion and 
colonisation may have homologues in non-pathogenic staphylococci and may 
have primary functions as survival factors. Although these survival factors may 
help S. aureus to cause disease in the sense that they allow the bacteria to 
survive and propagate sufficiently to seed the tissues where disease is caused, 
they may not be directly involved in the disease symptoms, themselves. Proteins 
such as SasG and its S. epidermidis homologue Aap, and Ebh and its S. 
epidermidis homologue Embp are often discussed in the context of virulence in 
S. aureus, however they all play roles during different stages of colonisation by 
interacting with the host (Roche, Meehan, et al. 2003; Christner et al. 2010). It is 
perhaps unsurprising, therefore, that such surface proteins which interact with 
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host molecules should be recruited into the virulence pathway in S. aureus 
(Roche, Massey, et al. 2003) (Cheng et al. 2014). Understanding the homologues 
of these virulence-associated proteins as survival factors in non-pathogenic 
species may enhance the understanding of their evolution and recruitment into 
pathogenesis of S. aureus.    
 
6.3 Clade groups of the Staphylococcus genus and phylogenetic 
relationships can be explored by orthologous genes  
A previous comparative genomic analysis of the genus Staphylococcus was 
carried out by Suzuki et al. In their study the phylogenetic relationships of the 
staphylococci were inferred from the presence of a group of 491 shared 
orthologues among 29 strains of 12 species of Staphylococcus. The phylogenetic 
relationships revealed S. pseudintermedius as the most basal lineage, with S. 
carnosus as the next most basal lineage. After these two species, the 10 other 
species included in their analysis were often isolated from human skin, 
therefore the study inferred from this that the evolution of human adaptation 
occurred after the branching of these 10 other species from S. carnosus (Suzuki 
et al. 2012). 
 
The same study also investigated whether the relationships of the 29 
staphylococcal strains revealed by the 491 shared orthologues were maintained 
when total gene content was investigated. In contrast to this study, and other 
studies of staphylococcal phylogeny (Takahashi et al. 1999; Lamers et al. 2012) 
the method employed by Suzuki et al revealed that the S. aureus strains 
clustered in one clade and the rest of the Staphylococcus species into another, 
and that S. simiae clustered with S. carnosus. Clustering of S. hominis and S. 
haemolyticus was not observed and S. saprophyticus clustered among the S. 
epidermidis group of species (Suzuki et al. 2012). 
 
The study presented here carried out a threefold analysis of: the total gene 
content of Staphylococcus species using orthologous clusters of genes; the 
groups of staphylococci that cluster together in the analysis of these 
orthologous clusters; and in turn the genes that drive the formation of these 
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clusters. In conjunction with the RandomForest algorithm this analysis revealed 
the possible genetic basis of the lifestyles of the groups of staphylococcal 
species. Groups of staphylococcal species have previously been proposed by 
multiple studies. Kloos et al originally proposed that staphylococcal species 
were divided into multiple species groups on the basis of DNA-DNA 
hybridisation methods (Kloos & Schleifer, 1991). These species groups, 
represented by S. epidermidis, S. saprophyticus, S. simulans, S. intermedius, S. 
hyicus, S. sciuri, S. aureus and S. caseolyticus were also identified by Takahashi et 
al on the basis of 16S rDNA sequence analysis, with the addition of an S. 
auricularis species group (Takahashi et al. 1999). S. caseolyticus has since been 
designated as a micrococcus and renamed Micrococcus caseolyticus, therefore 
only eight of the nine species groups represent Staphylococcus species. Lamers 
et al proposed a refinement of the S. epidermidis and S. aureus groups into one 
group, and the S. hyicus  and S. intermedius groups also into one group (Lamers 
et al. 2012). In the analysis here of orthologous groups of genes across the 
publically available genomes of staphylococci these species groups were also 
broadly conserved.  The clustering of species of the S. sciuri group, the S. 
simulans group, the S. intermedius group, the S. saprophyticus group, the S. 
epidermidis group, and the S. aureus included in the OrthoMCL analysis were 
conserved in this thesis (Figure 4.1, section 4.3.2). Of note, the S. epidermidis 
species group was the least well resolved in the 16S rDNA analysis and the 
comprising species were described as being “somewhat” closely related to one 
another (Takahashi et al. 1999). This species group is broken into smaller 
clusters which are reflected in the OrthoMCL analysis: S. lugdunensis clusters 
alone; S. hominis and S. haemolyticus cluster together; S. epidermidis and S. 
capitis cluster together. Furthermore, as Lamers et al propose the S. epidermidis-
aureus species group, (Lamers et al. 2012) here group A was separated into the 
S. epidermidis group and the S. aureus  group. The genetic basis of the two 
groups showed a high degree of overlap in the randomForest analysis.  
 
Although the phenotypic basis of these groups was explored by Kloos et al 
(Kersters & Vancanneyt 2005) the genetic basis driving them has not previously 
been explored. As the grouping and clustering patterns observed by Kloos & 
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Schleifer and Takahashi et al are maintained on the basis of orthologous gene 
content, a subsequent analysis which more thoroughly covers the genus 
Staphylococcus, coupled with use of algorithms, such as a randomForest analysis 
should be used to investigate the genetic drivers behind each of the groups.  
This interrogative strategy would help to explore further the lifestyles 
associated with the eight species groups. Additionally, the analysis by Takahashi 
et al included only 38 species of staphylococci, and the OrthoMCL analysis in 
this study included only 20 species (Takahashi et al. 1999). Therefore 
representation of the remaining species from the 51 Staphylococcus species that 
currently constitute the genus may result in additional species groups and 
clusters.  
 
6.4 The staphylococcal response to antimicrobial peptides 
 BraRS has a role in resistance to nisin and bacitracin in S. aureus, however it is 
not known if this role also extends to the other species that encode BraRS. SNPs 
were present in braS of S. aureus evolved in the presence of nisin, however this 
was not observed with the braRS-positive species S. hominis. Hiron et al showed 
that inactivation of both braRS and its ortholog graRS produced a similar 
increase in sensitivity to nisin, however the same gene mutants showed 
differential sensitivity to bacitracin, with the braRS mutant having a greater 
sensitivity to the latter than the graRS mutant (Hiron et al. 2011). Experimental 
evolution of both S. aureus and S. hominis in the presence of bacitracin and 
investigation of the resulting SNPs may reveal differential loci under selection in 
the presence of both antibiotics. Furthermore, inactivation of S. hominis braRS 
and graRS, and comparative analysis of the MICs of both mutants with 
bacitracin and nisin would reveal if the two TCSs respond comparatively in S. 
aureus and S. hominis. This strategy could be repeated for the transcription 
factor YurK and its adjacent ABC transporter in both S. hominis and S. aureus to 
assess their involvement in nisin and bacitracin resistance.  
 
Additional complexity of inter-relationships between regulons of genes is  
revealed by the genes under selection pressure during experimental evolution 
in the presence of nisin. The regulons of the TCSs GraRS and BraRS, as well as 
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GraRS and WalKR are known to overlap (Falord et al. 2011), and SNPs are 
present in these three TCSs and their regulons in evolved clones and clone 
pools. In addition to their overlapping regulons, it is possible that the TCSs 
BraRS and GraRS themselves are regulated differentially. The TCS Stk1/Stp1 is 
involved in the regulation of GraRS through phosphorylation of three conserved 
residues in the DNA binding domain of GraR. The regulons of Stk1/Stp1 and 
GraRS also overlap, for example transcriptomic analysis showed differential 
expression of the GraRS regulated genes VraFG and the agr operon in wild type 
and a Stk/Stp1 knockout mutant (Donat et al. 2009). Phosphorylation by Stk1 is 
vital to the regulation of D-alanylation of cell wall teichoic acids and substitution 
of the phosphorylation sites results in the same phenotype as a graR 
inactivation mutant. Additionally, despite conservation of two of the threonine 
residues, BceR of the BceRS TCS in Bacillus subtilis is not phosphorylated by 
Stk1 (Fridman et al. 2013).  BceRS is homologous to the BraRS TCS, therefore it 
may be possible that BraRS and GraRS are differentially regulated and therefore 
activate an overlapping regulon of genes through different mechanisms to 
ensure a breadth of responses to the diversity of antimicrobial peptides and 
antibiotics encountered by the staphylococci. This kinase/phosphatase is 
conserved in both the BraRS positive species from this analysis S. hominis 
J31and S. aureus 171 as well as the BraRS-negative species S. saprophyticus 883 
with an average of 63.7% protein sequence identity. Knockout mutants of 
Stk1/Stp1 in both S. hominis and S. saprophyticus would show if the regulation 
of GraRS by this signal transduction system is conserved across the 
staphylococci. Furthermore, the study by Fridman et al did not investigate 
phosphorylation of BraR by Stk1 in S. aureus (Fridman et al. 2013), investigation 
of this is necessary to explore if BraRS and GraRS are both phosphorylated by 
Stk1 and therefore under its regulation, thus adding an additional aspect of 
cross talk between TCSs.  
 
In conclusion, this study set out to identify the genetic toolbox at the disposal of 
major skin staphylococci, including a detailed investigation of the genetic 
complement of S. hominis. Although this was achieved through in-depth 
interrogation of the S. hominis genome and investigation of the shared genes of 
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skin colonising species of staphylococci, no inferences about how and where 
these genes are used can be made. In addition to the genomic data from skin-
colonising bacteria, greater detail is required about the specific skin locations 
and micro-niches they inhabit is required. Understanding of the fine 
architecture and topography of the skin surface could perhaps be obtained from 
microscopy of skin explants. Skin sampling techniques able to distinguish 
between the upper levels of the skin surface, and the creases and reliefs would 
give deeper insight into the structure of bacterial communities. Such analysis 
might enable propositions as to the likely environmental drivers of speciation. 
 
Remodelling of bacterial communities has been proposed as a method for 
restoring health where there is disease and to limit effects upon personal 
hygiene (Manichanh et al. 2010). In order to remodel a bacterial community it is 
essential to know:  
 
1. What species of bacteria constitute this community 
2. How these species interact with one another 
3. How these species interact with the host   
 
Until the ecology of the skin, and how it relates to the fine topography of the 
niche, is better understood through more sophisticated sampling techniques, 
remodelling of the skin microbiome will remain a challenge.  
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Supplementary information 
 
Table S1 Description of the coding sequences of the S. hominis complete phage CDS highlighted in bold 
represent BLAST hits to PHASTs non-redundant protein database, all other CDS represent BLAST hits to PHAST’s 
phage/prophage protein database.Column3 
CDS position BLAST hit S. hominis protein ID 
B10 intact phage 1   
83326..83338  attL    TTTATATCAAATC   
complement(83848..85
122)  
PHAGE_Bacill_G_NC_023719: gp344  B10-PB_00084 
complement(85067..86
452)  
PHAGE_Staphy_vB_SepiS_phiIPLA7_NC_018284: integrase  B10-PB_00085 
86531..86543  attL    TATGATATAATTT   
86575..87183  PHAGE_Staphy_phiSauS_IPLA35_NC_011612: hypothetical 
protein SauSIPLA35_gp02 
 B10-PB_00086 
complement(87180..
87353)  
hypothetical protein  B10-PB_00087  
complement(87417..
87764)  
hypothetical protein  B10-PB_00088  
complement(87818..88
429)  
PHAGE_Staphy_phi2958PVL_NC_011344: probable 
transcriptional repressor 
 B10-PB_00089 
88602..88829  PHAGE_Staphy_phi2958PVL_NC_011344: hypothetical protein 
phi2958PVL_gp07 
 B10-PB_00090 
88857..89654  PHAGE_Staphy_phiRS7_NC_022914: pathogenicity island 
protein 
 B10-PB_00091 
89658..90503  hypothetical protein  B10-PB_00092  
90742..90987  PHAGE_Staphy_YMC/09/04/R1988_NC_022758: hypothetical 
protein 
 B10-PB_00093 
complement(90956..91
321)  
PHAGE_Staphy_phi7401PVL_NC_020199: hypothetical protein  B10-PB_00094 
91374..91505  PHAGE_Staphy_StB27_NC_019914: hypothetical protein  B10-PB_00095 
91480..91665  PHAGE_Staphy_StB27_NC_019914: hypothetical protein  B10-PB_00096 
91744..92031  PHAGE_Staphy_vB_SepiS_phiIPLA7_NC_018284: hypothetical 
protein 
 B10-PB_00097 
92003..92230  PHAGE_Staphy_PH15_NC_008723: hypothetical protein ph45  B10-PB_00098 
92220..92885  PHAGE_Staphy_vB_SepiS_phiIPLA7_NC_018284: erf 
superfamily protein 
 B10-PB_00099 
92899..93312  PHAGE_Staphy_vB_SepiS_phiIPLA7_NC_018284: single 
stranded DNA binding protein 
 B10-PB_00100 
93327..93998  PHAGE_Staphy_vB_SepiS_phiIPLA7_NC_018284: hypothetical 
protein 
 B10-PB_00101 
93995..94732  PHAGE_Staphy_phiRS7_NC_022914: DnaD and phage-
associated domain protein 
 B10-PB_00102 
94729..95088  PHAGE_Staphy_vB_SepiS_phiIPLA7_NC_018284: hypothetical 
protein 
 B10-PB_00103 
95081..96316  PHAGE_Staphy_vB_SepiS_phiIPLA7_NC_018284: DNA helicase  B10-PB_00104 
96313..96537  PHAGE_Staphy_vB_SepiS_phiIPLA7_NC_018284: hypothetical 
protein 
 B10-PB_00105 
96512..96754  PHAGE_Staphy_vB_SepiS_phiIPLA7_NC_018284: hypothetical 
protein 
 B10-PB_00106 
96765..97193  PHAGE_Staphy_P954_NC_013195: DNA methyltransferase  B10-PB_00107 
97190..97606  PHAGE_Staphy_CNPH82_NC_008722: hypothetical protein 
cn50 
 B10-PB_00108 
 237 
97593..97967  PHAGE_Staphy_vB_SepS_SEP9_NC_023582: hypothetical 
protein 
 B10-PB_00109 
97967..98326  hypothetical protein  B10-PB_00110  
98326..98499  hypothetical protein  B10-PB_00111  
98504..98707  hypothetical protein  B10-PB_00112  
98704..99156  PHAGE_Staphy_vB_SepiS_phiIPLA7_NC_018284: hypothetical 
protein 
 B10-PB_00113 
99159..99875  PHAGE_Staphy_vB_SepiS_phiIPLA7_NC_018284: endonuclease  B10-PB_00114 
99872..100057  PHAGE_Staphy_CNPH82_NC_008722: hypothetical protein 
cn56 
 B10-PB_00115 
100054..100473  PHAGE_Staphy_37_NC_007055: ORF027  B10-PB_00116 
100474..100818  PHAGE_Staphy_vB_SepiS_phiIPLA5_NC_018281: nuclease  B10-PB_00117 
100821..101129  hypothetical protein  B10-PB_00118  
101130..101480  PHAGE_Staphy_vB_SepiS_phiIPLA7_NC_018284: DNA binding 
protein 
 B10-PB_00119 
101529..101807  PHAGE_Staphy_StB27_NC_019914: hypothetical protein  B10-PB_00120 
101800..101982  PHAGE_Staphy_StauST398_1_NC_021326: integrase regulator  B10-PB_00121 
101982..102404  hypothetical protein  B10-PB_00122  
102409..102633  hypothetical protein  B10-PB_00123  
102637..102825  PHAGE_Staphy_2638A_NC_007051: ORF083  B10-PB_00124 
102879..103166  hypothetical protein  B10-PB_00125  
103193..103414  PHAGE_Bacill_phi105_NC_004167: immunity repressor  B10-PB_00126 
103428..103886  PHAGE_Staphy_2638A_NC_007051: ORF020  B10-PB_00127 
103987..104712  PHAGE_Lister_B025_NC_009812: gp65  B10-PB_00128 
104856..105239  PHAGE_Staphy_phiBU01_NC_026016: N/A  B10-PB_00129 
105226..106893  PHAGE_Lister_LP_101_NC_024387: terminase large subunit  B10-PB_00130 
106913..108091  PHAGE_Lister_LP_101_NC_024387: portal protein  B10-PB_00131 
108054..108767  PHAGE_Staphy_2638A_NC_007051: ORF013  B10-PB_00132 
108779..109987  PHAGE_Lister_LP_101_NC_024387: major capsid protein  B10-PB_00133 
110005..110292  PHAGE_Lister_LP_101_NC_024387: hypothetical protein 
LP101_007 
 B10-PB_00134 
110276..110644  PHAGE_Staphy_StB20_NC_019915: phage head-tail joining 
protein 
 B10-PB_00135 
110634..111023  PHAGE_Staphy_phiSa119_NC_025460: N/A  B10-PB_00136 
111023..111439  PHAGE_Staphy_phiBU01_NC_026016: N/A  B10-PB_00137 
111452..112075  PHAGE_Staphy_StB20_NC_019915: major tail protein  B10-PB_00138 
112096..112275  PHAGE_Staphy_vB_SepiS_phiIPLA7_NC_018284: rho 
termination protein 
 B10-PB_00139 
112343..112714  PHAGE_Staphy_StB20_NC_019915: hypothetical protein  B10-PB_00140 
112934..118216  PHAGE_Staphy_phi13_NC_004617: tail length tape measure 
protein 
 B10-PB_00141 
118220..119065  PHAGE_Staphy_StauST398_2_NC_021323: phage tail tape 
measure protein-like protein 
 B10-PB_00142 
119078..120844  PHAGE_Staphy_phiSauS_IPLA88_NC_011614: putative tail 
fiber protein 
 B10-PB_00143 
120896..122866  PHAGE_Staphy_vB_SepiS_phiIPLA5_NC_018281: virion 
associated hydrolase 
 B10-PB_00144 
122871..123143  hypothetical protein  B10-PB_00145  
123200..123691  PHAGE_Staphy_StB27_NC_019914: holin  B10-PB_00146 
123741..124040  PHAGE_Entero_BC_611_NC_018086: Holin  B10-PB_00147 
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124040..125749  PHAGE_Staphy_vB_SepiS_phiIPLA5_NC_018281: amidase  B10-PB_00148 
128713..128725  attR    TATGATATAATTT   
131512..131524  attR    TTTATATCAAATC   
   
C80 intact phage 3   
512225..512236  attL    TTTGTTTAATTT  0 
516695..517276  PHAGE_Uganda_virus_NC_014791: polyprotein  C80-PB_00520 
517276..517797  hypothetical protein  C80-PB_00521  
518020..518094  tRNA   
complement(518225..5
18608)  
PHAGE_Staphy_phiBU01_NC_026016: N/A  C80-PB_00523 
complement(518568..5
19128)  
PHAGE_Staphy_phiBU01_NC_026016: N/A  C80-PB_00524 
complement(519304..5
19975)  
PHAGE_Staphy_CNPH82_NC_008722: hypothetical protein 
cn33 
 C80-PB_00525 
complement(520025..5
20576)  
PHAGE_Lactob_prophage_Lj965_NC_005355: putative 
superinfection immunity protein 
 C80-PB_00526 
complement(520827..5
21819)  
PHAGE_Bacill_SPBc2_NC_001884: putative DNase/RNase 
endonuclease 
 C80-PB_00527 
536746..536757  attR    TTTGTTTAATTT   
I4 Intact phage 4 
2201825..2201849  attL    TTATTCCAATTGCTTTATTGACGTT   
complement(2203767..
2204735)  
PHAGE_Strept_pyogenes_315_1_NC_004584: hypothetical 
protein SpyM3_0691  I4-PB_02212 
2205205..2205897  PHAGE_Choris_'L'_NC_021248: N1R/p28-like protein  I4-PB_02213 
complement(2206302..
2207495)  
PHAGE_Amsact_moorei_entomopoxvirus__L__NC_002520: 
hypothetical protein AMV156  I4-PB_02214 
complement(2207480..
2210383)  
PHAGE_Mythim_'L'_NC_021246: unknown similar to 
AMEV156 I4-PB_02215 
complement(2210391..
2211293)  
PHAGE_Bacill_vB_BanS_Tsamsa_NC_023007: hypothetical 
protein  I4-PB_02216 
complement(221136
1..2211531)  Lantibiotic Pep5 precursor I4-PB_02217  
complement(221158
9..2211777)  hypothetical protein  I4-PB_02218 
complement(2211852..
2212595)  
PHAGE_Tricho_ni_ascovirus_2c_NC_008518: hypothetical 
protein TNAV2c_gp071  I4-PB_02219 
2213687..2214382  
PHAGE_Anomal_entomopoxvirus_NC_023426: putative ATP-
binding cassette transporter  I4-PB_02220 
2214384..2214593  ABC-2 family transporter protein  I4-PB_02221 
2214554..2215084  
ABC-type transport system involved in multi-copper 
enzyme maturation, permease component   I4-PB_02222 
complement(2215657..
2215785)  Putative transposon Tn552 DNA-invertase bin3   I4-PB_02223 
complement(2215796..
2216077)  PHAGE_Entero_phi80_NC_021190: N/A  I4-PB_02224 
2216718..2219357  PHAGE_Megavi_lba_NC_020232: hypothetical protein   I4-PB_02225 
2219381..2220325  Glycine betaine-binding protein precursor   I4-PB_02226 
2220674..2221243  putative dihydroxyacetone kinase regulator  I4-PB_02227 
complement(222232
9..2222745)  Glyoxalase-like domain protein  I4-PB_02228 
complement(222285
2..2223352)  MepB protein   I4-PB_02229 
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complement(222347
9..2223622)  hypothetical protein  I4-PB_02230 
complement(2223723..
2224259)  PHAGE_Bacill_Waukesha92_NC_025424: N/A I4-PB_02231 
2224616..2224807  hypothetical protein I4-PB_02232  
complement(222516
7..2225889)  ABC-2 family transporter protein I4-PB_02233 
complement(2225905..
2226540)  PHAGE_Bacill_G_NC_023719: gp245  I4-PB_02234 
2226688..2226954  hypothetical protein I4-PB_02235  
complement(222721
2..2227490)  hypothetical protein I4-PB_02236  
complement(222749
7..2228234)  hypothetical protein  I4-PB_02237 
complement(222823
1..2228983)  hypothetical protein  I4-PB_02238  
complement(2228984..
2229892)  
PHAGE_Anomal_entomopoxvirus_NC_023426: putative ATP-
binding cassette transporter I4-PB_02239 
2230368..2230691  
PHAGE_Acinet_Acj61_NC_014661: putative quaternary 
ammonium compound-resistance protein qacE I4-PB_02240 
complement(223128
7..2231472)  hypothetical protein   I4-PB_02241  
complement(223146
9..2232314)  Replication protein I4-PB_02242  
2234074..2234910  Divergent AAA domain protein  I4-PB_02243 
2234918..2234942  attR    TTATTCCAATTGCTTTATTGACGTT   
2235017..2235493  Firmicute plasmid replication protein (RepL)  I4-PB_02244 
2236765..2237292  
PHAGE_Entero_phiX174_sensu_lato_NC_001422: major spike 
protein  I4-PB_02245 
2237301..2238287  
PHAGE_Entero_phiX174_sensu_lato_NC_001422: minor spike 
protein  I4-PB_02246 
2238351..2239892  
PHAGE_Entero_phiX174_sensu_lato_NC_001422: DNA 
replication initiation protein gpA   I4-PB_02247 
2240006..2240149  PHAGE_Entero_phiX174_sensu_lato_NC_001422: C  I4-PB_02248 
2240146..2240604  
PHAGE_Entero_phiX174_sensu_lato_NC_001422: external 
scaffolding protein   I4-PB_02249 
2240604..2240720  
PHAGE_Entero_phiX174_sensu_lato_NC_001422: DNA 
packaging protein   I4-PB_02250 
2240757..2242040  
PHAGE_Entero_phiX174_sensu_lato_NC_001422: capsid 
protein   I4-PB_02251 
ZBW5 intact phage 1  
502486..503067  PHAGE_Cassav_brown_streak_virus_NC_012698: polyprotein  ZBW5-PB_00512 
503067..503579  hypothetical protein  ZBW5-PB_00513  
503803..503877  tRNA   
503862..503882  attL    ATCCCTCCCAGGACGCTAATA   
complement(504008..5
05033)  
PHAGE_Staphy_JS01_NC_021773: integrase  ZBW5-PB_00515 
complement(505091..5
05732)  
PHAGE_Deep_s_D6E_NC_019544: structure protein  ZBW5-PB_00516 
complement(505832..5
06293)  
PHAGE_Staphy_StB27_NC_019914: hypothetical protein  ZBW5-PB_00517 
complement(506306..5
06632)  
PHAGE_Lactob_Sha1_NC_019489: bifunctional S24 family 
peptidase/transcriptional regulator 
 ZBW5-PB_00518 
506853..507050  PHAGE_Lactoc_bIL286_NC_002667: repressor  ZBW5-PB_00519 
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507095..507697  hypothetical protein  ZBW5-PB_00520  
507660..507974  PHAGE_Staphy_69_NC_007048: ORF045  ZBW5-PB_00521 
507979..508167  PHAGE_Staphy_StB27_NC_019914: hypothetical protein  ZBW5-PB_00522 
508230..508997  hypothetical protein  ZBW5-PB_00523  
508999..509280  hypothetical protein  ZBW5-PB_00524  
509240..509464  PHAGE_Staphy_StB20_NC_019915: hypothetical protein  ZBW5-PB_00525 
509457..510119  PHAGE_Staphy_vB_SepiS_phiIPLA7_NC_018284: erf 
superfamily protein 
 ZBW5-PB_00526 
510130..510552  PHAGE_Staphy_vB_SepiS_phiIPLA7_NC_018284: single 
stranded DNA binding protein 
 ZBW5-PB_00527 
510736..511404  PHAGE_Staphy_X2_NC_007065: ORF017  ZBW5-PB_00528 
511404..512102  PHAGE_Staphy_CNPH82_NC_008722: putative DNA 
replication protein 
 ZBW5-PB_00529 
512108..512464  PHAGE_Staphy_vB_SepiS_phiIPLA5_NC_018281: hypothetical 
protein 
 ZBW5-PB_00530 
512451..513698  PHAGE_Staphy_CNPH82_NC_008722: putative DNA helicase  ZBW5-PB_00531 
513698..513919  PHAGE_Staphy_StB20_NC_019915: hypothetical protein  ZBW5-PB_00532 
513897..514142  PHAGE_Staphy_StB20_NC_019915: hypothetical protein  ZBW5-PB_00533 
514153..514581  PHAGE_Staphy_P954_NC_013195: DNA methyltransferase  ZBW5-PB_00534 
514578..514997  PHAGE_Staphy_CNPH82_NC_008722: hypothetical protein 
cn50 
 ZBW5-PB_00535 
514984..515358  PHAGE_Staphy_6ec_NC_024355: hypothetical protein 
PHAGE6E_115 
 ZBW5-PB_00536 
515358..515531  hypothetical protein  ZBW5-PB_00537  
515536..515739  hypothetical protein  ZBW5-PB_00538  
515736..516200  PHAGE_Staphy_EW_NC_007056: ORF046  ZBW5-PB_00539 
516364..516384  attR    ATCCCTCCCAGGACGCTAATA   
complement(516461..5
17216)  
PHAGE_Staphy_2638A_NC_007051: ORF015  ZBW5-PB_00540 
   
ZBW5 intact phage 5  
2253755..2253766  attL    ATTATCTTTATC   
2258306..2260987  PHAGE_Megavi_lba_NC_020232: hypothetical protein  ZBW5-PB_02267 
2261011..2261955  Glycine betaine-binding protein precursor  ZBW5-PB_02268  
2262305..2262598  putative dihydroxyacetone kinase regulator  ZBW5-PB_02269  
2262652..2262864  hypothetical protein  ZBW5-PB_02270  
2263280..2264452  PROPHAGE_Escher_CFT073: transposase  ZBW5-PB_02271 
2264883..2266091  Putative surface protein precursor  ZBW5-PB_02272  
2266045..2266725  PHAGE_Staphy_CNPH82_NC_008722: conserved phage 
protein 
 ZBW5-PB_02273 
2266722..2266907  PHAGE_Staphy_CNPH82_NC_008722: hypothetical protein 
cn56 
 ZBW5-PB_02274 
2266904..2267251  PHAGE_Staphy_CNPH82_NC_008722: putative nuclease 
protein 
 ZBW5-PB_02275 
2267254..2267562  PHAGE_Staphy_S25_3_NC_022920: hypothetical protein  ZBW5-PB_02276 
2267549..2267740  hypothetical protein  ZBW5-PB_02277  
2267741..2268259  PHAGE_Staphy_StauST398_3_NC_021332: hypothetical 
protein 
 ZBW5-PB_02278 
2268318..2268737  hypothetical protein  ZBW5-PB_02279  
2268753..2269034  PHAGE_Staphy_PH15_NC_008723: hypothetical protein ph64  ZBW5-PB_02280 
 241 
2269024..2269200  Transcriptional activator RinB  ZBW5-PB_02281  
2269200..2269622  hypothetical protein  ZBW5-PB_02282  
2269627..2269851  hypothetical protein  ZBW5-PB_02283  
2269855..2270043  PHAGE_Staphy_2638A_NC_007051: ORF083  ZBW5-PB_02284 
2270057..2270455  PHAGE_Staphy_phiRS7_NC_022914: hypothetical protein  ZBW5-PB_02285 
2270594..2270920  PHAGE_Staphy_2638A_NC_007051: ORF026  ZBW5-PB_02286 
2271074..2271433  PHAGE_Staphy_2638A_NC_007051: ORF031  ZBW5-PB_02287 
2271430..2273091  PHAGE_Staphy_2638A_NC_007051: ORF005  ZBW5-PB_02288 
2273111..2274256  PHAGE_Staphy_P954_NC_013195: HK97 family phage portal 
protein 
 ZBW5-PB_02289 
2274249..2275112  PHAGE_Staphy_2638A_NC_007051: ORF013  ZBW5-PB_02290 
2275174..2276352  PHAGE_Lister_LP_101_NC_024387: major capsid protein  ZBW5-PB_02291 
2276370..2276666  PHAGE_Staphy_2638A_NC_007051: ORF036  ZBW5-PB_02292 
2276656..2277027  PHAGE_Staphy_phiBU01_NC_026016: N/A  ZBW5-PB_02293 
2277017..2277439  PHAGE_Staphy_2638A_NC_007051: ORF023  ZBW5-PB_02294 
2277436..2277843  PHAGE_Staphy_2638A_NC_007051: ORF024  ZBW5-PB_02295 
2277844..2278458  PHAGE_Staphy_P954_NC_013195: phage tail superfamily  ZBW5-PB_02296 
2278472..2278639  PHAGE_Staphy_2638A_NC_007051: ORF096  ZBW5-PB_02297 
2278703..2279065  PHAGE_Staphy_2638A_NC_007051: ORF028  ZBW5-PB_02298 
2279329..2285580  PHAGE_Staphy_phiRS7_NC_022914: tail length tape measure 
protein 
 ZBW5-PB_02299 
2285581..2287071  PHAGE_Staphy_phiBU01_NC_026016: N/A  ZBW5-PB_02300 
2287087..2292195  PHAGE_Staphy_phi5967PVL_NC_019921: phage minor 
structural protein 
 ZBW5-PB_02301 
2292173..2292328  PHAGE_Staphy_phiSa119_NC_025460: N/A  ZBW5-PB_02302 
2292372..2292671  PHAGE_Staphy_StauST398_4_NC_023499: hypothetical 
protein 
 ZBW5-PB_02303 
2292682..2292978  PHAGE_Staphy_vB_SepiS_phiIPLA7_NC_018284: hypothetical 
protein 
 ZBW5-PB_02304 
2293403..2294260  hypothetical protein  ZBW5-PB_02305  
complement(2294401..
2294805)  
PHAGE_Staphy_phiETA_NC_003288: hypothetical protein 
phiETA_02 
 ZBW5-PB_02306 
complement(2294808..
2295209)  
PHAGE_Staphy_42E_NC_007052: ORF031  ZBW5-PB_02307 
complement(2295407..
2297143)  
PHAGE_Staphy_StB27_NC_019914: lysine  ZBW5-PB_02308 
complement(2297156..
2297443)  
PHAGE_Staphy_StB27_NC_019914: holin  ZBW5-PB_02309 
complement(229761
6..2299055)  
Bifunctional AAC/APH  ZBW5-PB_02310  
complement(2299056..
2299460)  
PHAGE_Erwini_phiEaH2_NC_019929: N-acetyltransferase 
GCN5 
 ZBW5-PB_02311 
complement(2299597..
2299740)  
PHAGE_Staphy_StB27_NC_019914: hypothetical protein  ZBW5-PB_02312 
complement(2299733..
2300077)  
PHAGE_Staphy_StB27_NC_019914: hypothetical protein  ZBW5-PB_02313 
complement(2300091..
2301137)  
PHAGE_Staphy_StB27_NC_019914: tail protein  ZBW5-PB_02314 
complement(2301190..
2303127)  
PHAGE_Staphy_StB27_NC_019914: peptidoglycan hydrolase  ZBW5-PB_02315 
complement(2303177..
2303668)  
PHAGE_Staphy_StB27_NC_019914: holin  ZBW5-PB_02316 
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complement(2303690..
2304886)  
PHAGE_Staphy_StB27_NC_019914: tail protein  ZBW5-PB_02317 
complement(2304899..
2306773)  
PHAGE_Staphy_StB27_NC_019914: Zn carboxypeptidase  ZBW5-PB_02318 
complement(2306784..
2308034)  
PHAGE_Staphy_StB27_NC_019914: endopeptidase  ZBW5-PB_02319 
complement(2308044..
2309000)  
PHAGE_Staphy_StB27_NC_019914: tail protein  ZBW5-PB_02320 
complement(2309013..
2312405)  
PHAGE_Staphy_StB27_NC_019914: tail tape measure protein  ZBW5-PB_02321 
complement(2312405..
2312770)  
PHAGE_Staphy_StB27_NC_019914: hypothetical protein  ZBW5-PB_02322 
complement(2312800..
2313171)  
PHAGE_Staphy_StB27_NC_019914: tail assembly protein  ZBW5-PB_02323 
complement(2313240..
2313833)  
PHAGE_Staphy_StB27_NC_019914: major tail protein  ZBW5-PB_02324 
complement(2313848..
2314243)  
PHAGE_Staphy_StB27_NC_019914: head structural protein  ZBW5-PB_02325 
complement(2314254..
2314604)  
PHAGE_Staphy_StB27_NC_019914: hypothetical protein  ZBW5-PB_02326 
complement(2314594..
2314908)  
PHAGE_Staphy_StB27_NC_019914: minor head protein  ZBW5-PB_02327 
complement(2314905..
2315240)  
PHAGE_Staphy_StB27_NC_019914: DNA packaging minor 
head protein 
 ZBW5-PB_02328 
complement(2315268..
2316179)  
PHAGE_Staphy_StB27_NC_019914: major head protein  ZBW5-PB_02329 
complement(2316195..
2316785)  
PHAGE_Staphy_StB27_NC_019914: scaffold protein  ZBW5-PB_02330 
complement(231689
4..2317043)  
hypothetical protein  ZBW5-PB_02331  
complement(2317036..
2318073)  
PHAGE_Staphy_StB27_NC_019914: minor head protein  ZBW5-PB_02332 
complement(2318057..
2319508)  
PHAGE_Staphy_StB27_NC_019914: portal protein  ZBW5-PB_02333 
complement(2319509..
2320795)  
PHAGE_Staphy_StB27_NC_019914: TerL  ZBW5-PB_02334 
complement(2320788..
2321240)  
PHAGE_Staphy_StB27_NC_019914: TerS  ZBW5-PB_02335 
complement(2321438..
2321854)  
PHAGE_Staphy_vB_SepiS_phiIPLA5_NC_018281: RinA  ZBW5-PB_02336 
complement(2321928..
2322374)  
PHAGE_Staphy_StB27_NC_019914: hypothetical protein  ZBW5-PB_02337 
2322138..2322149  attR    ATTATCTTTATC   
complement(2322371..
2322538)  
PHAGE_Staphy_StB27_NC_019914: RinB  ZBW5-PB_02338 
complement(2322531..
2322809)  
PHAGE_Staphy_StB27_NC_019914: hypothetical protein  ZBW5-PB_02339 
complement(232282
3..2322987)  
hypothetical protein  ZBW5-PB_02340  
complement(232300
7..2323321)  
hypothetical protein  ZBW5-PB_02341  
complement(2323410..
2323961)  
PHAGE_Staphy_vB_SepiS_phiIPLA5_NC_018281: dUTPase  ZBW5-PB_02342 
complement(232396
2..2324138)  
hypothetical protein  ZBW5-PB_02343  
complement(232413
1..2324418)  
hypothetical protein  ZBW5-PB_02344  
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complement(2324422..
2324766)  
PHAGE_Staphy_vB_SepiS_phiIPLA5_NC_018281: nuclease  ZBW5-PB_02345 
complement(2324767..
2325186)  
PHAGE_Staphy_37_NC_007055: ORF027  ZBW5-PB_02346 
complement(2325183..
2325368)  
PHAGE_Staphy_vB_SepiS_phiIPLA5_NC_018281: hypothetical 
protein 
 ZBW5-PB_02347 
complement(2325365..
2326045)  
PHAGE_Staphy_CNPH82_NC_008722: conserved phage 
protein 
 ZBW5-PB_02348 
complement(232611
3..2326517)  
Replication protein  ZBW5-PB_02349  
complement(2326762..
2328024)  
PHAGE_Pieris_rapae_granulovirus_NC_013797: desmoplakin  ZBW5-PB_02350 
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Figure S.1 Heat map representation of the presence of clustered orthologous 
proteins across the staphylococci. Swapping the S. hominis strains J6 for J11 revealed 
no difference in the groups of staphylococci discussed in Chapter 4. A high number of 
shared clusters of orthologous proteins is indicated by red colouration, few shared 
clusters is indicated by white.  
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Figure S.2 Heat map representation of the presence of clustered orthologous 
proteins across the staphylococci. Swapping the S. aureus strain newman  for 
USA300 revealed no difference in the groups of staphylococci discussed in Chapter 4. A 
high number of shared clusters of orthologous proteins is indicated by red colouration, 
few shared clusters is indicated by white.  
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Figure S.3 Heat map representation of the presence of clustered orthologous 
proteins across the staphylococci. Swapping the S. epidermidis strain ATCC12228  for 
RP62A revealed no difference in the groups of staphylococci discussed in Chapter 4. A 
high number of shared clusters of orthologous proteins is indicated by red colouration, 
few shared clusters is indicated by white.  
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Figure S.4 Heat map representation of the presence of clustered orthologous 
proteins across the staphylococci. Swapping the S. saprophyticus strain strain ATCC 
15305 for CCM883 revealed no difference in the groups of staphylococci discussed in 
Chapter 4. A high number of shared clusters of orthologous proteins is indicated by red 
colouration, few shared clusters is indicated by white.  
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Figure S.5 Heat map representation of the presence of clustered orthologous 
proteins across the staphylococci. Swapping the S. pseudintermedius  strain strain 
NCTC_11048 for ED99 revealed no difference in the groups of staphylococci discussed 
in Chapter 4. A high number of shared clusters of orthologous proteins is indicated by 
red colouration, few shared clusters is indicated by white.  
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Table S.2 A description, usage instructions and input files required for all bespoke scripts used in this thesis. Scripts are provided on the memory stick 
accompanying this thesis 
Thesis 
section  
Author  Description Usage 
3.2.1, 3.2.7, 
4.2.2 
Thomas Craig Table_alt_cluster_singleton.py Converts the clusters from an 
OrthoMCL output file into a table of 
the presence (1) and absence (0) of 
these clusters in each genome used 
in the analysis 
Python Table_alt_cluster_singleton.py 
concatenated_proteins.faa 
orthomcl_output.out 
 
Input files: 
 Concatenated fasta file of all 
proteins used in the OrthoMCL 
analysis 
 OrthoMCL output files 
 
Output files 
 Presence (1)/Absence (0) table 
3.2.1 Ben Wareham core_pan_plot In conjunction with wrapper, once 
loaded into R the script calculates 
the core and pan-genome sizes for x 
number of strain combinations 
increasing from 1 to x 
Wrapper(data,x) > table.csv 
 
Input files 
 Tab-delimited output from the 
script 
Table_alt_cluster_singleton.py  
 
Output files 
 Comma sepatated file with 3 
columns for the combinations of 
strains up to x. 
Col1=Strains IDs 
Col2=Size of core genome 
Col3=Size of pan genome 
3.2.1 Ben Wareham New_genes_added In conjunction with wrapper, once 
loaded into R the script calculates 
the new genes added for x number 
of strain combinations increasing 
from 1 to x 
Wrapper(data,x) > table.csv 
 
Input files 
 Tab-delimited output from the 
script 
Table_alt_cluster_singleton.py  
 
Output files 
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 Comma sepatated file with 2 
columns for the combinations of 
strains up to x. 
Col1=Strains IDs 
Col2=Number of new genes added 
3.2.2 Jennifer Kelly extract_COGID Adds COG annotation to OrthoMCL 
clusters if all annotations in a cluster 
are the same 
Perl extract_COGID.pl orthomcl_output.out 
CODID_list.txt > COG_annotated_clusters.txt 
 
Input files 
 OrthoMCL output file 
 COGID list: tab delimited file of all 
proteins used in the OrthoMCL 
analysis and their COGID 
annotated by WebMGA 
(http://weizhong-
lab.ucsd.edu/metagenomic-
analysis/) 
 
Output files 
  
3.2.4 Rosanna Coates-
Brown 
LPXTG_capture.pl Searches the input genome for the 
extended LPXTG motig and writes 
the corresponding protein to a multi 
fasta file 
Perl LPXTG_capture.pl query_genome.fasta 
> output.fasta 
 
Input files 
 Target genome in fasta format 
 
Output files 
 Multi fasta file of LPXTG protein 
sequences  
5.2.4 Rosanna Coates-
Brown 
SNP_analysis.sh Aligns reads from experimentally 
evolved strains to wild type 
reference strains using BWA, 
converts resulting SAM files to BAM 
files, uses these BAM files for SNP 
calling with bcftools and quality 
filters these SNPs  
bash SNP_analysis.sh 
<reference_genome.fasta> <read_1.fastq> 
<read_2.fastq> <output_prefix> 
 
Input files 
 The reference genome the reads 
will be aligned to 
 The forward and reverse 
sequencing reads in separate fastq 
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files 
 A prefix for the output files 
Output files 
 Prefix_R[1/2].sai file containing 
coordiates of aligned reads 
 Sam file of reads mapped to the 
reference genome- 
prefix_mappedfile.sam 
 Bam file of above 
 Sorted bam file of above 
 Sam file of the headers from 
sorted bam file above 
 Bam file of above with duplicate 
mapped reads removed 
 Bcf file of above 
 Vcf file of SNPs called using bcf 
tools 
 Quality filtered vcf file produced 
using vcfutils.pl 
 
   
5.2.4 Rosanna Coates-
Brown 
Significant_SNPs.sh Calls the scripts 
heterozygote_allele_percentages_bas
ic.pl and snp_final_parse.pl 
 
Filters the output from 
SNP_analysis.sh to find the 
percentage of alternative base calls 
and include only alternative base 
calls in >33.33% of reads 
Bash Significant_SNPs.sh 
<mpileup_nobaseinfo.bcf> <qualfiltered.vcf> 
<prefix_for_output> 
 
Input files 
 Output file from SNP_analysis.sh 
 
Output files 
 Text file of filtered snps 
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